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Abstract 
 
 In this study the chromosomal arsenic resistance (ars) genes shown to be present in all 
Acidithiobacillus. caldus isolates were cloned and sequenced from At. caldus #6.  Ten 
open reading frames (ORFs) were identified on a clone conferring arsenic resistance, 
with three homologs to arsenic genes, arsC (arsenate reductase), arsR (regulator) and 
arsB (arsenite export).  This ars operon is divergent, with the arsRC and arsB genes 
transcribed in opposite directions.  Analysis of the putative amino acid sequences of these 
arsRC and arsB  genes revealed that they are the most closely related to the ars genes of 
Acidithiobacillus ferrooxidans.  
 
These ars genes were functional when transformed into an Escherichia coli ars deletion 
mutant ACSH50Iq, and conferred increased levels of resistance to arsenate and arsenite.  
ArsC was required for resistance to arsenate, but not for resistance to arsenite.  None of 
the other ORFs enhanced arsenic resistance in E. coli.  A transposon located arsenic 
resistance system (TnAtcArs) has been described for highly arsenic resistant strains of the 
moderately thermophilic, sulfur-oxidizing, biomining bacterium At .caldus #6. In the 
latter study it was shown that TnAtcArs confers higher levels of resistance to arsenate 
and arsenite than the chromosomal operon.  TnAtcArs was conjugated into a weakly ars 
resistant At. caldus strain (C-SH12) and resulted in greatly increased arsenite resistance.  
RT-PCR analysis revealed that arsR and arsC are co-transcribed.  Despite ORF1 
(cadmium inducible-like protein) and ORF5 (putative integrase for prophage CP-933R) 
not being involved in resistance to arsenic, ORF1 was co-transcribed with arsRC and 
ORF5 with arsB.  Using arsR-lacZ and arsB-lacZ fusions it was shown that the 
chromosomal ArsR-like regulator of At. caldus acts as a repressor of the arsR and arsB 
promoter expression.  Induction of gene expression took place when either arsenate or 
arsenite was added.  The chromosomal located ArsR was also able to repress TnAtcArs, 
but the transposon-located ArsR was unable to regulate the chromosomal system.   
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Opsomming 
 
In hierdie studie is die chromosomale arseen weerstandbiedendheidsgene (ars gene), 
teenwoordig in alle Acidithiobacillus caldus isolate, gekloon en die DNA volgorde 
daarvan vanaf At. caldus #6 bepaal.  Tien oopleesrame (ORFs) is geïdentifiseer op ‘n 
kloon wat arseen weerstandbiedend is, met drie homoloog aan ars gene, nl. arsC 
(arsenaat reduktase), arsR (reguleerder) en arsB (membraan-geleë pomp wat arseniet 
uitpomp).  Die ars operon is gerangskik met die arsRC en arsB gene wat in 
teenoorgestelde rigtings getranskribeer word.  Analise van die afgeleide 
aminosuurvolgorde van dié ars gene het getoon hulle is naverwant aan die ars gene van 
Acidithiobacillus ferrooxidans.  
 
Die ars gene was funksioneel na transformasie na ‘n E. coli ars mutant (ACSH50Iq), en 
het ‘n hoër vlak van weerstand teen arsenaat en arseniet gebied.  ArsC was nodig vir 
weerstand teen arsenaat, maar nie vir weerstand teen arseniet nie.  Geen van die ander 
ORFs het arseen weerstandbiedendheid in E. coli bevorder nie.  Voorheen is ‘n ars 
operon, geleë op ‘n transposon (TnAtcArs), in ‘n hoogs arseen-weerstandbiedende stam 
van die middelmatige termofiliese, swawel-oksiderende, bio-ontgunning (“biomining”) 
bakterie Acidithiobacillus caldus #6 beskryf.  In laasgenoemde studie is gevind dat 
TnAtcArs hoër vlakke van weerstand bied teen arsenaat en arseniet as die chromosomale 
operon.  TnAtcArs is na ‘n lae arseen-weerstandbiedende At. caldus stam (C-SH12) 
gekonjugeer.  Die resultaat was ‘n groot verhoging in arseen weerstandbiedendheid.  RT-
PCR analise het onthul dat arsR en arsC saam getranskribeer word.  Benewens die feit 
dat ORF1 (kadmium induseerbare protein) en ORF5 (afgeleide integrase vir profaag CP-
933R) nie betrokke is in weerstand teen arseniet and arsenaat nie, is ORF1 saam met 
arsRC getranskribeer en ORF5 saam met arsB.  Deur gebruik te maak van die fusie-gene 
arsR-lacZ en arsB-lacZ is bewys dat die chromosomale ArsR reguleerder van At. caldus 
as ‘n inhibeerder van die arsR en arsB promoter uitdrukking funksioneer.  Indusering van 
geen uitdrukking vind plaas wanneer arseniet of arsenaat bygevoeg word.  Die 
chromosomaal-geleë ArsR is ook in staat om TnAtcArs te inhibeer, terwyl die transposon 
geleë ArsR nie daartoe in staat is om die chromosomale ars sisteem te reguleer nie.  
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1.1. Acidithiobacillus caldus and its role in biomining 
 
Acidithiobacillus caldus is a moderately thermophilic acidophile with optimum growth at 
pH 2.5 and a temperature of 45 oC.  It can grow in a temperature range of 32 oC to 52 oC, 
and a pH range of 1.0 - 4.6.  Cells are short rods, motile, Gram-negative and are capable 
of chemolithoautotrophic growth by the oxidation of reduced inorganic sulfur 
compounds.  At. caldus is incapable of oxidizing ferrous iron or iron sulfides.  It obtains 
its carbon by the reductive fixation of atmospheric CO2.  On solid tetrathionate medium 
the colonies are small, circular, convex and with precipitated sulfur in the centre 
(Hallberg et al., 1994; Hallberg et al., 1996a and Hallberg et al., 1996b).  This bacterium 
was previously classified as Thiobacillus caldus, but as a result of 16S rRNA sequence 
analysis, it became clear that the genus Thiobacillus included members of the α-, β- and 
γ-subclasses of Proteobacteria.  A new genus, Acidithiobacillus, was then created to 
accommodate these highly acidophilic bacteria.  This new genus contains four species of 
the γ-subclass of Proteobacteria, namely At. thiooxidans, At. ferrooxidans, At. caldus and 
At. albertensis (Kelly and Wood, 2000). 
 
 
The ability of this organism to oxidize inorganic sulfur makes it very useful in converting 
insoluble metal sulfides into soluble metal sulfates which can be leached from their 
surroundings.  At. caldus plays an important role in a commercial biooxidation process 
called biomining.  This process uses the oxidizing properties of various acidophilic 
bacteria either to convert insoluble metal sulphides to water soluble metal sulphates or as 
a pretreatment process to break up the structure of the mineral, thus permitting other 
chemicals to penetrate and solubilize the metal.  An example of the first process is the 
solubilization of copper from minerals such as covellite (CuS) or chalcocite (Cu2S).  An 
example of the second process is the removal of arsenic, iron and sulfur from gold-
bearing arsenopyrite.  The gold that remains in the mineral is then more easily accessible 
to cyanide for subsequent extraction (Van Aswegen et al., 1991).       
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There are currently two main types of microbially assisted biomining processes for the 
recovery of metals.  The first process is an irrigation-type or heap leaching process and 
involves the percolation of leaching solutions through crushed ore that have been stacked 
in columns, dumps or heaps (Rawlings et al., 1999a).     Each dump is irrigated with iron- 
and sulfate-rich wastewater from which copper has been removed.  Microorganisms 
growing on the surface of the mineral in the heap catalyze the chemical reactions that 
result in the conversion of insoluble copper sulfides to soluble copper sulfate. The copper 
sulfate-containing leach solutions are collected at the bottom of the dump and sent for 
metal recovery by a process of solvent extraction and electrowinning.   Although heap 
reactors are very cost effective, they are very difficult to aerate efficiently and the pH and 
nutrient levels are difficult to manage.  These dumps are relatively cheap to construct and 
mainly consist of waste ore, and therefore it is considered to be a low technology process.  
The metal recovered in the largest quantity by this process is copper (Rawlings, 2002, 
2005).  
 
The second process is a stirred tank process and employs highly aerated, continuous-flow 
bioreactors.  The bioreactors are arranged in a series, with finely milled ore or 
concentrate being added to the first tank together with inorganic nutrients in the form of 
fertilizer-grade (NH4)2SO4 and KH2PO4.  The mineral suspension then flows through a 
series of highly aerated tanks that are pH and temperature controlled until biooxidation of 
the mineral concentrate is complete.  Because mineral biooxidation is an exothermic 
process, cooling of the bioreactors is important.  Large volumes of air are blown through 
each reactor, and a large agitator ensures that an even suspension of the solids is carried 
over to the next tank.  A big advantage of this process is that mineral solubilization in 
these tanks takes place in days, while heap reactors can take up to months to solubilize 
the minerals.  These reactors are extremely expensive to construct and maintain, and 
therefore their use is mainly restricted to high-value ores and concentrates.  Stirred tank 
bioreactors are mostly used as a pretreatment process for the recovery of gold from ores 
where the gold is finely divided in a mixture of pyrite or arsenopyrite.  These gold 
particles cannot easily be accessed by cyanide for subsequent solubilization of the 
mineral.  Treatment of the ores with this process decomposes the arsenopyrite, which 
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allows the cyanide to come in contact with the gold (Rawlings, 2002, 2005; Rohwerder et 
al., 2003).        
 
These biomining organisms have several physiological features in common.  They are all 
chemolithoautotrophic and use ferrous iron or reduced inorganic sulfur (or both) as an 
electron donor.  A result of sulfur-oxidation is the production of sulfuric acid, and 
therefore these organisms are all acidophilic and have a pH optimum of 1.5 – 2.0.  They 
can all fix CO2 and generally are resistant to a wide range of metal ions.  In these 
biomining processes, air provides the carbon source (CO2) and the electron acceptor (O2), 
water provides trace elements and is also the medium of growth. The mineral ore supplies 
the electron donor in the form of ferrous iron and/or reduced inorganic sulfur (Rawlings, 
2002).  In general, the same organisms are found in heap-leaching and stirred tank 
processes.  The proportions of the organisms may vary, however, depending on the 
mineral being solubilized and conditions under which the heaps or tanks are operated 
(Rawlings, 2005).  Unlike other fermentation processes, biomining processes are not 
sterile, and no attempt is made to maintain sterility.  This is not necessary because these 
highly acidophilic organisms create an environment that is only suited for themselves and 
not for other organisms.  Another reason why this process does not need to be sterile is 
because the microorganism that decomposes the mineral the most efficiently will out-
compete those that are less efficient (Rawlings, 2002).      
 
In processes that operate at moderate temperatures in the range of 35oC - 40oC the most 
important bacteria are considered to be the iron- and sulfur-oxidizing At.  ferrooxidans, 
the sulfur-oxidizing At. thiooxidans and At. caldus, and the iron-oxidizing Leptospirillum 
ferrooxidans and Leptospirillum ferriphilum (Suzuki, 2001).  For many years At. 
ferrooxidans was believed to be the most important biomining organism at 40oC, but with 
the development of techniques such as PCR amplification of 16S rRNA genes from total 
DNA extracted from environmental samples, it became clear that At. ferrooxidans plays a 
minor role in continuously operating stirred tank reactors operating under steady-state 
conditions.  Here a combination of Leptospirillum and At. thiooxidans or At. caldus are 
the most important oxidizing bacteria.   In a pilot scale, stirred tank operation in which a 
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polymetallic sulfide ore was treated at 45oC, it was found that At. caldus-like, L. 
ferriphilum-like and Sulfobacillus-like bacteria was dominant (Okibe et al., 2003).  At. 
ferrooxidans may be the dominant organism in dump or heap leaching environments 
where there is a lower redox potential (Rawlings et al., 1999a; Rawlings, 2002; 
Rawlings, 2005).     
 
Because At. caldus and At. thiooxidans are closely related, initial studies indicated that 
At. thiooxidans dominated continuous-flow tanks that operated at 40oC.  By using 
restriction enzyme analysis to identify the bacteria in biooxidation tanks, Rawlings et al. 
(1999b) have shown that these tanks used to treat gold-bearing arsenopyrite concentrates 
are in fact dominated by At. caldus instead of At. thiooxidans.  At. caldus are the most 
dominant sulfur-oxidizing bacteria in pilot plants that treat copper concentrates at 40oC 
and nickel concentrates at 45-55oC and are considered to be the “weed” of biomining 
bacteria under these conditions (de Groot et al., 2003).  However, for the biooxidation of 
most ores to proceed efficiently, bacteria capable of oxidizing both sulfur and iron need 
to be present.  At. caldus and At. thiooxidans cannot, like At. ferrooxidans and L. 
ferrooxidans, oxidize an ore such as pyrite when growing in pure culture (Okibe and 
Johnson, 2004).  The reason for this is that the sulfur in the ore is only available to these 
bacteria after the iron has been oxidized.  Therefore, they need to be grown in a mixed 
culture with iron-oxidizing bacteria.  Oxidation of an ore by such a consortia of bacteria 
generally takes place at a higher rate than in pure culture (Rawlings et al., 1999a).      
 
Several roles of At. caldus in the biomining environment have been suggested.  Dopson 
and Lindström (1999) showed in laboratory studies that At. caldus is able to enhance the 
ability of the iron-oxidizing bacterium Sulfobacillus thermosulfidooxidans to oxidize 
arsenopyrite ores at 45 oC.  A result of the chemical leaching process is the formation of 
sulfur (S0).  When sulfur accumulates, it forms a layer on the surface of the mineral.  It 
might be that the presence of At. caldus increases the leaching rate by removing the 
elemental sulfur that builds up on the mineral surface, thereby allowing bacterial and 
chemical (Fe3+) access to the mineral (Dopson and Lindström, 1999).  Bacteria need to 
attach to the mineral to cause leaching (Arredondo et al., 1994).  Another possible 
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mechanism by which At. caldus may affect the leaching rate of arsenopyrite is by the 
production of organic growth factors.  These growth factors may stimulate heterotrophic 
and mixotrophic growth of bacteria.  It is also possible that At. caldus might provide 
organic material in the form of cross-feeding that aids mixotrophic growth.  This cross-
feeding could also be in the form of a symbiotic relationship, where the iron oxidizing 
bacteria such as Leptospirillum spp. may reduce the concentration of organic chemicals 
that inhibits growth by accumulation in the cytoplasm.  A last possible mechanism by 
which At. caldus might affect the arsenopyrite leaching rate is by production of surface-
active agents to solubilize the sulfur (Dopson and Lindström, 1999). 
 
During this process of mineral solubilization, arsenic compounds are leached from the 
arsenopyrite ore.  These arsenic compounds are toxic to the bacteria used in this process.  
During early stages of development of the biooxidation process, solubilization of the 
arsenopyrite ore was inefficient and slow and bacteria required a retention time of over 
12 days to oxidize the concentrate efficiently for gold recovery.  The reason was that the 
bacteria were not tolerant to such high levels of arsenic.  Initially the bacteria were 
sensitive to less than 1 g arsenic/l.  At the Fairview mine in Barberton, South Africa, 
soluble AsV concentrations as high as 12 g/l were reported and at the Sao Bento mine in 
Brazil AsIII concentrations of 3-6 g/l (Dew et al., 1997).  This arsenic inhibition was so 
severe that after a period of time the arsenic had to be removed from the tanks before the 
process could continue.  This removal of the arsenic was time consuming and very 
uneconomic.  However, in a period of 2 years, through a process of selection using a 
bacterial chemostat, the bacterial consortium became sufficiently resistant to these high 
levels of arsenic and no further removal of arsenic compounds was needed.  The retention 
time needed to oxidize the concentrate efficiently was also reduced from 12 days to less 
than 7 days (Rawlings and Woods, 1995).  After another 3 years of operation at the 
Fairview mine, the retention time was reduced to a little over 3 days, and the quantity of 
the suspended mineral concentrate had been increased from 10% to 19% w/v.   
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1.2. Properties of arsenic 
It is believed that Albertus Magnus discovered arsenic around 1250.  Arsenic is a semi-
metal or metalloid that exists in the environment in two biologically important oxidation 
states, namely AsV (arsenate) and AsIII (arsenite).  It is one of the most prevalent toxic 
metals in the environment (although in very low concentrations) and is commonly 
associated with the ores of metals like gold, copper and lead.  Arsenite absorbs less 
strongly and to fewer minerals than arsenate, which makes it a more mobile oxyanion 
than arsenate.  Arsenate is the predominant form of arsenic in aerobic environments, 
while arsenite is more predominant in an anoxic environment (Oremland and Stolz, 2003; 
Rosen, 2002a).   
 
Arsenite is said to be about 100 times more toxic than arsenate.  In a study where the 
genotoxic activity of arsenite and arsenate was tested in TK6 human lymphoblastiod cell 
lines, arsenite was far more genotoxic than arsenate (Guillamet et al., 2004).  The toxicity 
of arsenite lies in its ability to bind to the sulfur groups of essential cysteines in proteins.  
Because arsenite binds two sulfur groups it can cross link proteins, altering their overall 
shape and thereby impeding their function.  Because of the similarity in structure and 
solubility between arsenate and phosphate, arsenate can act as a phosphate analog and 
competes for the formation of ATP (Coddington, 1986).  Kenney and Kaplan 
strengthened this theory by showing that arsenate substituted phosphate in both the 
sodium pump and the anion exchanger of human red blood cells (Kenney and Kaplan, 
1988).   The transport of arsenate into bacterial cells is via two phosphate transport 
membrane systems, the Pit and Pst system, while the Pst system seems to be the 
predominant system for arsenate uptake.  Arsenite is transported into bacterial cells by 
aqua-glycerolporins (glycerol transport proteins) (Sanders et al., 1997) (Figure 1.1).  A 
mutation in the glycerol facilitator of E. coli (GlpF) converted the E. coli strain to 
antimony (SbIII) resistance.  Because the chemical properties of arsenite and antimony are 
similar, it is very likely that GlpF is also an AsIII transporter (Mukhopadhyay et al., 2002; 
Rosen, 2002a; Rosen, 2002b).  Recently Meng et al. (2004) confirmed AsIII uptake by 
GlpF in E. coli.   
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Figure 1.1:  Uptake mechanisms of arsenate and arsenite in E. coli.  Arsenate is brought 
into cells by phosphate transporters, the Pst and the Pit system (top left).  Arsenate is then 
reduced to arsenite by the ArsC (arsenate reductase, middle).  Arsenite uptake is 
facilitated by the aquaglycerolporin GlpF (top right).  Arsenite is actively extruded by the 
ArsAB complex (AsIII/SbIII-translocating ATPase, bottom right).  If ArsA is absent, ArsB 
acts as a secondary arsenite carrier protein and efflux is coupled to membrane potential 
(bottom left).  Adapted from Rensing et al. (1999).       
 
Arsenical compounds have been used for many purposes, mainly in medicine (mostly for 
treating protozoan diseases), in agriculture (as herbicides, fungicides, pesticides and 
animal feed additives) and as a poison.  In 1908 Paul Ehrlich won the Nobel Prize in 
medicine for the use of arsenic compounds as chemotherapeutic agents (Mukhopadhyay 
et al., 2002).  Due to the fact that arsenic is so prevalent in the environment, 
microorganisms have developed various resistance mechanisms to counteract its toxicity.   
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1.3. Bacterial resistance to arsenic 
Due to the abundance of arsenic in the environment, microorganisms come into contact 
with this metalloid on a regular basis.  Therefore it is not surprising that chromosomal 
and plasmid located genes which confer resistance to arsenic have been isolated from 
bacteria.  Different mechanisms of resistance to arsenic have evolved in microorganisms, 
such as the overproduction of intracellular thiols (e.g. the protozoan Leishmania), 
phosphate pathways that do not transport arsenate efficiently (e.g. cyanobacteria), the 
oxidation of arsenite to the less toxic arsenate (e.g. Alcaligenes faecalis), sequestration in 
a vacuole (e.g. fungi) and methylation (Rosen, 1999; Oremland and Stolz, 2003; 
Cervantes et al., 1994; Wang et al., 2004).  The best characterized and most studied way 
of detoxification is a mechanism where intracellular AsV is converted to AsIII and a 
specific efflux pump then extrudes AsIII from the cytoplasm (ars operon).  This system 
has been extensively studied and will be the focus of this study. 
 
The ars operon has been isolated from Gram-positive and Gram-negative bacteria.  There 
are two common forms of the ars operon.  The first and most common form consists of 
three genes, arsRBC.  This form of the ars operon is located on chromosomes and 
plasmids of many organisms, but the best studied is the chromosomal ars system of E. 
coli K-12 and the ars systems on plasmids pI258 and pSX267 of Staphylococcus (Diorio 
et al., 1995).  The second operon is found on plasmids of Gram-negative bacteria (e.g. 
plasmid R773 and R46 of E. coli and plasmid pKW301 of Acidiphilium multivorum) and, 
more recently, on transposons of At. caldus (AY821803), L. ferriphilum (DQ057986), A. 
faecalis (Ay297781) and M. flagellatus (NZ_AADX01000013) (Tuffin et al., 2006).  this 
operon consists of five genes, arsRDABC (Figure 1.2) (Suzuki et al., 1998).  Both these 
operons have been organized into a single transcriptional unit.  The arsR and arsD genes 
encode two different regulatory proteins.  ArsR is a trans-acting repressor that senses 
intracellular AsIII and controls the basal level of expression of ArsB and ArsC (Yang et 
al., 2005).  ArsD is an inducer-independent protein and controls the upper level of 
expression (Saltikov and Olson, 2002).  ArsA is an arsenite stimulated ATPase, 
energizing ArsB (a membrane-bound arsenite and antimony efflux pump) by ATP 
hydrolysis (Silver, 1996).  In the presence of ArsA, arsenite and antimony are exported 
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actively out of the cell by using cellular ATP.  If the ArsA is absent, these oxyanions can 
still be excreted by ArsB using membrane potential (Cai et al., 1998).  ArsC is an 
arsenate reductase that converts arsenate to arsenite to get exported by the efflux pump.  
 
 
Figure 1.2:  Homologies among the arsenic resistance determinants of Staphylococcus 
plasmids pSX267 and pI258, E. coli plasmids R773 and R46, and the chromosomal ars 
operon of E. coli.  The sizes of putative gene products (in amino acids [aa]) are shown 
above or below the genes (boxes).  The numbers between the dashed lines are 
percentages of similarity among the ArsR, ArsB and ArsC proteins.  O/P, 
operator/promoter.  Adapted from Silver and Phung (1996).   
 
With new technology constantly developing and data generated from genome sequencing 
projects, it became clear that ars operons may differ from the two common forms 
described above.  Southern blot hybridization experiments where different arsenic 
resistance genes were probed against total DNA isolated from bacteria revealed that these 
genes are very widespread among microorganisms (Dopson et al., 2001).  PCR 
experiments with degenerate primers to these resistance genes also revealed the 
prevalence of ars operons.  There are however, other forms of arsenic operons that differ 
from the arsRBC and arsRDABC conformation.  Other genes that have also been reported 
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to be associated with arsenic resistance are arsH and arsM.  For example, an operon that 
is different in gene order and that contains an extra gene was identified in At. 
ferrooxidans (Butcher et al., 2000).  This operon consisted of arsCRBH genes with the 
arsCR and arsBH genes divergently transcribed.  The function of the arsH gene is still 
unknown, but it was not required for and did not enhance arsenic resistance in E. coli.  
Cyanobacterium Synechocystis sp. strain PCC 6803 has an arsBHC arsenic resistance 
operon, where the arsH was also not required for resistance (Lopez-Maury et al., 2003).  
Neyt et al. (1997) found an arsHRBC operon on plasmid pYV of Yersinia enterocolitica 
with the arsH gene also divergently transcribed.  The presence of this gene however, 
either in cis or trans was essential for arsenic resistance.  This was surprising, because 
arsRBC are sufficient to confer resistance in E. coli and staphylococci.  The authors 
suggested that arsH might have a regulatory function similar to arsD.  The same 
arsHRBC operon was also found on the IncH12 plasmid R478 (Ryan and Colleran, 
2002).  PCR amplification using primers to the arsH gene showed that this gene is 
present in many other arsenic resistant IncH12 plasmids.  Removal of the arsH, like in Y. 
enterocolitica, rendered the cell sensitive to arsenic.  The legume symbiont 
Sinorhizobium meliloti contains a very interesting ars operon.  It consists of four genes, 
an arsA, followed by an aqpS (aquaglyceroporin) and then arsCH.  A deletion of arsH 
also rendered the cell sensitive to arsenite and arsenate (Yang et al., 2005).   
 
The archaeon, Halobacterium sp. strain NRC-1 contains a gene encoding a mammalian 
arsenite-methyltransferase homolog, named arsM.  A deletion of this gene increased 
sensitivity to arsenite, indicating a novel mechanism of arsenic resistance, possibly by 
methylating intracellular arsenite and thereby creating a concentration gradient to the 
outside of the cell.  It is also possible that arsenite could be methylated to a volatile 
trimethyl-arsine that would leave the cell by diffusion (Wang et al., 2004; Tuffin et al., 
2005).   
 
The ars operon of the acidophilic archaeon Ferroplasma acidarmanus consists of only 
two arsenic resistance genes, arsRB (Gihring et al., 2003).  An arsC gene was absent in 
the genome.  Although no arsC gene is present, the organism was still resistant to 
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arsenate.  It is suggested that F. acidarmanus employs phosphate specific transporters to 
reduce non-specific uptake of arsenate.   F. acidarmanus also lacks a complete arsA-
homologous open reading frame (ORF).  The ArsB may thus not function as a subunit of 
a primary pump, but as a secondary carrier using membrane potential to export arsenite 
out of the cell.  This may not be the case however, as acidophilic microorganisms 
commonly have a reversed membrane potential (Butcher et al., 2000).  Membrane 
potential may not be a suitable energy source to export arsenite out of the cell.  The 
mechanism of arsenite efflux by F. acidarmanus is still unknown.    
 
Another variation of the conventional ars operons is in Mycobacterium tuberculosis, 
where the arsB and arsC genes are fused into a single gene, encoding a 498-residue 
fusion protein (Mukhopadyay et al., 2002).  The reason for the fusion of these two genes 
is unknown.  Another very interesting arsenic operon is that of the legume symbiont 
Sinorhizobium meliloti.  The operon consists of an arsR gene, followed by an aqpS gene 
in place of arsB.  A third ORF downstream of aqpS showed homology with an arsC and 
the fourth to an arsH gene.  AqpS showed homology with the bacterial glycerol 
facilitator, GlpF, which facilitates transport of arsenite and antimonite into bacterial cells.  
S. meliloti utilizes a unique arsenic detoxification pathway where ArsC converts arsenate 
to arsenite, which is then transported down a concentration gradient through the AqpS 
channel to the outside of the cell (Yang et al., 2005).        
 
Sato and Kobayashi (1998) found an ars operon on the skin element of Bacillus subtilis 
that also differs from the conventional three or five gene operons.  This operon contains 
the arsRBC genes, but also a fourth gene (ORF2) located between the arsR and arsB 
genes.  This gene did not show homology to any known ars genes, but did show 
homology to an ORF of unknown function situated upstream of the arsRBC operon in 
Mycobacterium tuberculosis.  These experiments conducted on the ars genes however, 
did not define the role of ORF2 in the arsenic resistance mechanism of Bacillus subtilis.  
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1.4. Proteins involved in the ars operon   
 
1.4.1. The ArsAB pump 
The best studied ArsAB pump is that encoded by the ars operon of E. coli plasmid R773.  
ArsA normally is part of an aggregate with the membrane-bound ArsB protein, and 
together forms an ArsAB AsIII/SbIII-translocating ATPase, which extrudes AsIII and SbIII 
oxyanions out of the cell.  The 63 kDa ArsA ATPase is the catalytic component of the 
ArsAB pump, with AsIII/SbIII stimulated ATPase activity.  It hydrolyses ATP in the 
presence of antimonite and arsenite.  The 45 kDa ArsB subunit (which forms the 
oxyanion-translocating pathway) uses the chemical energy released by ArsA to secrete 
arsenite and antimonite out of the cell (Tisa and Rosen, 1990).  The arsRDABC operon 
confers higher levels of resistance than the arsRBC operon, indicating that the ATP-
driven ArsAB pumps out arsenite more efficiently.  This illustrates that ArsB in complex 
with ArsA can reduce the intracellular concentration of AsIII/SbIII to a greater extent than 
ArsB alone (Rosen, 1999).    
 
1.4.1.1. ArsA (ATPase subunit)   
When ArsA is expressed in the absence of ArsB, it is found in the cytosol and can be 
purified as a soluble protein (Walmsley et al., 1999).  The 583-residue ArsA has two 
homologous halves, a N-terminal A1 (residues 1-288) and a C-terminal A2 (residues 314-
583), which are connected by a flexible linker of 25 residues (residues 289-313) 
(Bhattacharjee et al., 2000) (Figure 1.3).  These two homologous halves are most likely 
the result of ancestral gene duplication and fusion (Chen et al., 1986).  The crystal 
structure of the ArsA has been determined (Zhou et al., 2000), and three types of domains 
were found.  Firstly, there are two nucleotide binding domains (NBDs) for ATP that 
contain residues from both A1 and A2.  Secondly, there is a metalloid-binding domain 
(MBD).  This site is allosterically activated and is positioned at the opposite end of the 
protein from the NBDs.  The third domain is a signal transduction domain (DTAP) that 
connects the MBD to the two NBDs (Rosen, 2002a).  There is also a linker that connects 
the A1 and A2 halves of ArsA.   
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Figure 1.3:  Model of the structure of the ArsA ATPase from plasmid R773.  The protein 
consists of two homologous domains, a N-terminal A1 and a C-terminal A2, connected 
by a flexible linker region.  Each domain contains a nucleotide binding domain (NBD), a 
signal-transduction domain (DTAP) and a metalloid binding domain.  The cysteine 
residues have been found to comprise the metalloid binding domain (MBD).  Binding of 
arsenite to the cysteine residues brings the A1 and A2 domains together, resulting in 
hydrolysis of ATP.  Adapted from Rosen (2002a). 
 
 
The Nucleotide Binding Domains (Catalytic Site)    
The ArsA protein has two nucleotide binding domains, NBD1 and NBD2.  Both these 
domains are composed of residues from the A1 and A2 halves of ArsA (Zhou et al., 
2000).  Both NBDs are located at the interface between A1 and A2, in close proximity to 
each other (Zhou et al., 2001).  Mutations in either A1 or A2 NBD resulted in a sensitive 
strain with loss of resistance to arsenite, ATPase activity and transport (Karkaria et al., 
1990; Kaur and Rosen, 1992).  This indicates that both the A1 and A2 NBDs are required 
for oxyanion-translocating ATPase activity. The sequence for the consensus binding sites 
of ATP (P-loop) is G15KGGVGKTSIS25 and G334KGGVGKTTMA344 in the A1 and A2 
halves, respectively (Chen et al., 1986).  By using site-directed mutagenesis Li et al. 
(1996) altered the first glycine residues in A1 and A2 to cysteine residues.  Cells 
expressing a G15C (A1) mutant and a G15C/G334C double mutant exhibited moderate 
sensitivity to arsenite, whereas a G334C mutant in A2 retained arsenite resistance.  
Arsenite resistance was restored in the moderate sensitive mutants to the wild type with a 
single substitution of A344V.  Because A344V is located adjacent to the C-terminal NBD, it 
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suggests a spatial proximity of Gly15 and Ala344 and thus indicates that the A1 and A2 
domains do interact to form a catalytic unit.  Li and colleagues further studied this 
interaction of the A1 and A2 NBDs and found that the bigger the residue substitution at 
position 15 in A1, the weaker the resistance to arsenite.  The larger the residue at position 
344 in A2, the greater the suppression of the G15 mutants (Li et al., 1998).  This shows an 
inverse relationship between ATPase activity and residue volume at position 15, 
indicating that the geometry at the interface between A1 and A2 NBDs imposes steric 
constraints on residues allowed in the A1-A2 interface.  
 
By looking at the structure of ArsA in complex with Mg.ADP, it is clear that the A1 NBD 
(NBD1) is in a closed conformation and has ADP bound, while the A2 NBD (NBD2) has 
an open conformation, and ATP can be exchanged into this site.  This indicates that 
NBD2 will be much more accessible than the NBD1 (Zhou et al., 2000; Rosen, 2002b).  
These findings are consistent with studies done by Kaur (1999) which suggests that A2 is 
a low affinity, easily exchangeable site, while A1 is a high affinity, poorly exchangeable 
site.  Further studies have also shown that the nature of the nucleotide bound at A2 is 
reflected in the conformation of the A1 domain (Zhou et al., 2001).  In the absence of 
antimonite or arsenite, ATP binding and hydrolysis is at a slow basal rate and occurs 
firstly in A1, which then results in a change in A2 so that A2 is now more competent to 
bind ATP.  In the presence of AsIII/SbIII (multisite conditions), ATP binding and 
hydrolysis by A2 produces a change in A1, giving it a more open conformation.  The 
result is the release of tightly bound ADP from A1 and the subsequent binding of another 
ATP molecule to A1 (Jia and Kaur, 2003).   
 
In the presence of AsIII/SbIII, Walmsley et al. (2001) found that NBD1 hydrolyzed ATP 
250-fold faster than NBD2.  Although the two NBDs have overall structural similarities 
and similar evolutionary relationships, the two NBDs have intrinsic differences.  These 
findings gave more weight to the possibility that the two NBDs have separate roles in 
catalysis (Zhou et al., 2002).  This hypothesis was further strengthened when a thrombin 
site was introduced into the linker that connects A1 and A2 to distinguish between events 
at NBD1 and NBD2.  After labeling and thrombin digestion, A1 and A2 migrated at 
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different mobilities on SDS-PAGE.  This showed that the two NBDs have different 
properties, and possibly different functions (Jiang et al., 2005).  They further showed that 
a) both nucleotides are catalytic and hydrolyze ATP in the absence and presence of SbIII, 
b) the affinity for ATP is increased in both NBD1 and NBD2 by SbIII, and c) NBD1 has a 
higher affinity for ATP than NBD2.  These findings raised the question as to the function 
of NBD2.  One possibility is that it could once have been an important evolutionary 
structure, but that it is not involved in ATP transport anymore.  This possibility seems 
fairly unlikely, however, as Kaur and Rosen (1992) have shown that mutagenesis of 
NBD2 resulted in loss of ATPase activity and AsIII resistance.  Another possible function 
is that it could play a regulatory role.  A third possibility is that the two NBDs could play 
equivalent roles in an intact ArsAB complex.  The noted differences might be the result 
of the analysis of ArsA in the absence of ArsB (Jiang et al., 2005).    
 
Previously it was shown that Mg2+ is required for ArsA ATPase activity (Hsu and Rosen, 
1989).  An increase in intrinsic tryptophan fluorescence occurred only on the addition of 
MgATP, which indicated conformational changes at the NBDs.  This effect was observed 
only in the presence of ATP, suggesting that Mg2+ binds to ArsA as a complex with ATP 
(Zhou et al., 1995).  From sequence alignment of ArsA homologs with enzymes such as 
NifH, RecA and GTP-binding proteins such as Ras p21, it was suggested that Asp45 
might be a putative Mg2+ ligand.  From the crystal structure of Ras p21 bound to GTP, 
the conserved Asp residue formed a portion of the Mg2+ binding site (Pai et al., 1990).  
The Mg2+ ion bring together different components of the GTP binding core, resulting in 
information flow between domains.  To examine the role of Asp45, mutants were 
constructed in which Asp45 was changed to Asn, Glu or Ala.  Cells expressing these 
mutated arsA genes almost completely lost arsenite resistance.  These results supported 
the role of Asp45 as a Mg2+ ligand (Zhou and Rosen, 1999).    
 
The Metalloid Binding Domain (Allosteric Site) 
Arsenite and antimonite have been shown to allosterically activate ArsA ATPase activity 
(Rosen et al., 1999).  AsIII stimulates ATPase activity 3-5 fold, while SbIII as an activator 
stimulates ATPase activity 10-20 fold.   In the absence of the metalloids, a low level of 
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ATPase activity is observed by ArsA.  No other oxyanion tested had an effect on activity 
(Hsu and Rosen, 1989).  One possibility was that the activation by SbIII or AsIII might be 
through the binding as oxyanions to anion binding sites.  As metalloids however, they 
might react as soft metals through covalent binding with cysteine thiolates.  In such a 
reaction, where arsenite reacts with thiolates such as dithiothreitol or glutathione, arsenite 
acts as a soft metal, forming direct metal-sulfur As-S bonds (Rosen et al., 1999).  If the 
activation of ArsA does involve direct metal-sulfur bonds, alteration of participating 
cysteine residues would greatly affect the activation of ArsA.  The thiol-modifying 
reagent methyl methanethiosulphonate (MMTS) inhibits ArsA catalysis, suggesting that 
cysteine residues are involved in catalysis (Bhattacharjee et al., 1995).  
 
The ArsA of E. coli has four cysteine residues, Cys26, Cys113, Cys172 and Cys422 (Figure 
1.4).  For AsIII or SbIII to act as an allosteric activator, two or more cysteine residues must 
be in close proximity in the folded protein to interact with the metalloid.  To investigate 
the role of the cysteine residues in the activation of ArsA, each cysteine was altered to a 
serine residue by site-directed mutagenesis (Bhattacharjee et al., 1995).  The purified 
C26S ArsA showed identical properties to those of the wild-type ArsA, with no change in 
resistance to AsIII or SbIII.  This suggested that Cys26 is not involved in activation of 
ArsA.  In contrast, cells expressing the other three mutants were sensitive to SbIII and 
AsIII.  The purified C113S, C172S and C422S enzymes each exhibited a similar affinity for 
ATP to the wild-type ArsA, but the concentration of SbIII or AsIII required for activation 
of ArsA was substantially increased, most likely reflecting a decrease in affinity for the 
metalloid.  This resulted in reduced ATPase activity and rendered the mutants sensitive to 
AsIII and SbIII.   
 
These three cysteines are distant from each other in the primary structure of ArsA, but as 
the protein folds it brings them into close proximity.  AsIII or SbIII then interact with these 
cysteines to form a metal-thiol cage.  To determine the distance between the cysteine 
residues, the wild-type ArsA and ArsA with Cys-Ser substitutions were treated with the 
homobifunctional crosslinker dibromobimane (bBBr) (Bhattacharjee and Rosen, 1996).  
bBBr has two bromomethyl groups that can crosslink a thiol pair located within 3-6 Å of 
 17
each other to form a fluorescent adduct.  An ArsA protein with only one cysteine group 
altered by mutagenesis still formed fluorescent adducts.  Proteins lacking any two of the 
three cysteines at residue 113, 172 or 422 did not form fluorescent adduct.  These results 
demonstrate that Cys113, Cys172 and Cys422 are in close proximity of each other in the 
tertiary structure so that AsIII or SbIII can interact with these three cysteine residues in a 
trigonal pyramidal geometry.    
   
 
Figure 1.4:  The primary sequence of ArsA is represented linearly, with the homologs 
A1 and A2 halves aligned and linked by the flexible linker region.  Boxes indicate 
regions of greatest similarity.  The black boxes indicate the location of the P-loop of the 
NBDs and the signal transduction domains (DTAP).  The locations of the four cysteines 
are indicated.  Cys113, Cys172 and Cys422 form the metalloid binding domain (MBD).  
Adapted from Bhattacharjee et al. (2000)  
 
 
Based on the structure of the ArsA protein, Zhou et al. (2000) suggested that it may be 
possible that a change in the affinity of ArsA for AsIII/SbIII might inject metal ions into 
ArsB as a result of conformational changes during ATP hydrolysis.  This was contrary to 
previous ideas that the ions that activate ArsA are not transported by ArsB.  To further 
investigate this hypothesis, ArsA was crystallized in complex with ATP, the non-
hydrolyzable ATP analog AMP-PMP and the transition state analog of ATP hydrolysis, 
ADP.AIF3 (Zhou et al., 2001).  When ArsA crystals were formed or incubated in the 
presence of ATP, ATP was found at NBD2, and ADP at NBD1.  Surprisingly, when 
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crystals were incubated with AMP-PNP, it was found only at NBD1.  The inability to 
obtain crystals in the presence of AMP-PNP, suggested that crystals can only be formed 
if NBD1 contains ADP.  A reason for this might be that conformational changes 
associated with ATP binding and hydrolysis at NBD1 is not allowed in the crystal.  Using 
pre-steady-state kinetics, it has been shown that binding of ATP favors the uptake of 
AsIII/SbIII, while the release of ADP from NBD2 is associated with the release of these 
ions from the MBD (Walmsley et al., 2001).   
 
Changes in helices of A1 and A2 corresponded with ATP hydrolysis at NBD2.  Helices 
H9-H10 of A1 and A2 forms the arms of a gate, alternating in the “open” and “closed” 
positions at the interface with ArsB (Figure 1.5).  When AsIII/SbIII first reacts with ArsA, 
the H9-H10 region of A1 provides the ceiling of the cavity where the ion binds.  When 
hydrolysis occurs at NBD2, the bound ion moves from the cytosolic side into a protected 
pocket at the interface with ArsB.  Release of ADP from NBD2 triggers the release of the 
AsIII/SbIII ion inside this pocket.  ATP hydrolysis at NBD1 is then required to bring ArsA 
back to the ground state.  Based on the above, the catalytic cycle of ArsA functions 
similar to that of a reciprocating engine (Zhou et al., 2001).  Many elements of this model 
remain to be proven.    
 
Signal Transduction Domain (DTAP) 
The catalytic and allosteric sites of the ArsA ATPase are located distant from each other 
in the enzyme, requiring a mechanism that can transmit the information from the MBD 
(allosteric site) to the NBD (catalytic site) where ATP hydrolysis occurs.  This flow of 
information has been shown to be mediated by a 12-residue consensus sequence, 
DTAPTGHTIRLL (Bhattacharjee et al., 2000).  This sequence is termed DTAP or the 
signal transduction domain and is found in each half of ArsA. 
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Figure 1.5:  Schematic model of the proposed mechanism of the ArsA ATPase.  Helices 
of the A1 (red) and A2 (green) domains form the arms of a gate that alternates between 
the open and closed conformations.  An AsIII ion is shown as a purple triangle. Adapted 
from Zhou et al. (2001).  See text for details. 
 
 
ArsA has four tryptophan residues located at positions 159, 253, 522 and 542.  The 
function of the DTAP domain in ArsA was examined by using the effects of substrates 
and effectors on intrinsic tryptophan fluorescence (Zhou et al., 1997).  Using site-directed 
mutagenesis two single-tryptophan ArsAs were constructed, containing either Trp141 or 
Trp159 at the N- and C-terminal side of the A1 DTAP domain respectively.  In the Trp141 
protein all native tryptophan residues were changed to tyrosine, and Phe141 was changed 
to tryptophan.  In the Trp159 ArsA the other three tryptophan residues were changed to 
tyrosine.  These two tryptophan residues served as intrinsic probes of the environment of 
the DTAP domain.  During ATP hydrolysis this domain undergoes conformational 
changes that may be involved in coupling the allosteric and catalytic sites.  The 
fluorescence spectra indicated that the N-terminal Trp141 is located in a hydrophobic 
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region, while the C-terminal Trp159 is located in a relatively hydrophilic environment.  
Binding of Mg.ADP moved Trp141 into a more hydrophilic region, exposing the N-
terminal end of the DTAP domain to a more polar environment.  Upon binding of 
Mg.ATP, Trp159 moved into a more hydrophobic environment, leaving the C-terminal end 
in a less polar environment.  The catalytic and allosteric domains are thus connected to 
each other by a “flipping” movement in the signal transduction domain during catalysis.  
 
Linker Region 
The sequence of the E. coli plasmid R773 ArsA indicated that A1 and A2 are connected 
by a flexible linker peptide.  The function of this linker sequence was examined by 
extending it with five glycine residues or by the deletion of 5, 10, 15 or 23 residues (Li 
and Rosen, 2000).  Cells expressing an arsA gene with the extended linker exhibited 
similar resistance and affinity for ATP and SbIII to the wild type.  Cells expressing the 
arsA genes with deleted linkers had increasing levels of AsIII sensitivity and a decreased 
affinity for ATP and SbIII.  The authors proposed that the linkers have evolved to the 
shortest length that still allow the two halves of the protein to interact and that it was not 
the sequence of the linker that was important, but the length of the linker.  Jia and Kaur 
(2001) however, studied the role of the E. coli R773 linker by creating point mutations 
and complementation experiments and found that the nature of the residues in the linker 
are important for correct conformation of the NBDs and for catalytic activity.  The 
increase in sensitivity seen by Li and Rosen may not have been due to the shortening of 
the linker, but because of the role the linker plays in the function of ArsA.  Jia and Kaur 
expressed an N-terminal A1 clone, that lacks the linker sequence, with two different C-
terminal A2 clones, one without the linker and the other one containing the linker 
sequence.  Because each domain of ArsA was on a separate polypeptide, deletion of the 
linker would not inhibit movement of the two domains.  Unless the linker is required for 
the function of ArsA, the absence of the linker would have little effect on the ArsA 
function.  The N- and C-terminal halves were able to complement each other only if the 
linker was present, indicating that the linker is essential for function.  Point mutations of 
certain residues in the linker resulted in a loss of AsIII resistance and ATPase activity.  
These mutations also affected the conformation of ArsA.  The authors proposed that 
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residues in the linker region play an active role in the function of the protein and that 
there is an interaction between the linker and the NBDs.   
 
1.4.1.2. ArsB (Membrane bound efflux pump) 
The arsB gene of the E. coli R773 ars operon encodes a protein of approximately 45.5 
kDa.  Hydropathy plots demonstrated the hydrophobic character of the protein.  At least 
10 regions of 19 or more residues has a high average hydropathy, indicating these regions 
may be potential membrane-spanning α-helices.  Using an ArsB-β-galactosidase hybrid 
protein, β-galactosidase activity of different extracts was measured.  Results indicated 
that the fusion protein was localized to the inner membrane and it was postulated to be 
the anion channel component of the ArsAB pump (Chen et al., 1986; San Francisco et 
al., 1989).   
 
The ArsB protein is difficult to study due to the poor expression of the arsB gene.  It was 
suggested that the level of the arsB expression is controlled at a translational level.  
Analysis of the arsB translational initiation region (TIR) revealed a possible hairpin at the 
third codon.  Another potential mRNA secondary structure was identified immediately 
upstream of the ribosome binding site (Dou et al., 1992).  These structures may interfere 
with the ribosome, causing it to pause at the start of the arsB sequence, thereby reducing 
the amounts of ArsB produced.  The use of the T7 expression system has allowed San 
Francisco and colleagues to visualize the ArsB protein as a [35S] methionine-labeled 
membrane protein (San Francisco et al., 1989). 
 
Tisa and Rosen (1990) performed binding studies with purified ArsA protein to 
membranes with and without the arsB gene product to determine if expression of the 
arsB gene is required to anchor the ArsA protein to the inner membrane.  In cells 
expressing the arsB gene, the presence of the ArsA protein on the membrane was shown 
by immunoblotting of the membrane with antiserum prepared against the ArsA protein.  
In cells expressing an ArsA protein with either a truncated or no ArsB protein, ArsA 
protein was found only in the cytosol.  This indicated that the expression of the arsB gene 
is essential to anchor the ArsA protein to the inner membrane.  Membranes of cells 
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lacking an arsA gene were able to bind purified ArsA protein when added exogenously, 
suggesting that the ArsB protein is inserted into the membrane in a functional form in the 
absence of ArsA.           
 
By fusing certain regions of the arsB gene to reporter genes, a more accurate prediction 
of the topology of certain regions in the ArsB could be determined compared with the 
hydropathy plots reported by Chen et al. (1986).  Three types of gene fusions have been 
used.  Fusions with the phoA gene (which encodes for alkaline phosphatase) shows high 
activity if the fusion is made in the coding region for the periplasmic section of the ArsB, 
while fusions with the lacZ gene (which encodes for β-galactosidase) shows high activity 
if the fusion is made in the coding region for the cytosolic region of the ArsB.  Fusions 
with the blaM gene (which encodes for β-Lactamase) will provide resistance to ampicillin 
if the fusion is made in the coding region for the periplasmic part of the ArsB.  Based on 
the results of these fusions, a model was proposed where the ArsB protein has 12 
membrane-spanning α-helices joined by six periplasmic loops and five cytoplasmic 
loops.  The N- and C-termini are suggested to be located in the cytosol (Wu et al., 1992). 
 
From studies of the energetics of the ArsAB pump it has been shown that this complex is 
an arsenite-translocating ATPase (Dey et al., 1994; Karkaria et al., 1990).  Certain 
observations suggested that this hypothesis may be too simple.  Firstly, a characteristic 
motif of secondary carrier proteins is 12 membrane-spanning α-helices.  Thus, the ArsB 
has a similar structure to secondary carrier proteins.  Secondly, staphylococcal ars 
operons have no arsA gene, but still confer resistance to arsenite and extrude arsenite in 
an energy-dependent manner, suggesting that the ArsB protein can extrude arsenite in the 
absence of ArsA (Diorio et al., 1995).  Thirdly, when the R773 arsB gene is expressed in 
the absence of the arsA gene, it still confers an intermediate level of arsenite resistance in 
E. coli.  These observations raised the question as to whether energy was supplied by 
another ATPase elsewhere in the genome in the absence of arsA, or if another form of 
energy drives the pump in the absence of ArsA.  Dey and Rosen (1995) investigated the 
possibility of the R773 ArsB utilizing two different kinds of energy.  To do this they used 
an unc strain of E. coli to compare arsenite resistance and in vivo energetics of arsenite 
 23
transport in a strain expressing both arsA and arsB genes and in a strain only expressing 
the arsB gene.  The unc strain of E. coli lacks the H+-translocating ATPase and is thus 
unable to convert ATP and the electrochemical proton gradient.  An arsA deletion mutant 
pBC101 (arsRDBC) and a clone that only contains arsA (pArsA) were transformed into 
the unc deletion strain of E. coli.  ATP levels were controlled by growing the cells in 
glucose (generates ATP through substrate-level phosphorylation) or succinate (generates 
almost no ATP).  Cells expressing both arsA and arsB genes only actively exclude 
arsenite in the presence of ATP (when growing in glucose).  When fluoride (which 
inhibits glycolysis and thus prevents ATP synthesis) was added, the active exclusion of 
arsenite was inhibited.  Cyanide, which prevents respiration, but does not alter ATP 
levels, failed to inhibit exclusion of arsenite (Dey and Rosen, 1995).  This result indicated 
that the removal of arsenite in cells containing both arsA and arsB genes was ATP 
dependent.  In cells expressing only the arsB gene, arsenite was excluded in the presence 
and absence of ATP.  This exclusion was inhibited by the addition of cyanide, showing 
that respiration rather than ATP levels sufficiently excludes arsenite.  When the 
uncoupler CCCP (carbonyl cyanide m-chlorophenylhydrazone) which destroys the pH 
and ion gradients was added to cells only expressing arsB, arsenite was immediately 
taken up by the cells.  This indicated that a proton motive force is necessary for the 
transport of arsenite when only the ArsB protein is present (Figure 1.1).    
 
These results indicated that ArsB on its own is significant for arsenite resistance.  The 
question of why the arsA gene exists was then raised.  Dey and Rosen (1995) 
hypothesized that the ArsAB complex is a more effective resistance mechanism than 
ArsB alone.  Under conditions of stress, the ATP levels will drop more slowly than the 
membrane potential, making the ArsAB complex a much more effective mechanism in 
the environment where conditions can change rapidly.  The specificity of this extrusion 
system is also of great importance.  It only transports arsenite and antimonite.  This 
specificity may be a mechanism by which the cell circumvents phosphate starvation, 
because if the ArsB system were able to transport arsenate, it might also transport the 
structurally similar phosphate oxyanion, leaving the cell depleted of phosphate (Messens 
et al., 1999). 
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 Researchers also wanted to determine the chemical nature of the arsenite that is being 
pumped through ArsB.  Chen et al. (1996) suggested two possibilities.  AsIII or SbIII may 
be electrophoretically transported in response to a positive exterior membrane potential.  
Another possibility is that AsIII or SbIII binds to the cysteine residue in the ArsB protein 
and is then transported as a soft metal.  To investigate the role of the only cysteine in 
ArsB, Cys369 was changed to serine and alanine codons by site-directed mutagenesis 
(Chen et al., 1996).  Cells bearing both pBC101 (arsRDBC) and pArsA (arsA) showed 
high levels of resistance to arsenite.  No change in resistance was detected when pBC101 
was replaced with the mutant arsB C369S or arsB C369A.  Thus, Cys369 is not required for 
arsenite resistance, indicating that the transport of arsenite by ArsB alone does not 
involve metal thiol chemistry.  The most likely alternative way of transport is suggested 
to be electrophoretic anion transport.  These weaker interactions assist with easy release 
of AsIII or SbIII extracellularly (Rosen, 1999).  This was confirmed when the uptake of 
labeled arsenite by everted membrane vesicles expressing only arsB was coupled to 
membrane potential (Kuroda et al., 1997).    
 
1.4.2. ArsC (Arsenate Reductase) 
In the primordial anaerobic environment, arsenite would have been the major chemical 
species.  This led to the evolution of transporters such as ArsB that could extrude arsenite 
out of the cell.  As the atmosphere became more oxidizing, arsenate would have replaced 
arsenite, as arsenate is the thermodynamically favorable form under aerobic conditions.  
A mechanism of arsenate resistance is of great importance for survival.  Proteins evolved 
that were able to reduce arsenate to arsenite, which could then be pumped out of the cell 
by existing transport systems, such as ArsB (Rosen, 1999; Jackson and Dugas, 2003).   
 
Chen et al. (1986) identified a 16 kDa protein on plasmid R773 of E. coli that was 
essential for resistance to arsenate, but not arsenite.  It was first thought that ArsC 
functioned as an intracellular substrate-binding protein, making arsenate accessible to the 
ArsAB membrane complex, which would then function as an arsenate efflux system.  Ji 
and Silver (1992) demonstrated that this hypothesis was incorrect.  They showed that 
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arsenite was exported from a cell when arsenate was added in the presence of ArsC from 
Staphylococcus aureus plasmid pI258.  They concluded that the S. aureus ArsC protein 
(131 aa) functions as an arsenate reductase, converting intracellular arsenate to arsenite, 
which could then be extruded out of the cell by ArsB.  They also found arsenate 
reductase activity in the cytoplasm.  An important question was the mechanism of energy 
coupling for the reduction of arsenate to arsenite.  Purified ArsC protein coupled in vitro 
with thioredoxin and dithiothreitol (a nonbiological thiol compound) reduced arsenate to 
arsenite.  Reduced glutathione or 2-mercaptoethanol was unable to reduce arsenate to 
arsenite.  Thioredoxin can regenerate reduced cysteine residues on intracellular enzymes.  
The involvement of cysteine residues found in the sequence of ArsC in the reduction of 
arsenate to arsenite was suggested and that thioredoxin is necessary to keep the cysteine 
residues in a reduced state (Ji and Silver, 1992). 
 
The ArsC protein (141 aa) of E. coli plasmid R773 also functions as an arsenate 
reductase, even though it exhibits less that 20% identity to the ArsC of S. aureus plasmid 
pI258 (Oden et al., 1994).  Mutations in gshA (encodes γ-glutamylcysteine) and gshB 
(encodes glutathione synthetase), which form glutathione, showed wild-type levels of 
arsenite resistance when the R773 ars operon was present, but reduced levels of arsenate 
resistance.  Strains with mutations in either trxB (thioredoxin reductase) or trxA 
(thioredoxin) had wild type resistance to arsenate and arsenite.  These results indicated 
that unlike the ArsC of S. aureus that requires thioredoxin for conversion of arsenate to 
arsenite, the ArsC of E. coli requires glutathione for the detoxification of arsenate (Oden 
et al., 1994).  
 
Sequence homologies and amino acid sequence alignments suggested that arsenate 
reducing enzymes arose independently a number of times (Rosen, 1999).  Recent X-ray 
crystallographic solutions of protein structure and reaction pathways also indicated on an 
independent evolvement of different arsenate reductases.  Based on the latter findings, 
arsenate reductases are divided into three families.  The first family includes E. coli and 
uses glutathione/glutaredoxin (GSH/Grx) to reduce arsenate.  The second family includes 
S. aureus and B. subtilis and uses thioredoxin (Trx) to reduce arsenate.  The third family 
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is the only eukaryotic family and is called the yeast Arr2p family (Mukhopadhyay et al., 
2002; Mukhopadhyay and Rosen, 2002).  This family was not relevant to the work 
presented in our study and will therefore not be discussed. 
 
The GSH/Grx clade 
The main characteristic of this family of arsenate reductases is that arsenate reduction is 
dependent on the presence of reduced glutathione and glutaredoxin.  Since these reducing 
equivalents derive from cysteine thiolates, Liu et al. (1995) investigated the possibility 
that cysteinyl residues within the protein are involved in catalysis.  The ArsC protein of 
plasmid R773 has only two cysteine residues, Cys12 and Cys106.  By using site-directed 
mutagenesis four mutants in the Cys12 codon were constructed.  Cells expressing all the 
mutant arsC genes were sensitive to arsenate.  This indicated that Cys12 plays an essential 
role in catalysis and that it must be located at the active site of ArsC.  Tsai et al. (1997) 
hypothesized that a single thiol group may be efficient for reductase activity.  An enzyme 
complex forms by arsenylating Cys12, with the interaction of glutaredoxin with the 
complex.  The result is the transfer of electrons to reduce arsenate to arsenite.    
 
The product of the grxA gene, glutaredoxin 1 (Grx1), is a glutathione-dependent dithiol 
hydrogen donor for enzymes such as arsenate reductases.  In the search for alternate 
reductants of ribonucleotide reductase, two new glutaredoxins, Grx2 and Grx3 (each of 
which has a Cys-Pro-Tyr-Cys dithiol consensus sequence) were identified.  By studying 
the efficiency of these glutaredoxins to serve as a hydrogen donor, Grx2 was identified as 
the predominant glutaredoxin in E. coli cells (Shi et al., 1999).  The general function of 
Grx is that it can either catalyze intraprotein disulfide bond reduction or catalyze the 
reduction of mixed disulfides between a Cys thiol and glutathione (Bushweller et al., 
1992).  All three glutaredoxins of E. coli have two cysteine residues in their active site.  It 
has been shown that the N-terminal cysteine is required for both protein disulfide 
reduction and reduction of mixed protein-glutathione disulfides.  To determine the 
function of the glutaredoxins in arsenate reduction, single cysteine mutants of all three E. 
coli glutaredoxins were constructed.  Mutants lacking the C-terminal cysteine had no 
effect on ArsC activity.  When the N-terminal cysteine was substituted with serine, 
 27
neither Grx1, Grx2 or Grx3 could serve as a hydrogen donor for arsenate reduction.  This 
was consistent with a reaction cycle where the ArsC forms a mixed disulfide with 
glutathione.  The role of glutaredoxin is thus to regenerate the reduced arsenate reductase 
by reducing the mixed disulfide (Shi et al., 1999). 
 
Martin et al. (2001) reported X-ray crystal structures for three forms of ArsC, without 
bound arsenic and crystals complexed with arsenate and arsenite respectively.  No 
relationship was found between the tertiary structures of E. coli R773 (GSH/Grx clade) 
and the structures of S. aureus and B. subtilis (Trx clade).  While the Trx clade has a core 
of four parallel β-sheet regions, the GSH/Grx clade has one antiparallel β-sheet segment.  
The Trx clade ArsC also exhibits a low rate of phosphatase activity, while the ArsC of 
the GSH/Grx clade does not exhibit any phosphatase activity (Zegers et al., 2001) 
 
For arsenate reduction to occur in E. coli, ArsC must form an active quaternary complex 
with GSH, arsenate and Grx simultaneously (Liu and Rosen, 1997).  The catalytic Cys12 
in the active site of ArsC is surrounded by a group of five basic residues, His8, Arg16, 
Arg60, Arg94 and Arg107.  Together these five residues lower the pKa value of Cys12 to 6.4 
(Gladysheva et al., 1996; Martin et al., 2001).  Three of these basic residues, Arg60, Arg94 
and Arg107 interact directly with the arsenate and arsenite intermediates.  Arg60 and Arg94 
temporarily exchange places in the presence of arsenate to enhance hydrogen-bonding 
and stabilization of the intermediate.  Arg107 remains stationary and binds the O1 oxygen 
attached to arsenic throughout the reduction reaction (Shi et al., 2003).  The role of Arg60 
in product formation was further evaluated by mutagenesis.  Crystal structures of an ArsC 
protein with a substitution for Arg60 equilibrated with arsenite revealed that Arg60 plays 
an important role in the stability of the bound arsenite product (DeMel et al., 2004).  
 
Based on previous research and crystal structures by Martin et al. (2001) and DeMel et 
al. (2004) the following reaction mechanism is proposed (Figure 1.6): 
Step1 involves the nucleophilic attack by Cys12 on an arsenate that is noncovalently 
bound at the sulfate ion in the active site, followed by the release of OH-.  The result is 
the formation of a thioarsenate binary adduct of ArsC (Intermediate I).  The existence of 
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this adduct was demonstrated by a difference in electron density.  The close proximity of 
Arg60, Arg94 and Arg107 plays a very important role in the binding of arsenate.  Upon 
reaction of arsenate with ArsC, Arg60 and Arg94 move to new orientations in the protein 
that allow both side chains to bind to the arsenate adduct. 
Step 2 involves the nucleophilic attack of glutathione on the arsenate adduct, with the 
release of water.  The result is the formation of a {ArsC Cys12}S-As-S{glutathione} 
tertiary complex (Intermediate II).  Glutathione only reacts after arsenate binds to the 
active site.  The reaction also requires a free thiol on glutathione and ArsC to proceed.  
The structure of intermediate II has not yet been obtained. 
Step 3 involves the binding of glutaredoxin to intermediate II, with the reduction of 
arsenate, producing a dihydroxy arsenite intermediate (Intermediate III).  A mixed 
disulfide (GrxS-SG) is released that would be recycled by glutathione reductase using a 
second equivalent of GSH.  This intermediate can only be observed in mutant structures 
because it is not stable in the native enzyme. 
In step 4 a monohydroxy, positively charged arsenite adduct is formed (Intermediate IV).  
This arsenite adduct has an unusual structure because it has only two atoms linked to the 
arsenite atom.  This thiarsahydroxyl complex is much more unstable that most cysteine-
arsenite complexes.  It is suggested that this unstable conformation is necessary to ensure 
that arsenite does not function as an inhibitor of ArsC. 
In step 5 arsenite is released upon the addition of a free OH-.  ArsC now returns to its 
original conformation.  
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Figure 1.6:  The proposed reaction mechanism of the E. coli R773 ArsC arsenate 
reductase (taken from DeMel et al., 2004).  See text for details. 
 
The ars operon of Synechocystis sp. Strain PCC 6803 contains an ArsC homolog that 
exhibits 36 and 45% sequence identity to S. aureus and B. subtilis, respectively.  This 
ArsC (SynArsC) exhibited weak phosphohydrolase activity, which is indicative of its 
descent from the LMW PTPase (low molecular weight protein tyrosine phosphatase) 
family of protein phosphatases.  Like the ArsC of pI258, SynArsC contains three 
essential cysteine residues.  All of the above indicate that SynArsC should belong to the 
Trx clade of arsenate reductases.  SynArsC however, employs glutathione and 
glutaredoxin instead of thioredoxin as the source of reducing equivalents, making it part 
of the GSH/Grx clade of arsenate reductases.  It appears that SynArsC and pI258 
represent different branches in the evolution of their shared phosphohydrolytic ancestor 
(Li et al., 2003)      
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The catalytic mechanism of SynArsC combines certain features from its S. aureus 
homolog with others from the E. coli R773 ArsC.  Like R773, SynArsC forms a complex 
with glutathione.  Both the active site cysteine residue and arsenate were needed for 
complex formation.  Glutaredoxin also restored SynArsC to its reduced, catalytically 
ready state.  A major difference between the mechanism of SynArsC and R773 is that the 
latter requires only a single active-site cysteine, while SynArsC needed two more 
cysteine residues (Cys80 and Cys82) for catalysis.  These two cysteines are similarly 
positioned to cysteine residues that play a key role in the reaction mechanism of pI258.  
Li et al. (2003) proposed a possible reaction scheme for SynArsC: 
Step 1-3 is the same as for R773.  An arsenoenzyme intermediate is formed that is 
attacked by glutathione to form a cysteinyl-arsenoglutathione tertiary complex.  This 
complex is then broken down to yield arsenite by the binding of glutaredoxin.  Step 4-6 is 
a modified version of the reaction mechanism of pI258 ArsC.   
In step 4 a reaction takes place between the mixed disulfide bond of Cys8 and glutathione 
and the internal disulfide between Cys80 and Cys82.  The result is a shift of the mixed 
disulfide with glutathione to the surface of the enzyme. 
In step 5 glutaredoxin reduces the mixed disulfide. 
Step 6 involves the restoration of the active site cysteine to its reduced, reactive state.  
The original disulfide bond between Cys80 and Cys82 is also restored. 
 
The Trx Clade 
The most important characteristic of this family of arsenate reductases is that it requires 
the coupling to thioredoxin (Trx), thioredoxin reductase (TR) and NADPH to be 
enzymatically active (Ji et al., 1994).  The ArsC of S. aureus pI258 has a characteristic 
PTPase fold.  It consists of a four-stranded parallel β-sheet and three α-helices.  Unlike 
the R773 ArsC, the ArsC of pI258 shows phosphatase activity with the model substrate 
p-nitrophenyl phosphate (Zegers et al., 2001).  The pI258 ArsC sequence revealed that it 
has four cysteine residues, Cys10, Cys15, Cys82 and Cys89.  Cys82 and Cys89 are not found 
in the R773 ArsC.  Messens et al. (1999) found that a substitution for any of Cys10, Cys82 
or Cys89 leads to an inactive enzyme.  Cys10 is similarly located to Cys12 of E. coli R773 
ArsC.  Cys10 also functions as the reaction site of the arsenate reductase.  By a series of 
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endoproteinase digestions after catalysis and peptide products identified by mass 
spectroscopy analysis, a Cys82-Cys89 oxidized cysteine was assigned to be the redox 
couple responsible for electron donation to arsenate. 
 
Zegers et al. (2001) determined the crystal structures of the reduced and oxidized forms 
of the S. aureus pI258 arsenate reductase.  The secondary and tertiary structures showed 
great homology to those of LMW-PTPases from mammals, indicating that the pI258 
ArsC may have evolved from LMW-PTPases.  The homology between pI258 ArsC and 
LMW-PTPases is concentrated mainly in the catalytic motif of tyrosine phosphatases (P-
loop), which has an identical CXGNXCR signature.  The pI258 ArsC sequence has very 
little homology to R773, except for a common Cys-X5-Arg anion binding motif.  
 
Messens et al. (2002) provided further X-ray crystal structures for the pI258 arsenate 
reductase, providing evidence that Cys82 nucleophilically attacks Cys10 to form a Cys10-
Cys82 disulfide.  This provides electrons to reduce arsenate to arsenite.  The overall 
structure of the reduced (active) and oxidized (Cys82-Cys89, inactive) forms are basically 
the same, except for a major change in conformation, with Cys89 moving towards Cys82 
to form a disulfide bond.  In addition to the three essential cysteine residues, Arg16 in the 
P-loop was also essential for catalysis as a substitution for Arg16 resulted in a loss of 
ArsC activity.  Mutational studies by Lah et al. (2003) revealed that potassium had a 
definite stabilizing effect on pI258 arsenate reductase. 
 
Messens et al. (2004) also studied the mechanism by which thioredoxin regenerates the 
pI258 ArsC to its active form.  A disulfide bridge between Cys10 and Cys15 in the P-loop 
is formed under oxidative stress.  This Cys10-Cys15 bridge is buried in the tertiary 
structure and is thus not accessible to thioredoxin.  It is hypothesized that the protection 
of this bond may be a way to protect Cys10 against irreversible oxidation, such as the 
oxidation to sulfenic and sulfinic acids.  Formation of a disulfide bridge between Cys10 
and Cys15 is thus responsible for redox regulation.  To reduce this buried Cys10-Cys15 
disulfide bridge, thioredoxin first reduces the surface exposed Cys82-Cys89 disulfide 
bridge.  Released Cys82 then attacks Cys10 in the buried disulfide bridge, forming a Cys10-
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Cys82 disulfide intermediate.  Cys89 then attacks Cys82, forming a Cys82-Cys89 disulfide 
bridge, releasing Cys10.  A second molecule of thioredoxin reduces the newly formed 
Cys82-Cys89 disulfide bridge, leaving a fully reduced ArsC.   
 
A third X-ray crystal structure for an arsenate reductase was reported, this time for the 
ArsC in the SKIN element in the chromosome of Bacillus subtilis (Bennet et al., 2001).  
The B. subtilis SKIN element ArsC contains 139 aa residues and shares about 65% 
identity to the ArsC of S. aureus.  It exhibited phosphatase activity with p-nitrophenyl 
phosphate. It also uses thioredoxin to convert arsenate to arsenite and it contains the same 
essential cysteine residues (Cys10, Cys82 and Cys89) and Arg16 as the S. aureus pI258 
ArsC.  Arg16 is thought to stabilize the active site and to lower the pKa values of Cys10, 
Cys82 and Cys89 in order for the reduction of arsenate to arsenite to occur.  By using high 
resolution NMR spectroscopy, the solution structures of both the reduced and oxidized 
forms of the B. subtilis ArsC has been determined (Guo et al., 2005).  Backbone 
dynamics demonstrated that in the reduced form the Cys82-Cys89 segment forms a helix 
that is not tightly structured and undergoes substantial conformational changes in the 
millisecond time scale.  This may facilitate the formation of covalent intermediates and 
the subsequent reduction of arsenate to arsenite.  In the oxidized form Cys82-Cys89 shows 
flexibility on a sub-nanosecond time scale, which is favorable for interaction with 
thioredoxin, which regenerates the ArsC for the next cycle of arsenate reduction.     
 
Based on work done by Zegers, Messens and Bennet a reaction mechanism for the S. 
aureus and B. subtilis ArsC is proposed (Figure 1.7).   
Step 1:  The reaction starts with ArsC in the reduced state.  Arsenate triggers a 
nucleophilic attack of the thiol of Cys10.  A covalent Cys10-HAsO3- intermediate is 
formed with the release of a hydroxyl that is protonated by the acidic Asp105 to form a 
water molecule.   
Step 2 involves the three essential cysteine residues in a triple redox relay system.  
Firstly, the thiol of Cys82 attacks Cys10 to form a Cys10-Cys82 disulfide bond.  Cys10 
donates its electron pair to the arsenate, reducing it to arsenite, which then dissociates 
from the enzyme.  Secondly, Cys89 attacks Cys82, forming a Cys82-Cys89 disulfide bond, 
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releasing Cys10.  The disulfide bridge formed by Cys82-Cys89 becomes exposed to the 
enzyme surface.  The positively charged Arg16 plays a very important role in stabilizing 
the P-loop and lowering the pKa values of the three cysteines involved to activate them 
for the above mentioned reactions. 
In Step 3 thioredoxin reduces the exposed Cys82-Cys89 disulfide, regenerating ArsC for 
the next cycle of reduction. 
 
 
 
 
Figure 1.7:  The proposed reaction mechanism of the B. subtilis ArsC arsenate reductase. 
The notation H+S- refers to the sulfhydryl group of a cysteine residue that will be 
protonated when placed in close proximity of a NH2+ group.  The notation E refers to the 
ArsC enzyme.  Adapted from Bennet et al. (2001).  See text for details.  
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1.4.3. Regulation of the ars operon 
1.4.3.1. ArsR 
The small 13 kDa ArsR protein from the E. coli plasmid R773 has been intensively 
studied.  The arsR gene encodes a trans-acting repressor that binds as a dimer to an 
operator and represses transcription.  Wu and Rosen (1991) showed that the expression of 
this ArsR protein was autoregulated and that this expression was repressed in the absence 
of inducers (AsIII and SbIII).  In the presence of inducers the expression was induced.  
Although the ArsR has been shown to be a trans-acting regulator, the arsR sequence 
contains no obvious DNA binding motif.  Further studies by Wu and Rosen (1993a) led 
to the finding of the ArsR protein binding site.  Using DNase I footprinting assays they 
found that the ArsR repressor binds to the DNA just upstream (from -64 to -40) of the -35 
site.  The ArsR would thus interfere with transcriptional initiation.  The ArsR binding site 
contains an imperfectly symmetrical dyad that may be important for repressor recognition 
and binding.  Hydroxyl radical footprinting revealed two small 4 bp regions of protection.  
Ten bp separated these two regions, indicating that the repressor only binds to one side of 
the DNA.  The two short protected areas also indicated that the active form of ArsR must 
be a dimer.  Gel retardation assays demonstrated the formation of DNA-ArsR protein 
complexes, with the release of the ArsR protein on interaction with AsIII or SbIII (Wu and 
Rosen, 1993a). 
 
The ArsR protein belong to a new family of metalloregulatory proteins called the 
SmtB/ArsR family.  This family functions exclusively as transcriptional repressors and 
includes the Synechococcus sp. SmtB repressor (activated by zinc) that represses the 
smtA gene (encodes for metallothionein), the E. coli ArsR repressor and the S. aureus 
pI258 CadC repressor (activated by cadmium).  Cook et al. (1998) determined the crystal 
structure of the SmtB metallothionein repressor.  It is suggested that the ArsR proteins 
will have a similar structure to SmtB.  Bairoch (1993) proposed that the E. coli ArsR 
contains a DNA-binding helix-turn-helix structure at residues 32-52, containing two 
conserved cysteine residues. Sequence alignments of members belonging to the 
SmtB/ArsR family of regulators revealed a highly conserved ELCVCDL region (Shi et 
al., 1994). However, not all the members of this family contain this consensus sequence, 
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e.g. the ArsR of At. ferrooxidans (Butcher and Rawlings, 2002).  To identify the inducer 
binding domain in ArsR, three mutants with a noninducible phenotype (C32Y, C32F and 
C34Y) were isolated.  The mutated ArsR proteins were still able to bind to the ars 
promoter, but they had reduced inducer response.  This indicated that Cys32 and Cys34 
forms part of the metal binding site of ArsR and that the cysteine residues are located 
outside of the DNA-binding helix-turn-helix motif.  Binding of a metal induces a 
conformational change in the helix-turn-helix domain, resulting in the dissociation of the 
repressor from the DNA.  A His50 mutation (H50Y) located in the helix-turn-helix motif 
resulted in constitutive expression, suggesting a decrease in binding of the ArsR protein 
to DNA (Shi et al., 1994).  
 
In most molecule thiolates-AsIII complexes, AsIII is three-coordinated, therefore Shi et al. 
(1996) proposed that a third arsenic ligand (only Cys32 and Cys34 had been identified) 
may be involved in metal binding.  In addition to Cys32 and Cys34, the ArsR contains 
three more cysteine residues, Cys37, Cys108 and Cys116.  Cys108 and Cys116 have been 
shown not to be involved in repressor function (Wu and Rosen, 1991).  When Cys37 was 
altered to alanine, it had no effect on regulation or DNA binding.  X-ray absorption 
spectroscopy of the AsIII-ArsR complex showed that AsIII is coordinated to three sulfur 
atoms.  Shi et al. (1996) investigated the possibility that only two coordinates are needed 
for metal binding.  Phenylarsine oxide (PAO) was used as it can form only two 
coordinates, but can still act as a good inducer.  Interaction with PAO can be measured 
using matrix-bound PAO.  ArsR proteins in which only Cy32 or Cys34 were altered to 
glycine bound strongly to the PAO resin, but a C32G/C34G double mutant was unable to 
bind to POA.  If binding requires two groups, an additional ligand must have been 
present when only Cys32 or Cys34 was involved.  It was suggested that binding requires 
two cysteine residues, and that any combination of Cys32, Cys34 and Cys37 will produce a 
conformational change that results in the release of the ArsR repressor from the DNA.  
Cys37 is thus dispensable for function, but participates in binding when present.   
 
The chromosome of E. coli also contains an arsRBC operon (Carlin et al., 1995). Xu et 
al. (1996) further studied the E. coli chromosomal ArsR.  The chromosomal and R773 
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ArsRs exhibit 75% sequence similarity and therefore, as expected, most characteristics 
were shown to be the same.  The chromosomal ArsR was able to regulate expression of 
the ars operon, functioned as a homodimer and bound to promoter DNA.  Induction also 
resulted in the dissociation of the repressor from the DNA.  Analysis of the ArsR binding 
site revealed that both the chromosomal and R773 ars sequence contained a TCAT and a 
TTTG region separated by 7 bp.  It was thus possible that the two regulators could bind to 
each other’s promoter.  It was found that the chromosomal repressor and the repressor 
from R773 were interchangeable, as the chromosomally-encoded repressor was able to 
regulate expression of the R773 ars operon, and the R773 repressor cross-regulated 
expression of the chromosomal ars operon (Xu et al., 1996).    
 
It was proposed that members of the ArsR/SmtB family of repressor proteins have at least 
three domains, namely a metal binding domain, a DNA binding domain and a 
dimerization domain.  While the first two domains have been identified, no evidence 
could locate the dimerization domain to a specific region in ArsR.  Xu and Rosen (1997) 
investigated the dimerization properties of the E. coli chromosomal ArsR by using the 
yeast two-hybrid system.  Results indicated that residues 1-8 and 90-117 are not required 
for the dimerization of ArsR.  β-galactosidase assays and gel mobility shift assays 
showed that dimers, but not monomeric ArsRs were able to bind to the ars promoter.  
This led to the conclusion that a core of approximately 80 residues is sufficient for all the 
ArsR regulatory properties: metal binding, DNA binding and dimerization.  
 
An evolutionary and structural study of six members of the SmtB/ArsR family produced 
new insights on the evolution of metal resistance in this family (Busenlehner et al., 
2003).  The authors found that two distinct metal binding sites exist in this family.  The 
first is present in the α3 helix [ELCV(C/G)D] and is termed the α3N metal binding site.  
The second metal binding site is present in the α5 helix and is called the α5C metal 
binding site.  The α3N site is represented by S. aureus pI258 CadC, Listeria 
monocytogenes CadC and the E. coli ArsR, while the α5C binding site is represented by 
Synechococcus SmtB, Synechocystis ZiaR, S. aureus CzrA and Mycobacterium 
tuberculosis NmtR (Figure 1.8).  The authors suggested that individual members of this 
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family have evolved distinct metal specificity profiles by the alteration of one or both of 
the α3N and α5C metal binding sites.  The structures of all the metal-inducible operons 
contain one or two (in the case of the smt operon) imperfect 12-2-12 inverted repeats 
(Busenlehner et al., 2003). 
 
 Figure 1.8:  Different metal resistance operons regulated by the SmtB/ArsR family of 
transcriptional regulators.  Dark grey boxes indicate repressor genes, while light grey 
boxes indicate resistance genes.  Arrows indicate the positions of the imperfect 12-2-12 
inverted repeats.  Adapted from Busenlehner et al. (2003).    
 
In an attempt to increase the bioaccumulation of arsenic, the chromosomal ArsR of E. 
coli was overexpressed (Kostal et al., 2004).  This overexpression resulted in elevated 
levels of arsenite in cells.  High levels of ArsR could possibly compete with ArsB for 
intracellular AsIII, thus rendering the bound AsIII in a nontoxic form by sequestration.  
Another possibility is that the overproduction of ArsR may result in repression of the ars 
operon, reducing the efflux efficiency of ArsB and increasing the intracellular 
sequestration of AsIII.  This could be a promising alternative to chemical ligands for the 
treatment of contaminated water.    
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1.4.3.2. ArsD          
A second regulatory protein, the ArsD, has been identified for the plasmid encoded R773 
ars operon of E. coli (Wu and Rosen, 1993b).  Like the ArsR protein, the ArsD also 
encodes a trans-acting regulatory protein.  Although both the ArsR and ArsD proteins are 
13kDa homodimers, they share no sequence similarity.  A frameshift mutation introduced 
within the arsD gene resulted in elevated levels of expression of three downstream ars 
genes.  When the arsD gene was co-expressed in trans the elevated expression of the ars 
operon was reduced to wild-type levels.  It appeared that the down-regulation of the ars 
operon was dependent on the amount of ArsD present.  This indicated that the arsD gene 
is required for resistance when the arsABC genes are controlled by the ars promoter.  The 
authors suggested that a regulatory circuit is formed by ArsR and ArsD (Wu and Rosen, 
1993b).    
 
Chen and Rosen (1997) revealed that ArsD is a homodimer consisting of two monomeric 
129 aa residue monomers.  By using DNase I footprinting experiments it was shown that 
ArsD binds to the same promoter site occupied by ArsR before induction.  The ArsD 
however, binds with two orders of magnitude lower affinity than ArsR.  Repression of 
ArsR was relieved with 10μM arsenite, while ArsD repression could only be relieved 
with the addition of 100μM arsenite.  This suggested that the ArsR has a higher affinity 
for inducer than ArsD. 
 
ArsD has three vicinal cysteine pairs, Cys12-Cys13, Cys112-Cys113 and Cys119-Cys120.  Li et 
al. (2001) investigated the role of these cysteines in the repression of the ars operon.  No 
effect on repressor or metalloid responsiveness was observed when the Cys119-Cys120 pair 
were mutated or deleted.  Mutations in either the Cys12-Cys13 or the Cys112-Cys113 pair 
had no effect on repression of the ars operon, but resulted in a loss of inducibility.  This 
result suggested that both the Cys12-Cys13 and Cys112-Cys113 pair form metalloid-binding 
sites.  Binding of both of the cysteine pairs to AsIII or SbIII is believed to be required for 
ArsD function.  The fact that ArsD binds to the promoter as a dimer, suggests that ArsD 
appears to have four one-half metalloid-binding sites instead of two (Li et al., 2001).  
Based on the above results experiments were designed to test whether these binding sites 
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act in tandem or independently to trigger a conformational change in ArsD in order to 
dissociate from the promoter (Li et al., 2002).  Results of tryptophan fluorescence 
experiments suggested cooperativity between the four binding sites of ArsD.  The authors 
proposed that metalloid-binding sites are formed between equivalent residues of each 
subunit of the dimer.  They also propose that the binding sites bind metalloids 
sequentially, starting with Cys113 and ending with Cys12.  Dissociation will occur when 
the concentration of metalloid bound to ArsD is sufficient. 
 
Based on work done by Chen and Rosen (1997) a model for regulation of the ars operon 
by ArsR and ArsD was proposed (Figure 1.9): When no environmental arsenite or 
antimonite (inducer) is present, ArsR (which has a higher affinity than ArsD for the ars 
promoter) would bind to the operator and repress expression of the ars operon.  ArsR also 
has a higher affinity for inducer than ArsD, and therefore a low level of inducer would 
result in the dissociation of the ArsR, resulting in the expression of the ars operon.  
Continued expression of the ars operon would result in increasing amounts of ArsD.  
When the ArsD concentration reaches a critical level it would bind to the ars operator site 
and repress expression.  This is important as the overexpression of certain proteins, like 
ArsB, is toxic to the cell.  Because ArsD has a lower affinity for inducer, a low 
concentration of inducer would not prevent the ArsD from binding to the operator site.  If 
the inducer level reaches a certain concentration, ArsD would dissociate from the 
operator and expression would take place.  These two regulators thus form a regulatory 
circuit with ArsR controlling the basal level of expression, while ArsD controls the upper 
level of expression.  
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  Figure 1.9:   A model for regulation of the E. coli R773 ars operon by the ArsR-ArsD 
metalloregulatory circuit.  Adapted from Chen and Rosen, (1997).  See text for details. 
 
 
1.5. Aim of thesis 
At. caldus plays a very important role in a commercial biooxidation process called 
biomining.  During this process various acidophilic bacteria either convert insoluble 
metal sulfides to water soluble metal sulphates or they break up the structure of the 
mineral, thus permitting other chemicals to penetrate the mineral and solubilize the 
desired metal.  During this process of mineral solubilization, toxic arsenic compounds are 
leached into the environment.  To survive in such an arsenic-rich environment, biomining 
bacteria evolved arsenic resistance mechanisms.  The bacterial consortium used in the 
biomining process became more resistant to arsenic over a period of time.  Research on 
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the ars systems of At. caldus revealed that At. caldus strain #6 is more resistant to arsenic 
than other At. caldus strains (Tuffin et al., 2004).   
 
Two copies of transposon-linked arsenic resistance operons have already been isolated 
from At. caldus #6 (Tuffin et al., 2004) and evidence suggests that there may be a third 
ars operon.  This study is aimed at isolating and characterizing the third ars operon of At 
caldus #6.  Expression and regulatory studies will be performed on the ars operon and 
possible interaction between the three operons analyzed.       
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2.1. Introduction 
 
Previously two copies of transposon-linked arsenic resistance operons were described for 
At. caldus strain #6 (Figure 2.1 a and b), with operon b a truncated version of operon a.  
These two operons were named family A and family B respectively.  The ars genes in 
clone family A are located within a 12.2 kb transposon.  This transposon has Tn21-like 
inverted repeats (IR) and contains a resolvase and transposase characteristic of the Tn21-
like family.  Located between the transposase and resolvase genes, arsenic resistance 
genes with high homology to arsR, arsC, duplicate copies of arsD and arsA, and arsB 
were identified.  Two more ORFs were identified between the second copy of arsA and 
the arsB.  ORF7 showed clear homology to the NADH-dependent dehydrogenase of 
Thermoanaerobacter tencongensis, while ORF8 showed homology to the cystathione-ß-
synthase (CBS) domain of Desulfitobacterium hafiense.  Clone family B contains a series 
of genes similar to those found in family A, except that only a single copy of arsD and 
arsA is present and no ORF8, arsB and tnpA or second IR have been reported (Tuffin et 
al., 2004).   
 
Probing of the DNA of At. caldus strain #6 with the transposon-borne arsB revealed a 
strong 15-kb signal, while a faint 2.5-kb signal was detected at low stringency conditions 
(Figure 2.2 a; de Groot et al., 2003).  The 2.5-kb signal represented a possible 
chromosomal arsB gene and the strong 15-kb signal the transposon arsB.  Probing with 
the chromosomal arsC of At. ferrooxidans yielded a stronger 2.5 kb signal, and a weaker 
signal in the 13-15 kb region (Figure 2.2 b).  These results suggested that there was a 
third arsenic operon in At. caldus.  Based on the above evidence, and on the known 
arsRBC structure of most chromosomal arsenic operons like that of E. coli, it was thought 
that At. caldus might contain a chromosomal arsenic operon.    
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Figure 2.1:  Two transposon-linked arsenic resistance operons identified in At. caldus 
strain #6.  IR, inverted repeats; tnpR and tnpA are genes encoding for resolvase and 
transposase, respectively; R, C, D, A and B are arsenic resistance genes; 7 and 8 are 
ORF7 and ORF8, respectively; trpL and trbJ are homologs to conjugation genes from the 
Ti plasmid of A. tumefaciens (taken from Tuffin et al., 2004). 
 
 
A preliminary study involved the screening of an At. caldus genebank for the ability to 
confer arsenic resistance to the E. coli arsenic mutant, ACSH50Iq.  Colony hybridizations 
were performed on clones that were able to confer resistance to arsenic.  Plasmids that 
did not give a signal when probed with the transposon-borne arsDA, but hybridized with 
arsB and arsC of At. ferrooxidans, were believed to contain the At. caldus chromosomal 
ars operon. Two plasmids fitted these criteria, pTcC-#4 and pTcC-#6, and were selected 
for further studies.  Restriction mapping of the inserts of the two plasmids revealed that 
pTcC-#4 contained the complete 8.6 kb insert of pTcC-#6, with an additional 1.1 kb on 
the one end.  Analysis of partial sequences revealed homology to arsR and arsB from 
other ars operons (Figure 2.3). The sequences differed from the transposon ars genes that 
have already been isolated from At. caldus.  
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Figure 2.2:  Southern hybridization of chromosomal DNA from six At. caldus strains, 
digested with BamHI and probed with (A) the transposon-borne arsB from At. caldus 
strain #6 (less stringent conditions) and (B) the arsC from At. ferrooxidans (De Groot et 
al., 2003).   
   
Figure 2.3:  Arrangement of the At. caldus #6 chromosomal ars operon (based on 
preliminary results).  
 
 
Here I report on the sequence analysis of the chromosomal ars operon of the arsenic 
tolerant At. caldus strain #6.  I further show that this operon is functional in E. coli and 
confers arsenite and arsenate resistance in E. coli ACSH50Iq.   
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2.2. Methods 
 
2.2.1. Media, bacterial strains and plasmids 
Bacterial strains, plasmids and primers used in this study are listed in Table 2.1.  E. coli 
strains were grown in Luria-Bertani (LB) broth medium (Sambrook et al., 1989) with 
ampicillin (100 μg/ml) or kanamycin (50 μg/ml) added as required.  At. caldus strains 
were grown at 37oC in tetrathionate medium (3 mM), autoclaved and adjusted to pH 2.5 
(Rawlings et al., 1999b)  
 
 
Table 2.1:  Bacterial strains, plasmids and primers used in this study  
           
Strain, plasmid 
or primer 
Description Source or 
reference 
Strains   
Acidithiobacillus 
caldus  
  
#6 Fairview mine, Barberton, S. Africa Rawlings et.al. 
(1999b) 
   
E. coli   
DH5α Ф80dlacZΔM15, endA1, recA1, gyrA96, thi-1, 
hsdR17 (rk-, mk+), relA1, supE44, deoR,Δ(lacZYA-
argF) U169  
Promega 
XL 1 Blue recA1, endA1, gyrA96, thi, hsdR17 (rk-, mk+), relA1, 
supE44, relA1, lac [F’ proAB+ lacIqZΔM15 
::Tn10(tetr)] 
Stratagene 
ACSH50Iq rpsL, Δ(lac-pro), Δars::cam Butcher & 
Rawlings 
(2002) 
BH5262 K-12 araD139?, galU, galK, hsdR, rpsL, argH1, 
trxA7004, ilvC::Tn10, gshA 
Lim et al. 
(1986) 
   
Plasmids   
pEcoR252 Apr, EcoRI inactivation cloning vector Zabeau & 
Stanley (1982) 
pBluescript SK Apr, LacZ’, ColE replicon, cloning vector Stratagene 
pGL10 Kmr, RK2/RP4 replicon, cloning vector A. Toukdarian 
pUCBM21 Apr, LacZ’, ColE1 replicon, cloning vector Boehringer-
Mannheim 
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pTrx6 Apr, contains At. ferrooxidans ATCC 33020 trxA 
gene cloned in pBluescript 
Powles  et al. 
(1995) 
pTcC-#4 Apr, 10kb Sau3A fragment of At. caldus #6 cloned 
into the BglII site of pEcoR252 
This study 
pTcC-#6 Apr, pTcC-#4 with arsC and ORF1 deleted. This study 
pTcC-PH29 Apr, A blunted 2.9kb PvuII-HindIII fragment from 
pTcC-#4 cloned into a blunted BglII site of  
pEcoR252  
This study 
pTcC-PH29GL Kmr, A 2.9kb PvuII-HindIII fragment from pTcC-
#4 cloned into a HindIII-SmaI site of pGL10   
This study 
pEcoBlunt Apr, pEcoR252 blunted at the BglII site and 
relegated to inactivate the EcoRI endonuclease 
Tuffin et al. 
(2005) 
pTcC-N1.3 Apr, A partial 1.3kb NcoI fragment from pTcC-
SH3.9 cloned into pUCBM21 
This study 
pTcC-Bs2.6 Apr, A blunted 2.6kb BstEII fragment from pTcC-
#4 cloned into a blunted BglII site of  pEcoR252 
This study 
pTcC-RB+5 Apr, pTcC-#6 cut with BstEII-SphI, blunted and 
ligated 
This study 
pTcC-RB-5 Apr, pTcC-#6 cut with PvuII-SphI, blunted and 
ligated 
This study 
   
  
 
2.2.2. DNA isolation and manipulations 
Small-scale plasmid preparation, restriction endonuclease digestion, ligation, gel 
electrophoresis and Southern blot hybridization were performed using standard methods 
(Sambrook et al., 1989).  Large-scale preparation of plasmid DNA was done with 
Nucleobond AX100 (Macherey-Nagel) or by using the alkaline lysis method, followed by 
CsCl gradient centrifugation.  Sequencing was done by the dideoxy chain termination 
method, using an ABI PRISMTM 377 automated DNA sequencer.  The sequence was 
analyzed using a variety of software programmes, but mainly by DNAMAN (version 4.1; 
Lynnon Biosoft).  Comparison searches were performed using the gapped-BLAST 
program of the National Center for Biotechnology Information (Altschul et al., 1997; 
http://www.ncbi.nlm.nih.gov/BLAST). The phylogenetic tree was constructed using the 
Multiple Sequence Alignment tool in DNAMAN. 
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2.2.3. Arsenic resistance assays 
To test for arsenic resistance in E. coli, constructs were transformed into competent E. 
coli ACSH50Iq cells.  Growth assays to determine resistance to arsenite (AsIII) were 
carried out in Luria Bertani (LB) medium.  Growth assays to determine the resistance to 
arsenate (AsV) were performed in low-phosphate medium (Oden et al., 1994), 
supplemented with 2 mM K2HPO4.  Overnight cultures were diluted 100-fold into fresh 
medium containing the appropriate antibiotics, 0.25 mM sodium arsenite and 0.5 mM 
sodium arsenate.  Cultures were incubated at 37oC and absorbance reading (600 nm) 
determined every hour until stationary phase.   
 
2.2.4. Analysis of the arsenate reductase mechanism 
To test for arsenate resistance in the E. coli, pTcC-PH29GL (contains the At. caldus 
chromosomal ars genes cloned in pGL10) and pTrx6 (contains the At. ferrooxidans trxA 
gene) were transformed in the E. coli BH5262 double mutant (which has mutations in the 
thioredoxin gene and the γ-glutamylcysteinyl gene).  As controls pGL10 was transformed 
into E. coli BH5262 with co-resident plasmids pTrx6 and pKS respectively, and pTcC-
PH29GL in E. coli BH5262 with co-resident pKS (Table 2.3).  To determine resistance to 
arsenate, cells were plated on Luria agar containing 0, 1 and 2 mM sodium arsenate and 
were incubated overnight at 370C.  
 
 
2.3. Results 
 
2.3.1. Cloning of construct pTcC-#4 
The inserts of the two plasmids, pTcC-#4 and pTcC-#6, that were isolated as described in 
the introduction, were mapped and revealed that pTcC-#4 contained the complete 8.6 kb 
insert of pTcC-#6, with an additional 1.1 kb on one end.  The source of the pTcC-#6 
insert was confirmed by Southern hybridization. An internal 1.3 kb NcoI fragment 
(Figure 2.4) was labeled and used to probe the chromosomal DNA of At. caldus strain #6 
and pTcC-#6 plasmid DNA digested with StuI, BamHI, NcoI and SalI.  The following 
fragments were obtained for both the chromosomal DNA of At. caldus strain #6 and 
Figure 2.4:  Diagram showing the restriction endonuclease map of pTcC-#4 and clones constructed in this study.  Also shown are the 
position of the 1.3 kb NcoI probe used to determine the origin of pTcC-#6 and the ten ORFs identified. 
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pTcC-#6:  a 0.4 kb and 0.7 kb BamHI fragment, a 4.2 kb and 4.7 kb StuI fragment (the 
reason why the 4.2 kb and the 4.7 kb bands are not identical is that the 4.7 kb BamHI 
fragment contains part of the vector), a 0.85 kb and 0.4 kb NcoI fragment and a 9.3 kb 
SalI fragment (Figure 2.5).  This indicated that the insert DNA originated from At. caldus 
strain #6 was present in a single copy and that no rearrangements in the region of the 
probe and restriction fragments tested had occurred during cloning. 
 
 
Figure 2.5:  Southern hybridization analysis of At. caldus chromosomal DNA and pTcC-
#6 plasmid DNA probed with an 1.3 kb internal arsB fragment and digested with StuI, 
BamHI, NcoI and SalI.   
 
 
2.3.2. Sequence analysis of pTcC-#4 
The entire insert of pTcC-#4 was sequenced in both directions and ten open reading 
frames (ORFs) were identified based on sequence similarity with known genes in the 
NCBI database.  The results and characteristics of the predicted products of the ten ORFs 
are shown in Table 2.2 and Figure 2.4.  Homologs to the arsB and arsC genes of other 
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bacteria were identified.  Between the arsB and arsC genes, a third ORF was identified 
that showed homology to many transcriptional regulators of the ArsR family.  This ars 
operon however, differs from conventional chromosomal arsRBC operons like those of 
E. coli and Staphylococcus spp.  Unlike other systems where the arsC gene is located 
downstream of the arsB gene, the At. caldus chromosomal arsC gene is located upstream 
of the arsB gene.  The arsC and arsR genes are divergently transcribed to the arsB in a 
manner previously reported only for At. ferrooxidans (Butcher and Rawlings, 2000). 
 
 
Table 2.2:  Location and of ORFs identified in pTcC-#4  
ORF Position No. 
of aa 
Most related protein 
and predicted size 
%identity/ 
similarity 
(part of 
protein) 
Reference 
NCBI 
accession 
number 
ORF1 604-131 157 Lactoylglutathione 
lyase [Thermobifida 
fusca]  143aa 
 
Cadmium inducible 
protein CadI  
[Mycobacterium 
tuberculosis] 152aa 
 
34/52 (63) 
 
 
24/39 (116) 
ZP_00291564 
 
 
NP_217157 
arsC 1106-615 163 arsenate reductase 
[Acidithiobacillus 
ferrooxidans] 163aa 
78/87 (159) AAF69239 
 
arsR 1477-1112 121 ArsR-like protein 
[Acidithiobacillus 
ferrooxidans] 118aa 
74/84 (95) AAF69241 
 
arsB 1567-2874 435 arsenical membrane 
pump 
[Acidithiobacillus 
ferrooxidans] 436aa 
85/90 (418) AAF69238 
 
ORF5 2911-3303 130 Putative integrase for 
prophage CP-933R   
[Shigella flexneri]  
201aa 
 
58/70 (96) NP_837464 
ORF6 3339-39671 210 Predicted 
nucleotidyltransferase 
[Dechloromonas 
aromatica RCB] 196aa 
35/52 (176) ZP_00203765 
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ORF7 4882-3962 306 Permeases of the 
drug/metabolite 
transporter (DMT) 
superfamily 
[Methylobacillus 
flagellatus KT] 305aa 
36/49 (280) ZP_00172424 
ORF8 5975-4962 337 NADH:flavin 
oxidoreductases 
[Geobacter 
metallireducens GS-15] 
355aa 
63/76 (333) ZP_00298761 
 
ORF9 6763-6035 242 Dienelactone hydrolase 
[Synechococcus 
elongatus PCC 7942] 
244aa 
36/51 (233) ZP_00163798 
 ORF10 7737-6862 291 Transcriptional 
regulator 
[Magnetococcus sp. 
MC-1] 205aa 
37/53 (196) ZP_00290374 
 
 
 
 
Alignments with other ArsB proteins in the NCBI database revealed that the 435 amino 
acid At. caldus chromosomal ArsB is most closely related to the ArsB protein of the At. 
ferrooxidans ars operon.  The predicted amino acid sequence of the At. caldus 
chromosomal ArsB exhibits 88% and 67% identity to the ArsB proteins of At. 
ferrooxidans and Psychrobacter arcticus 273-4 respectively, while only 60% identical to 
the At. caldus transposon ArsB protein.  Phylogenetic analysis of ArsB proteins showed 
that the At. caldus chromosomal ArsB groups with ArsB proteins of other Gram-negative 
bacteria (Figure 2.6).  Using the web-based program TMHMM (which predicts trans-
membrane spanning domains; http://www.cbs.dtu.dk/services/TMHMM) the 
chromosomal ArsB of At. caldus is predicted to have 11 trans-membrane spanning 
domains (Figure 2.7).   
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Figure 2.6:  Phylogenetic tree of different ArsB proteins.  The chromosomal At. caldus 
ArsB groups with other ArsB proteins of Gram-negative bacteria.  Accession numbers:  
At. ferrooxidans, AAF69238; P. aeruginosa, NP_250968; P. putida, NP_744082; At. 
caldus transposon, AAX35679; E. coli R46, NP_511239; K. oxycota pMH12, 
AAF89641; E. coli R773, ARB1_ECOLI; E. coli chromosome, NP_417959; Y. 
enterocolitica pYVe227, NP_052439; B. halodurans, NP_243865; B. subtilis ydfA, 
NP_388415; S. aureus pI258, P30329; S. xylosus pSX267, Q01255; B. subtilis skin 
element, BAA06969; S. cerevisiae Acr3p, ACR3_YEAST.     
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Figure 2.7:  Prediction of trans-membrane spanning domains by the web-based 
TMHMM program for the ArsB proteins of At. caldus chromosome (A), At. ferrooxidans 
(B) and E. coli R773 (C).   
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As discussed in Chapter 1 (1.4.2) bacterial ArsC proteins can be divided into two 
families.  The first family (GSH/Grx clade) requires glutathione (GSH) and glutaredoxin 
(Grx) to reduce arsenate to arsenite and includes the E. coli R773 ArsC.  The second 
family of arsenate reductases (Trx clade) includes the S. aureus pI258 and B. subtilis 
ArsC proteins.  Phylogenetic and alignment analysis showed that the At. caldus 
chromosomal ArsC groups with other ArsC proteins of the Trx clade (Figure 2.8 and 
2.9).  Members of the GSH/Grx clade of ArsC proteins are more closely related to each 
other than members of the Trx family with 93.52% sequence identity for the GSH/Grx 
family and only 53.3% sequence identity for the Trx family.  Alignments with ArsC 
proteins in the NCBI database revealed that the At. caldus chromosomal ArsC is most 
similar to the ArsC protein of At. ferrooxidans with 78% identity.  It is only 72% 
identical the At. caldus transposon ArsC protein.   The Trx clade ArsC proteins use 
thioredoxin as a reducing power and contain four cysteine residues, Cys10, Cys15, Cys82 
and Cys89, of which only three are essential (Cys10, Cys82 and Cys89) for the conversion 
of arsenate to arsenite.  Besides the three cysteine residues, Arg16 and Asp105 are also 
essential for catalysis.  Sequence analysis of the At. caldus chromosomal ArsC revealed 
that it contains four cysteine residues (Cys10, Cys15, Cys82 and Cys90) with spacing similar 
to the spacing in the ArsC proteins of the Trx clade (Figure 2.9).  The third and fourth 
cysteines are separated by seven amino acids instead of six, as is the case with At. 
ferrooxidans, P. putida and P. aeruginosa.  Arg16 and Asp105, which are essential for 
catalysis by the Trx ArsC are also conserved in the At. caldus ArsC.  
  
As discussed in Chapter 1 (1.4.3.1), the ArsR protein of E. coli R773 contains a possible 
DNA binding helix-turn-helix domain (Bairoch, 1993) and a highly conserved 
30ELCVCDL36 metal binding domain with conserved Cys32, Cys34 and Cys37 residues.  
Binding requires only two cysteine residues, and any combination of Cys32, Cys34 and 
Cys37 will result in the release of the repressor from the DNA (Shi et al., 1994; Shi et al., 
1996).  Busenlehner et al. (2003) reported that two distinct metal binding sites exist in the 
SmtB/ArsR family of transcriptional regulators.  The first (α3N) metal binding site is 
present in the α3 helix and contains the conserved ELCVCDL domain.  The second metal 
binding site (α5C) is present in the α5 helix (Figure 1.8).   The predicted amino acid 
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sequence of the At. caldus chromosomal ArsR was most similar to the ArsR protein of At. 
ferrooxidans with 74% similarity, while it was only 45% identical to the transposon-
linked ArsR protein of At. caldus.  An alignment of the At. caldus chromosomal ArsR 
protein with its closest matches from the NCBI database revealed that none of the ArsR 
proteins contained the conserved ELCVCDL domain in the α3 helix region (Figure 2.10), 
indicating that the chromosomal ArsR and its closest homologs may use a different metal 
binding site than ArsR proteins with the ELCVCDL metal binding domain.  The At. 
caldus chromosomal ArsR and its eight closest matches contains the conserved GXIA 
region (identified by Butcher and Rawlings, 2002) immediately downstream of the region 
corresponding to the ELCVCDL binding site.  They all also contain another conserved 
LVAYLTENCC region near the C-terminal end of the protein.  Secondary structure 
prediction of the At. caldus chromosomal ArsR (performed by the web-based program 
PsiPRED v2.4, http://www.predictprotein.org) revealed that it contains, like other ArsR 
proteins, two possible helix-turn-helix motifs (Figure 2.11).  The position and spacing of 
these helix-turn-helix domains of the At. caldus chromosomal ArsR is very similar to 
those of the well studied E. coli R773 ArsR.  All proteins that lacked the conserved metal 
binding domain have two extra residues before the αR helix (Figure 2.11).  The 
significance of these extra residues in arsenic resistance has yet to be shown.  
Phylogenetic analysis showed that the chromosomal At. caldus ArsR, together with its 
closest matches form a subgroup of ArsR regulators (Figure 2.12).   
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Figure 2.8:  Phylogenetic tree of different ArsC proteins.  The At. caldus chromosomal 
ArsC is most closely related to the transposon-located ArsC of At. caldus and the ArsC of 
At. ferrooxidans.  Accession numbers:   E. coli R773, AAA21096; E. coli chromosome, 
NP_417960; A. multivorum pKW301, BAA24824; K. oxycota, AF168737_5; E. coli R46, 
NP_511240; S. marcescens, CAB88404; Y. enterocolitica pYVe227, NP_052438; A. 
tumefaciens C58, NP_532180; B. subtilis skin element, ARSC_BACSU; S. aureus pI258, 
ARSC_STAAN; S. xylosus pSX267, ARSC_STAXY, At. ferrooxidans, AAF69239; At. 
caldus transposon, AAX35680; P. putida, CAC18654; P aeruginosa, NP_250969.   
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GSH/Grx clade 
    55Ec R773
    55Ec chrom
    55Ec R46
    55K oxytoca
    55S marces
    55Y ent pYV
    55Am pKW301
MSNITIYHNPACGTSRNTLEMIRNSGTEPTIILYLENPPSRDELVKLIADMGISV
MSNITIYHNPACGTSRNTLEMIRNSGTEPTIIHYLETPPTRDELVKLIADMGISV
MSNITIYHNPHCGTSRNTLEMIRNSGIEPTVILYLETPPSRDELLKLIADMGISV
MSNITIYHNPACGTSRNTLEMIRNSGNEPTVIHYLENPPSRDELVKLIADMGISV
MSNITIYHNPACGTSRNTLEMIRNSGTEPTVIHYLETPPSRAELVKLIADMGITV
MSNITIYHNPTCGTSRNTLEMIRNSGNEPTVIYYLETPPTHDELVKLIADMGITV
MSNITIYHNPACGTSRNTLEMIRNSGNEPTVIHYLENPPSRDELVKLIADMGISV
   110Ec R773
   110Ec chrom
   110Ec R46
   110K oxytoca
   110S marces
   110Y ent pYV
   110Am pKW301
RALLRKNVEPYEQLGLAEDKFTDDQLIDFMLQHPILINRPIVVTPLGTRLCRPSE
RALLRKNVEPYEELGLAEDKFTDDRLIDFMLQHPILINRPIVVTPLGTRLCRPSE
RALLRKNVEPYEELGLAEDKFTDDQLIDFMLQHPILINRPIVVTPLGTKLCRPSE
RALLRKNVEPYEELGLAEDKFTDGELIDFMLQYPILINRPIVVTPLGTRLCRPSE
RALLRKNVEPFEALGLAEDRFTDEQLIDFMLQHPVLINRPIVVTPLGTRLCRPSE
RALLRKNVEPYEELGLAEGTFSDEQLIGFMLEHPILINRPIVVTPLGTRLCRPSE
RALLRKNVEPYEELGLEEDKFTDDQLIDFMLQHPILINRPIVVTPLGTRLCRPSE
   140Ec R773
   140Ec chrom
   140Ec R46
   137K oxytoca
   140S marces
   140Y ent pYV
   140Am pKW301
VVLDILQDAQKGAFTKEDGEKVVDEAGKRL
VVLEILPDAQKGAFSKEDGEKVVDEAGKRL
VVLDILPDAQKAAFTKEDGEKVVDDSGKRL
VVLDILPDAQKGAFAKEDGEKVVDETR...
VVLDILYDAQKSAFTKEDGEKVVDEKGNRL
VVLDILPEPQQGAFTKEDGEKITDESGKRL
VVLDILPDAQKGAFAKEDGEKVVDEAGKRL
 
 
Trx clade 
    55Bs skin
    55At_ferro
    55Sx_pSX267
    52P_aerug__
    52P_putida
    55Sa_pI258
    55At_c_Ch
MENKIIYFLCTGNSCRSQMAEGWAKQYLGDEWKVYSAGIEAHGLNPNAVKAMKEV
MKTPEILFLCTGNSCRSILAEVTFNALAGPGMHATSAGSHPAGYVHTRSINLLER
MDKKTIYFICTGNSCRSQMAEGWGREILGEDWNVYSAGIETHGVNPKAIEAMKEV
...MRVLFMCTANSCRSILSEAMFNHLAPPGFEACSAGSQPSGRVHPRSLATLEQ
...MKVLFMCTANSCRSILSEAMFNHLAPDGFEAISSGSFPKGLVLPRSLSTLQA
MDKKTIYFICTGNSCRSQMAEGWGKEILGEGWNVYSAGIETHGVNPKAIEAMKEV
MKTPEILFLCTGNSCRSILAEATLNGLAQGRLHASSAGSHPAGYVHPRSVALLQR
   108Bs skin
   109At_ferro
   108Sx_pSX267
   107P_aerug__
   107P_putida
   108Sa_pI258
   109At_c_Ch
GIDISNQTSDIIDSDILNNADLVVTLCGDAADK..CPMTPPHVKREHWGFDDPAR
EGFRTDGLHSKSWEDLKET.PDIVITVCADAAGETCPAYLGPAIRTHWGVEDPAK
DIDISNHTSDLIDNHILKQSDLVVTLCSDADDN..CPILPPNVKKEHWGLEDPAG
AGIATHGLYSKGSEAFEGAPPDIVITVCDAAAGEACPLYLGAALKAHWGLADPSA
AGIRTEGLYSKGNDVFEGSPPDVVITVCDKAAGEACPVYFGPAVKAHWGLEDPSD
DIDISNHTSDLIDNDILKQSDLVVTLCSDADNN..CPILPPNVKKEHWGFDDPAG
EGFSTEGLASKSWDDLPTT.PDIVITVCASAAGETCPAYLGPALRAHWGVDDPAK
   139Bs skin
   162At_ferro
   131Sx_pSX267
   156P_aerug__
   156P_putida
   131Sa_pI258
   162At_c_Ch
AQGTEEEKWAFFQRVRDEIGNRLKEFAETGK......................
VTGTEAQIEAAFDTAYHILRHRIEALLQLPVAELLEKDPAKLRQELERIGTLL
KEWSE......FQRVRDEIKLAIENFKLR........................
LDGDEALRDAAFHATLARIEQRCRAFLGLPFATLDRDQLKR...ELERIGSL.
VQGDDARVQAAFDATLKTIATRCRAFFILPFAELSPTELQA...ELARIAEL.
KEWSE......FQRVRDEIKLAIEKFKLR........................
ATGSEAEIEAAFEKAYRILRHRIEALLQLPVAEWLAEDPSRLRTELERIGHSE
 
 
Figure 2.9:  Multiple sequence alignments of different ArsC proteins compared with the 
At. caldus chromosomal ArsC.  The At. caldus chromosomal ArsC protein groups with 
other ArsC proteins of the Trx clade.  See figure 2.5 for accession numbers. 
 59
 
 
 
Figure 2.10:  Multiple sequence alignments of different ArsR proteins (the eight closest 
matches obtained from a NCBI BLAST search) compared with the chromosomal ArsR of 
At. caldus. Also included are proteins from the ArsR/SmtB family of transcriptional 
regulators.  Labels and accession numbers are as follows:  CadC, S. aureus pI258 CadC 
(B32561); Ec_chrom, E. coli chromosome (AAS76526); Ec_R773, E. coli R773 
(CAA34168); pSX267, S. xylosus pSX267 (AAA27587); SmtB, Synechococcus 
PCC7942 SmtB, (S31197), ZntR, S. aureus ZntR (AAC32484); Atc_chr, At. caldus 
chromosome.  The nine closest matches are labeled by their accession numbers:  
AAF69241, At. ferrooxidans; AAX35682, At. caldus transposon; AAS45114, Alcaligenes 
faecalis; YP_159865, Azoarcus sp. EbN1; AAQ60110, Chromobacterium violaceum; 
YP_111442, Burkholderia pseudomallei K96243; YP_113846, Methylococcus capsulatus 
str. Bath; ZP_00627778, Nitrobacter hamburgensis X14.  The conserved ELCVCDL 
metal binding motif found in members of the ArsR/SmtB family of transcriptional 
regulators has been boxed with solid lines, while conserved regions of an atypical ArsR 
group identified by Butcher and Rawlings (2002) are boxed in broken lines.  The At. 
caldus chromosomal ArsR groups with the atypical ArsR group and also contains the two 
conserved domains.  Also shown is the At. caldus chromosomal ArsR α3 and α5-helices.                                
 
 60
       
 
 
 
Figure 2.11:  Secondary structure prediction of the (A) At. caldus chromosomal ArsR, 
(B) At. ferrooxidans ArsR, (C) At. caldus transposon ArsR and (D) E. coli R773 ArsR by 
the PsiPRED web-based program.  Also included are the α-helices and β-sheets as 
indicated by Busenlehner et al. (2003).  Proposed metal binding domains are located in 
the α3 and α5-helices, as described in the text.  
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Figure 2.12:  Phylogenetic tree of different ArsR proteins.  The At. caldus chromosomal 
ArsR and its eight closest matches cluster as a second subgroup of ArsR regulators.  See 
Figure 2.10 for accession numbers. 
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ORF1 showed sequence identity to a lactoylglutathione lyase (also known as glyoxalase 
I) of Thermobifida fusca.  Glyoxalase I forms part of the glyoxalase pathway that protects 
against cellular damage caused by reactive aldehydes such as methylglyoxal with the help 
of glutathione hemithioacetal as substrate (Vickers et al., 2004).  Glyoxalase I and 
glyoxalase II (hydroxyacylglutathione hydrolase) act in concert to convert the 
hemithioacetal adduct formed between glutathione and methylglyoxal into D-lactate and 
free glutathione (Thornalley, 1996).  Because ORF1 is located adjacent to arsC, the 
possibility exists that ORF1 may be involved in the conversion of arsenate to arsenite by 
the ArsC (if it uses glutathione as a reducing power).  ORF1 also showed sequence 
identity to a cadmium inducible protein (CadI) of Mycobacterium tuberculosis.  cadI 
homologs are often found adjacent to, or within ars operons (Hotter at. al., 2001).  CadI 
is related to members of the βαβββ metalloenzyme superfamily, which has important 
detoxification functions (Bernat et al., 1997).  When looking at the sizes of the predicted 
lactoylglutathione lyase and CadI proteins, it seems more likely that ORF1 functions as a 
CadI protein.  Furthermore, ORF1 is located adjacent to the chromosomal ars operon of 
At. caldus, as is the case with several CadI proteins of other bacteria (Hotter et al., 2001).  
Cadmium induces the ars operon of B. subtilis (Moore et al., 2005).  Experiments were 
conducted to determine if ORF1 may be involved in the conversion of arsenate to arsenite 
(2.3.3) and to determine if the At. caldus chromosomal ars operon can be induced by 
cadmium, as is the case of B. subtilis (3.3.1).    
 
      
2.3.3. The requirement of glutathione/thioredoxin for arsenate reductase 
It is well known that ArsC proteins are grouped on their source of reducing power that is 
used for the reduction of arsenate to arsenite.  The first family (GSH/Grx clade) uses 
glutathione and glutaredoxin to reduce arsenate, while the second family (Trx clade) uses 
thioredoxin for the reduction of arsenate to arsenite (Mukhopadhyay et al., 2002; 
Mukhopadhyay and Rosen, 2002). Based on the observation that the At. caldus 
chromosomal ArsC grouped with other ArsC proteins of the Trx clade (Figure 2.8 and 
2.9) and that it was 78% identical to the At. ferrooxidans ArsC (which has been shown to 
use thioredoxin to reduce arsenate to arsenite, Butcher et al., 2000), tests were conducted 
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to determine whether the At. caldus chromosomal ArsC protein would use thioredoxin 
rather than glutathione and glutaredoxin as a reducing power for the reduction of arsenate 
to arsenite.  To investigate this, an E. coli strain (BH5262) with mutations in the 
thioredoxin gene (trxA) and the γ-glutamylcysteinyl synthetase gene (gshA, responsible 
for the synthesis of glutathione) was transformed with various plasmids.  E. coli BH5262 
transformed with the At. caldus chromosomal ars genes (pTcC-PH29GL) and Trx6 
(contains the At. ferrooxidans trxA gene) were unable to confer resistance to 1 mM 
arsenate.  The ars mutant ACSH50Iq transformed with pTcC-PH29GL did confer 
resistance to 1 mM arsenate, indicating that the At. caldus chromosomal ars genes were 
sufficient for resistance to 1 mM arsenate (Table 2.3).  Surprisingly, the At. ferrooxidans 
thioredoxin containing plasmid, pTrx6, did not permit the E. coli double mutant BH5262 
containing the cloned At. caldus chromosomal ars genes (pTcC-PH29GL) to grow on 
arsenate, as reported when the At. ferrooxidans ars genes were tested in a similar 
experiment (Butcher and Rawlings, 2000).  Because the At. caldus chromosomal ArsC 
groups with the ArsC proteins of the Trx clade, it seems very unlikely that it will use 
glutathione as a reducing power.  It is possible that the At. ferrooxidans trxA gene may 
not complement the At. caldus chromosomal ArsC in the reduction of arsenate to 
arsenite.  This experiment could be repeated using a cloned trxA gene from At. caldus to 
confirm if the At. caldus chromosomal ArsC uses thioredoxin in the conversion of 
arsenate to arsenite.  Despite grouping with other ArsC proteins of the Trx clade (Figure 
2.9), it is possible that the At. caldus chromosomal ArsC may use glutathione to reduce 
arsenate to arsenite and that ORF1 may play a role in this reduction.  To investigate this, 
E. coli BH5262 was transformed with pTcC-#4.  If ORF1 aids the ArsC in reducing 
arsenate to arsenite, arsenate resistance would be acquired.  This was not the case 
however, as E. coli  BH5262 transformed with pTcC-#4 was sensitive to 1mM arsenate 
(Table 2.3).  This also indicated that none of the other ORFs on pTcC-#4 aid in the 
reduction of arsenate to arsenite.   
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Table 2.3:  Arsenate resistance in E. coli mutant strains 
E. coli strain Transformed with 
plasmid
Resistance to 1mM 
arsenate a
 
BH5262 
 
pGL10 + Trx6 
 
– 
 
BH5262 
 
pGL10 + pKS 
 
– 
 
BH5262 
 
pTcC-PH29GL + pKS  
 
– 
 
BH5262 
 
pTcC-PH29GL + Trx6 
 
– 
 
ACSH50Iq
 
pTcC-PH29GL 
 
+ 
 
BH5262 
 
pTcC-#4 
 
– 
 
a – indicates no growth on Luria Agar with 1mM sodium arsenate;  + indicates growth on 
Luria Agar with 1mM sodium arsenate    
 
 
 
2.3.4. ORF1 and ORF5 are not required for arsenic resistance in E. coli 
Arsenic assays were performed in order to determine (a) the resistance to arsenic that 
construct pTcC-#4 isolated from At. caldus confers on the E. coli arsenic mutant 
ACSH50Iq, (b) to determine if ORFs 5-10 (Figure 2.4; Table 2.2) play a role in arsenic 
resistance and (c) to determine if ORF1 aids the arsC gene product in converting arsenate 
to arsenite (see section 2.3.3).  Growth assays were performed in 0.25 mM arsenite (AsIII) 
and 0.5 mM arsenate (AsV).  Plasmid pTcC-#4 conferred greater resistance to the E. coli 
ars mutant ACSH50Iq in both arsenate and arsenite in comparison to the negative control 
pEcoBlunt (Figure 2.13 a and b).  Construct pTcC-#6 conferred lower resistance to 
arsenate, which was expected as it does not contain a functional arsC that is required for 
the conversion of arsenate to arsenite.  Arsenic resistance did not change significantly in 
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cells harboring only arsCRBORF5 (pTcC-PH29), suggesting that ORFs 6-10 were not 
required for arsenic resistance in E. coli ACSH50Iq.  Since ORFs 6-10 were not needed 
for arsenic resistance, we could directly compare pTcC-#4 and pTcC-PH29.  No 
differences in levels of resistance to arsenate were detectable between pTcC-#4  and 
pTcC-PH29.  This indicated that ORF1 is not required for the reduction of arsenate to 
arsenite in E. coli.    
 
Construct pTcC-Bs2.6 (which contains arsCRB) also showed high levels of resistance to 
arsenate and arsenite (Figure 2.13 a and b).  As it does not contain ORF5, it was 
suggested that ORF5 is not necessary for arsenic resistance in E. coli.  To determine the 
role ORF5 plays in arsenate resistance, pTcC-RB+5 and pTcC-RB-5 were constructed.  
Growth curves done with these constructs showed the same levels of resistance as pTcC-
#6, indicating that ORF5 does not play a role in arsenate resistance in E. coli ACSH50Iq 
in the absence of ArsC.   
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Figure 2.13:  Growth curves performed with the E. coli ars mutant ACSH50Iq, in the 
presence of 0.25 mM arsenite (A) and 0.5 mM arsenate (B).  Each data point represents 
the results of three assays of three independent experiments.  Error bars indicate standard 
deviations.  See figure 2.4 for location of the constructs.  Optical density (OD) readings 
were recorded at 600 nm. 
 
 
 
2.4. Discussion 
Acidithiobacillus caldus is a member of a consortium of bacteria used in a commercial 
biooxidation process called biomining.  During this process, toxic arsenic compounds are 
released into the environment.  Due to the fact that At. caldus is able to live in such a 
harsh environment, it was not surprising to find arsenic resistance genes in its genome.  
In this study we identified a chromosomal ars operon that conferred resistance to arsenate 
and arsenite.  It consists of three ars genes, arsCRB, with no arsA or arsD genes present.  
This is not surprising, as the conventional chromosomal ars operon of bacteria like E. 
coli also contains an arsRBC operon (Diorio et al., 1995).  However, the orientation of 
the At. caldus chromosomal ars operon was atypical.  Where the conventional 
chromosomal ars operons are transcribed as a single transcriptional unit, the At. caldus 
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chromosomal ars operon is divergently transcribed, with the arsC and arsR genes 
divergently transcribed to the arsB gene, as has also been shown for At. ferrooxidans. 
 
Results of BLAST searches in the NCBI database revealed that all three chromosomal 
arsenic resistance genes from At. caldus are most homologous to the arsenic resistance 
genes of another biomining bacterium, Acidithiobacillus ferrooxidans.  As described 
earlier, At. caldus is a moderately thermophilic sulfur oxidizer and At. ferrooxidans a 
mesophilic iron- and sulfur oxidizer.  The fact that such high homology was found (78%, 
74%, and 85% identity for the arsC, arsR and arsB genes, respectively) between the ars 
genes of At. caldus and At. ferrooxidans strengthens the hypothesis that they may have a 
relatively recent common ancestor.  The chromosomal ArsB protein of At. caldus 
grouped with ArsB proteins of other Gram-negative bacteria (Figure 2.6).  Using a web-
based program that predicts transmembrane spanning domains we predicted that the 
chromosomal ArsB has 11 membrane spanning domains.  In ars systems where an ArsA 
is absent, it is believed that the ArsB cannot function as a primary pump using ATP 
hydrolysis as an energy source, but as a secondary carrier using membrane potential to 
export arsenite out of the cell.  However, acidophilic microorganisms commonly have a 
reversed membrane potential, with a positive rather than a negative inside membrane 
potential (Martin, 1990).  Despite originating from an organism with a positive inside 
membrane potential, the chromosomal At. caldus ArsB efflux pump was functional in E. 
coli, as resistance to arsenite was observed.    
 
The At. caldus chromosomal ArsC grouped with ArsC proteins of the Trx family (Figure 
2.9), suggesting that it will be more likely to use thioredoxin than glutathione and 
glutaredoxin as a reducing power for the conversion of arsenate to arsenite.  To 
investigate this, E. coli BH5262 was transformed with the At. ferrooxidans thioredoxin 
gene (trxA) and pTcC-#4 in trans.  It was surprising to find that this gene was unable to 
confer arsenate resistance to E. coli BH5262.  It is possible that the At. ferrooxidans trxA 
gene may not complement the At. caldus chromosomal ArsC to reduce arsenate to 
arsenite, and therefore results in a arsenate sensitive phenotype. E. coli BH5262 
transformed with pTcC-#4 was also sensitive to arsenate, indicating that none of the 
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ORFs on pTcC-#4 were able to function as a reducing power to help ArsC in the 
conversion of arsenate to arsenite.  Sequence analysis of the At. caldus chromosomal 
ArsC revealed that it contains four cysteine residues (Cys10, Cys15, Cys82 and Cys90), and 
that it is spaced similar to the spacing in other ArsC proteins of the Trx family.  It also 
contains Arg16 and Asp105, which have been shown to be essential for catalysis of the Trx 
family ArsC.  Based on this sequence analysis, we proposed that the At. caldus 
chromosomal ArsC will function similar to the B. subtilis ArsC (Figure 1.7).  
 
Sequence alignments of members of the ArsR family of transcriptional regulator proteins 
showed that these proteins show low similarity to each other.  Alignments of the At. 
caldus chromosomal ArsR with eight of its closest matches from the NCBI database 
revealed that none of the ArsR proteins contained the conserved ELCVCDL metal-
binding domain (Figure 2.10).  Phylogenetic analyses of these ArsR proteins show that 
they form a subgroup of ArsR regulators (Figure 2.12).  Using a web-based program 
(PsiPRED v. 2.4), we predicted that the At. caldus chromosomal ArsR contains, like other 
ArsR proteins, two helix-turn-helix domains with 5 α-helices and 2 β-sheets (Figure 
2.11).  The At. caldus ArsR and its eight closest matches from the NCBI database all 
have two extra residues before the first helix of the identified DNA-binding helix-turn-
helix domain.    
 
The SmtB/ArsR family of transcriptional regulators have two metal binding sites, the 
α3N in the α3 helix and the α5C metal-binding site in the α5 helix.  They have shown that 
ArsR proteins contain the α3N metal binding site, with the ELCVCDL domain located in 
the α3 helix.  The At. caldus chromosomal ArsR and its closest matches all contain a very 
conserved LVAYLTENCC domain near the C-terminal end of the protein (Figure 2.10).  
This conserved domain is not present in ArsR proteins with the consensus ELCVCDL 
domain.  Five to seven residues separate another cysteine from the cysteine doublet at the 
end of the LVAYLTENCC domain of At. caldus and all of its closest matches.  These 
three cysteine residues may form the metal-binding domain of these atypical ArsR 
proteins.  This conserved region identified in the second ArsR group is present in the α5 
helix (Figure 2.10).  It is thus possible that the ArsR proteins may have two different 
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metal-binding domains, where one is located in the α3 helix and the other in the α5 helix.  
Analysis of a possible At. caldus chromosomal ArsR binding site did not reveal the 
TTTG and TCAT region identified in both the chromosomal and R773 ars sequences of 
E. coli.  
 
Along with the three arsenic resistance genes, seven other ORFs were identified on 
pTcC-#4 (Table 2.2).  Based on the proximity of ORF7-10 to one another and the 
direction of transcription, it is possible that these ORFs form an operon separate form the 
ars operon.  The function of this possible operon is unknown, but it may play a role in the 
transport of certain molecules in and out of the cell (Figure 2.4; Table 2.2).   
 
Both the arsC and arsB genes were expressed and were functional in the E. coli ars 
mutant ACSH50Iq.  Growth assays in the presence of arsenite and arsenate were 
conducted to determine if the other ORFs play a role in arsenic resistance.  It was found 
that ArsC is needed for resistance to arsenate, but not arsenite, while ArsB was essential 
for resistance to arsenite.  Comparing arsenic resistance conferred by the At. caldus 
chromosomal ars operon to arsenic resistance conferred by the At. caldus transposon ars 
operon (Tuffin et al., 2005), it seems that the transposon operon conferred much higher 
resistance to E. coli than the chromosomal ars operon.  We did expect constructs not 
containing ArsC (pTcC-#6, pTcC-RB-5 and pTcC-RB+5) to be more sensitive to 
arsenate than was observed (Figure 2.13 a and b).  A reason for increased arsenate 
resistance by these constructs may be that the ars mutant ACSH50Iq contains an element 
on the chromosome that can help with the conversion of arsenate to arsenite, which can 
then be transported out of the cell by the At. caldus ArsB.  
 
This studies of the At. caldus chromosomal arsenic resistance system was carried out in 
E. coli.  It would have been ideal if this studies could be repeated in At. caldus, as this 
system may not function the same way in E. coli as in At. caldus.  Due to a lack of 
mutants, genetic tools for this organism and the difficulty to obtain large quantities of 
cells, these studies are limited to E. coli at present.  
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3.1. Introduction 
  
Together with the work presented in Chapter 2, it is now clear that At. caldus #6 has three 
arsenic resistance operons, with two being located on transposons and a third on the 
chromosome.  This raises interesting questions about how each of the systems interact to 
give arsenic resistance, and how each of these systems are regulated to give optimal 
resistance.  In Chapter 4 work will be presented on the interaction of the transposon and 
chromosomal system to give arsenic resistance, while this chapter will focus on the 
regulatory mechanisms of the chromosomal operon, and whether the chromosomal and 
transposon resistance determinants can cross-regulate each other. 
 
Sequence analysis (Chapter 2) revealed that the At. caldus chromosomal ars genes are 
arranged in the order arsCRB, with the arsC and arsR genes reading divergently to the 
arsB gene.  This could suggest that arsCR and arsB may be transcribed as two separate 
transcriptional units.  This is different to the typical arsRBC systems, which are 
transcribed as a single transcriptional unit.  This divergent arrangement of ars genes has 
also been identified in At. ferrooxidans, where the arsCR were transcribed as one unit, 
separate to arsBH (Butcher et al., 2000).  We have shown in Chapter 2 that ORF1 and 
ORF5 were not required for, and did not enhance, arsenic resistance in E. coli.  However, 
the gene layout (with stop and start codons very close together) could suggest co-
transcription with the ars genes. 
 
In this chapter expression of the At. caldus chromosomal ars system will be analyzed.  
Would this system be regulated by ArsR at a transcriptional level, binding to an operator 
sequence and thereby blocking transcription?  It has been shown that with single unit 
operons like the chromosomal ars operon of E. coli K-12, the ArsR binds upstream of the 
ars operon (Diorio et al., 1995).  However, with the divergent operon, as has been shown 
in At. ferrooxidans, the ArsR autoregulates itself as well as arsB expression (Butcher and 
Rawlings, 2002).  Sequence analysis of the At. caldus chromosomal ArsR revealed that it 
does not contain the highly conserved ELCVCDL region that is found in members 
belonging to the SmtB/ArsR family of transcriptional regulators (Shi et al., 1994).  As 
previously described, this domain forms part of metal binding site where arsenite binds in 
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order to induce a conformational change in ArsR, with the dissociation of the repressor 
from the DNA.  The At. caldus chromosomal ArsR was most similar to the ArsR protein 
of At. ferrooxidans with 74% identity.  The At. ferrooxidans ArsR and the At. caldus 
transposon-located ArsR also lack the conserved metal binding domain, but have been 
able to regulate their ars operons respectively (Butcher and Rawlings, 2002; Tuffin et al., 
2005).  Based on the above, would ArsR function as a negative transcriptional regulator, 
and to what inducers would it respond?  Does the At. caldus chromosomal ArsR regulate 
both itself and arsB?  If it does regulate both, to what extent are they being regulated?  
Due to the presence of two different ArsR proteins in one organism, would there be any 
cross-regulation?  The At. caldus transposon ArsR has been shown to function as a 
typical ArsR (Tuffin et al., 2005).  Despite the fact that the two ArsRs only share 45% 
identity at protein level, there is a possibility of cross-regulation between the two ArsR 
proteins.       
 
 
3.2.  Methods 
 
3.2.1. Media, bacterial strains and plasmids 
Bacterial strains, plasmids and primers used in this study are shown in Table 3.1.  E. coli 
strains were grown in Luria-Bertani (LB) broth medium (Sambrook et al., 1989) with 
ampicillin (100 μg/ml) or kanamycin (50 μg/ml) added as required.  At. caldus strains 
were grown at 370C in tetrathionate medium (3 mM), sterilized and adjusted to pH 2.5 
(Rawlings et al., 1999b). 
 
Table 3.1:  Bacterial strains, plasmids and primers used in this study  
           
Strain, plasmid 
or Primer 
Description Source or 
reference 
Strains   
E. coli   
DH5α Ф80dlacZΔM15, endA1, recA1, gyrA96, thi-1, 
hsdR17 (rk-, mk+), relA1, supE44, deoR,Δ(lacZYA-
argF) U169  
Promega 
XL 1 Blue recA1, endA1, gyrA96, thi, hsdR17 (rk-, mk+), relA1, Stratagene 
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supE44, relA1, lac [F’ proAB+ lacIqZΔM15 
::Tn10(tetr)] 
ACSH50Iq rpsL, Δ(lac-pro), Δars::cam Butcher & 
Rawlings 
(2002) 
   
Plasmids   
pEcoR252 Apr, EcoRI inactivation cloning vector Zabeau & 
Stanley (1982) 
pBluescript SK Apr, LacZ’, ColE replicon, cloning vector Stratagene 
pGem-T® Apr, T-tailed PCR product cloning vector Promega 
pGL10 Kmr, RK2/RP4 replicon, cloning vector A. Toukdarian 
pMC1403 Apr, promoterless lacZY operon, ColE1 replicon Casadaban et 
al. (1983) 
pKK223-3 Apr, ptac, ColE1 replicon, cloning vector Pharmacia 
pTcC-#4 Apr, 10kb Sau3A fragment of At. caldus #6 cloned 
into the BglII site of pEcoR252 
This study 
ptacGL Kmr, 1.4 kb SphI-PvuI fragment from pKK223.3 in 
pGL10 
Tuffin et al. 
(2005) 
pGEM-
ChArsR 
Apr, PCR product of arsR (bp 1049-1544 ) obtained 
using ChArsRF/ ChArsRR primers, cloned in pGEM-
T 
This study 
pKKChArsR Apr, 460 bp EcoRI-HindIII fragment from pGEM-
arsR cloned in pKK223.3 
This study 
ptacChArsR Kmr, An arsR containing blunted 1.58 kb BamHI-
ScaI fragment from pKKArsR cloned into a blunted 
SmaI site in pGL10 
This study 
pChArsRLacZ Apr, PCR product of arsR promoter (bp 1455-1955) 
obtained with ChArsRLacZF/ ChArsRLacZR primers 
in pMC1403. 
This study 
pChArsBLacZ Apr, PCR product of arsB promoter (bp 1383-1586) 
obtained with ChArsBLacZF/ ChArsBLacZR primers 
in pMC1403. 
This study 
pTnArs1GL Kmr, The “transposon-like” arsenic operon isolated 
from At. caldus #6, truncated in the tnpA gene, in the 
cloning vector pGL10. 
Tuffin et al. 
(2005) 
TnArsRLacZ Apr, At. caldus transposon PCR product of arsR 
promoter in pMC1403 (also named ArsRLacZ , 
Tuffin et al., 2005) 
Tuffin et al. 
(2005) 
   
ptacTnArsR Kmr, At. caldus transposon arsR in pGL10 (also 
named ptacArsR, Tuffin et al., 2005)  
Tuffin et al. 
(2005) 
   
Primers* Sequence (5’-3’)  
ArsR-RT_Fw CGAAGAGCACAGCGATCG  This study 
ArsC-RT_Rev CCAGGATGGAACGACAGG  This study 
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ORF1-RT_Rev GATCGCGCAGCCAGAGTT  This study 
ArsC-RT_Fw CGGAAATCGAGGCCGCTT  This study 
ORF5-RT_Rev GTTTGGCAGGGATTGCGG  This study 
ArsB-RT_Fw ACCGTTCTGGCGGCGATT  This study 
ORF6-RT-Rev ATCTTCCTGGGTGCTGCC  This study 
ORF5-RT_Fw CGGGGAAGATCCTAGGTG  This study 
ChArsBLacZF 
(EcoRI) 
CGGAATTCTCGTGCTCCACCAGTAGG  This study 
ChArsBLacZR 
(BamHI) 
CCGGATCCAAGATGGCCAGGGCAAGC  This study 
ChArsRLacZF 
(EcoRI) 
CGGAATTCAAGTCGAGCCGCAACAGG  This study 
ChArsRLacZR 
(BamHI) 
CCGGATCCCGATCGCTGTGCTCTTC  This study 
ChArsRF 
(EcoRI) 
CGAATTCGCCGGTAGTCTTGACGAG  This study 
ChArsRR 
(HindIII) 
CCCAAGCTTCCAGGATGGAACGACAGG  This study 
ArsRLacZR2 
(BamHI) 
CGCGGATCCAGCGCGTTAGCAATCGC Tuffin et al. 
(2005) 
TnpRLacZR 
(BamHI) 
CGCGGATCCAGGATCGAACGGCGTG  Tuffin et al. 
(2005) 
ArsRF2 
(EcoRI) 
CGAATTCTGATGGTTGTAGTATTATTTAA Tuffin et al. 
(2005) 
ArsRR 
(HindIII) 
CCCAAGCTTCCGGTACAAAGAAACAGG  Tuffin et al. 
(2005) 
 
*Restriction enzyme sites incorporated into primers are indicated in parenthesis and are 
shown in bold in the primer sequence. 
 
3.2.2. DNA isolation and manipulations 
Small-scale plasmid preparation, restriction endonuclease digestion, ligation and gel 
electrophoresis were performed using standard methods described previously (Sambrook 
et al., 1989).  Large-scale preparation of plasmid DNA was done with the Nucleobond 
AX100 (Macherey-Nagel) or by the alkaline lysis method followed by CsCl gradient 
centrifugation (Current protocols).  Sequencing was done by the dideoxy chain 
termination method, using an ABI PRISMTM 377 automated DNA sequencer and the 
sequence was analyzed using a variety of software programmes, but mainly by the PC 
based DNAMAN (version 4.1) package from Lynnon Biosoft. 
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 3.2.3. PCR 
The polymerase chain reaction was performed with primers described in Table 3.1, using 
50 ng of plasmid DNA in a 50 μl volume containing 2 μM MgCl2, 0.25 μM of each 
primer, 200 μM each of dNTP’s and 1 U TaqI polymerase.  The reaction was carried out 
in a Biometra thermocycler with an initial denaturation temperature of 940C for 60s, 
followed by 25 cycles of denaturation (30s at 940C), an annealing step of 30s, and a 
variable elongation step at 720C.  Annealing temperatures and elongation times were 
altered as required.   
 
3.2.4. Construction of the promoter-lacZ fusions    
The putative promoter regions for the chromosomal arsR and arsB were amplified by 
PCR using the following primer pairs:  ChArsBLacZF/ChArsBLacZR (bp 1417-1938) for 
arsB and ChArsRLacZF/ChArsRLacZR (bp 1400-1569) for arsR (Figure 3.1).  The 
cloning of the putative promoter regions for the transposon-located arsR is described by 
Tuffin et al. (2005).  The PCR products were digested with either BamHI or EcoRI-
BamHI and ligated to the promoterless lacZ reporter gene of pMC1403.  Fusions were 
confirmed by DNA sequencing. 
 
3.2.5. β-galactosidase assays 
Overnight cultures were diluted 1:200 into fresh medium containing the appropriate 
antibiotics, 0.4 mM IPTG, sodium arsenate or sodium arsenite (25 μM) when indicated, 
and incubated at 300C to an OD600 of 0.5.  The β-galactosidase activities were measured 
using the method of Miller (1972).  
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                         arsC start 
                                     arsR end 
1         AGAAAGAGGATCTCGGGGGTTTTCATCGGTGTCACCTCGGTGGGGCGGCGGAAGCGGTGG 
          L  F  L  I  E  P  T  K  M       *  R  P  P  A  A  S  A  T  A   
 
61        CTGCTGCGCTGGATTCGGACTCGTCGGGGATAGTGCAGGATTGGGTGCCGCGACAGCAGT 
            A  A  S  S  E  S  E  D  P  I  T  C  S  Q  T  G  R  C  C  N   
 
121       TTTCGGTAAGGTAGGCGACCAGGGAGCGCACCACGGGCATCTGCGCCCGGTAGCGCTGGA 
            E  T  L  Y  A  V  L  S  R  V  V  P  M  Q  A  R  Y  R  Q  F 
 
181       AACGTCCCTCGCGGTGGACGATGACGAGATCGGCGTGCTGCAGAACCTTGAGGTGAAAGG 
            R  G  E  R  H  V  I  V  L  D  A  H  Q  L  V  K  L  H  F  S   
 
241       ATACGCCGTTGTGCAGTTGCCCGATCCGTTCGGCAATCTGGCCGGAGAAAAGGCCTTCCG 
            V  G  N  H  L  Q  G  I  R  E  A  I  Q  G  S  F  L  G  E  P 
              ChArsBLacZF 
301       GCTCGTGCTCCACCAGTAGGCGAAAAATGGCGAGCCGCACCGGCGAGGCCAGGGCCTCGA 
            E  H  E  V  L  L  R  F  I  A  L  R  V  P  S  A  L  A  E  L 
                          ChArsRLacZR    arsR start 
361       GGCGGGCGACAATGCGATCGCTGTGCTCTTCGGTCATGGGATTCCAATGGTTCAAGTTAG 
            R  A  V  I  R  D  S  H  E  E  T  M 
 
421       ATTGAATTATTGACAAATGTTTTTGGCTCGTCAAGACTACCGGCAATTTCACCCAAGGAG 
 
      arsB start ChArsBLacZR 
481       TACAGGATGCTTGCCCTGGCCATCTTCGTTGTGACCCTGATCCTCGTCATCTGGCAGCCC 
                 M  L  A  L  A  I  F  V  V  T  L  I  L  V  I  W  Q  P  
 
541       AAGGGACTCCAGATCGGTTGGAGTGCCATGGGCGGTGCGGTCGTCGCCCTGGCCACCGGG 
           K  G  L  Q  I  G  W  S  A  M  G  G  A  V  V  A  L  A  T  G   
 
601       GTCATCACCTGGAGCGATATTCCTGTGGTCTGGCATATCGTCTGGGATGCTACCTTTACC 
           V  I  T  W  S  D  I  P  V  V  W  H  I  V  W  D  A  T  F  T   
 
661       TTCGTCGCCCTCATCATCATCTCCCTGATTCTGGACGAAGCCGGTTTCTTCCATTGGGCG 
           F  V  A  L  I  I  I  S  L  I  L  D  E  A  G  F  F  H  W  A   
 
721       GCTCTGCACGTGGCGCGCTGGGGCGGTGGGCGTGGGCGTCGGCTCTTCCCCCTCATCGTC 
           A  L  H  V  A  R  W  G  G  G  R  G  R  R  L  F  P  L  I  V   
 
781       CTGCTGGGGGCGATGATTTCTGCCGTATTCGCCAACGACGGGGCGGCGCTGCTGCTCACC 
           L  L  G  A  M  I  S  A  V  F  A  N  D  G  A  A  L  L  L  T   
                              ChArsRLacZF 
841       CCCATCGTCATGGCCATCCTGTTGCGGCTCGACTTCTCACCCAAGGCCACCTTCGCCTTT 
           P  I  V  M  A  I  L  L  R  L  D  F  S  P  K  A  T  F  A  F   
 
Figure 3.1:  Sequence of the arsR-arsB intergenic region.  The primers used to create the 
arsR-lacZ and arsB-lacZ fusions (underlined), as well as the arsR start and end codons 
and the arsB start codon (grey boxes) are shown.  Arrows indicate the direction of 
transcription.  Putative ribosome binding sites for the arsR and arsB are marked in bold.  
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 3.2.6. RNA analysis and RT-PCR 
Total RNA was isolated as described previously (Trindade et al., 2003) from 50 ml of 
mid-exponential phase cultures of E. coli ACSH50Iq carrying various plasmids, grown in 
LB containing 25μM arsenate or μM arsenite or no arsenic, and with antibiotic selection. 
RNA was also isolated from At. caldus #6.  Cells were first grown in tetrathionate 
medium without arsenite, and were then diluted 1:100 into fresh medium containing 
25μM arsenite or no arsenite.  For RT-PCR, the 1st Strand cDNA synthesis kit (AMV; 
Roche) was used for cDNA synthesis and cDNA product detection.  The protocol of the 
manufacturer was used for the reverse-transcriptase reaction.  The PCR was performed as 
described above using 1.5μl of the 20μl (total volume) reverse-transcriptase reaction, and 
the extension times were altered as required for the different primer pairs.  The ORF1-
RT_Rev, ArsC-RT_Rev, ORF5-RT_Rev, and ORF6-RT-Rev primers were used for 
cDNA synthesis from ORF1, arsC, ORF5 and ORF6 mRNA respectively (Table 3.1; 
Figure 3.5).  For the PCR, the following primers were used in combination: ORF1-
RT_Rev/ArsC-RT_Fw; ArsC-RT_Rev/ArsR-RT_Fw; ORF1-RT_Rev/ArsR-RT_Fw; 
ORF5-RT_Rev/ArsB-RT_Fw; ORF6-RT-Rev/ORT5-RT_Fw and ORF6-RT-Rev/ArsB-
RT_Fw.  To detect DNA contamination in the mRNA extracts, reactions were performed 
with each primer pair without any AMV reverse transcriptase.    
 
 
 
3.3. Results  
 
3.3.1. Reporter-gene studies to investigate regulation of putative promoter       
regions  
ArsR and ArsB promoter studies were performed in the E. coli ars mutant ACSH50Iq 
using a promoterless lacZ fusion construct (pMC1403) with each of the promoter fusions 
(pChArsRLacZ and pChArsBLacZ).  Since only the first few amino acids are used when 
constructing an arsR-lacZ fusion, a functional ArsR would be absent.  Therefore, ArsR 
expressed from a tac promoter (ptacChArsR; Table 3.1) was added in trans.  β-
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galactosidase assays were performed with no arsenic added, or 5, 25 or 100 μM arsenate 
or arsenite added.  It is known that the transport of arsenate into bacterial cells is via 
phosphate transport systems (Sanders et al., 1997).  To determine if phosphate would 
compete with the uptake of arsenate into the cell, β-galactosidase assays with arsenate 
were done in LB (Luria Bertani) media and in a low phosphate media. 
 
When transformed into the E. coli ars mutant ACSH50Iq, pChArsRLacZ and 
pChArsBLacZ gave β-galactosidase activity of 10-20 and 50-70 Miller units respectively. 
This suggested that transcription of the cloned genes from the promoter region was 
stronger in the direction of arsB than arsRC.  In the presence of ArsR, arsB and arsR 
expression was repressed two-fold and twelve-fold respectively. Addition of arsenite and 
arsenate lifted the repression, and it was found that 25 μM of arsenite or arsenate is the 
best concentration to use for induction, as 5 μM did not fully induce the ars operon and 
100 μM affected cell growth.  No significant difference in induction between arsenite and 
arsenate was observed.    Arsenate was able to induce the ars operon more efficiently in 
low phosphate media than in LB media (Figure 3.2).   
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Figure 3.2:  β-galactosidase activity measured in E. coli ACSH50Iq carrying the arsR 
(pChArsRLacZ) and arsB (pChArsBLacZ) promoter constructs in the presence of no 
arsenic and 5, 25 and 100 μM arsenate and arsenite.  arsR expressed from a tac promoter 
(ptacChArsR) and a control plasmid (ptacGL10) were added in trans.  Assays in arsenite 
were done in LB media (A), while assays in arsenate were done in LB media (B) and low 
phosphate media (C).  Units are described as a percentage activity compared to 100 μM 
AsIII and AsV.  All assays were carried out in triplicate and error bars represent standard 
deviations of two or more experiments.  
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Sequence analysis revealed that ORF1 also showed homology to a cadmium inducible 
protein (CadI) of Mycobacterium tuberculosis.  CadI proteins have been found in several 
different organisms and the genes encoding it are often found between ars genes of 
organisms like Mycobacterium bovis and Mycobacterium tuberculosis (Hotter et al., 
2001).  Moore et al. (2005) found that 10 μM cadmium (CdII) was able to induce the ars 
operon of Bacillus subtilis by almost the same amount as 10 μM arsenate and arsenite.  
Based on these findings it was of interest to see if CdII could induce the At. caldus 
chromosomal ars operon. 
 
In the presence of ArsR, arsB and arsR expression was 7.3 and 8.7 β-galactosidase units 
respectively.  When the same constructs were expressed in the presence of CdII, β-
galactosidase units did not increase significantly, indicating that ArsR still repressed arsB 
and arsR (Figure 3.3).  These results indicated that the At. caldus chromosomal ars 
operon is not induced by CdII.    
 
 
 
Figure 3.3:  β-galactosidase activity measured in E. coli ACSH50Iq carrying the arsR 
(pChArsRLacZ) and arsB (pChArsBLacZ) promoter constructs in the presence of no 
cadmium and 25 μM cadmium.  pGL10 (ptacGL10) and the arsR expressed from a tac 
promoter (ptacChArsR) are added in trans. 
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 3.3.2. ORF1 and ORF5 are co-expressed with arsCRB 
Structural gene arrangement suggests that arsCR may be transcribed as one 
transcriptional unit, separate to arsB.  Although deletion experiments had indicated that 
they were not involved in arsenic resistance, because of their proximity to arsC and arsB, 
as well as their direction of transcription (Figure 3.5), we wanted to see if ORF1, ORF5 
and ORF6 were transcribed with the ars genes.  RT-PCR analysis was performed to 
determine if the ars genes were transcribed as a single operon and if ORF1, ORF5 and 
ORF6 were co-transcribed with the ars genes.  RNA was isolated from E. coli ACSH50Iq 
transformed with pTcC-#4 grown in medium in the presence and absence of arsenite and 
arsenate.  RNA was also extracted from At. caldus strain #6 grown in the presence of 
arsenite.  The positions of the primers used in this study are shown in Figure 3.5.  The 
RT-PCR experiment with the RNA extracted from At. caldus #6 was inconclusive, as 
some non-specific but no ars specific products could be obtained (data not shown).  A 
possible reason for the non-specific products may be the degradation of the mRNA as a 
result of the slow growth rate of At. caldus.  When using RNA samples extracted from E. 
coli ACSH50Iq in the presence and absence of arsenite and arsenate with the ORF1-
RT_Rev/ArsC-RT_Fw primer combination, a 522 bp fragment (Figure 3.4 a) was 
obtained.  This indicated that ORF1 is co-transcribed with arsC.  When using the ArsC-
RT_Rev/ArsR-RT_Fw primer combination, a 423 bp fragment was obtained, indicating 
that arsC is co-transcribed with arsR (Figure 3.4 a).  A 451 bp product was obtained 
when primers ArsB-RT_Fw/ORF5-RT_Rev were used, showing that arsB and ORF5 are 
co-transcribed (Figure 3.4 b).  If ORF5 and ORF6 were co-transcribed, a 473 bp product 
would have been obtained using primers ORF5-RT_Fw/ORF6-RT_Rev.  No such 
product was visible, indicating that co-transcription of ORF5 and ORF6 did not occur 
(data not shown).  In the absence of AMV no products were obtained, indicating that 
there was no DNA in the RNA preparations.    
 
 
 
 
 82
  83
 
 
 
   
Figure 3.4:  Ethidium bromide-stained agarose gels of RT-PCR amplification products.  
A:  Co-transcription of ORF1-ArsC shown by the presence of a 522 bp fragment in the 
presence of AMV when using the ORF1-RT_Rev/ArsC-RT_FW primer combination, 
while co-transcription of ArsC-ArsR is shown by the presence of a 423 bp fragment when 
using the ArsC-RT_Rev/ArsR-RT_Fw primer combination.  B:  When using the ArsB-
RT_Fw/ORF5-RT_Rev primer combination co-transcription of ArsB-ORF5 was shown 
by the presence of a 451 bp fragment.  pTcC-PH29 plasmid DNA was included as a 
positive control. 
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Figure 3.5:  Diagram showing the restriction endonuclease map of ORF1-ORF6 as well as the directions of the ORFs.  Also indicated 
are the positions of the primers used for the reverse transcriptase PCR experiment. 
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3.3.3. Cross-regulation of the transposon and chromosomal ars systems 
To determine whether the chromosomal ArsR can regulate the transposon ars system and 
whether the transposon ArsR can regulate the chromosomal ars system, the transposon 
ArsR expressed from a tac promoter (ptacTnArsR) was placed in trans with the promoter 
constructs pChArsRLacZ and pChArsBLacZ.  It was noted that the unregulated 
transposon ars operon lacZ fusion was expressed at much higher levels (1250-1450 
Miller units) than either the chromosomal arsB (15-24 u) and arsR (40-80 u) fusions. 
ptacTnArsR did not affect the chromosomal arsR (Figure 3.6 A) nor the chromosomal 
arsB (Figure 3.6 B) expression, as β-galactosidase activities were unchanged whether 
ptacTnArsR was present or absent.  However, when ptacChArsR and ptacTnArsR were 
added to their respective arsR-fusion constructs (pChArsRLacZ and pTnArsRLacZ) in 
trans, a two-fold (Figure 3.6 A) and four-fold (Figure 3.6 C) repression was observed, 
which was completely alleviated in the presence of arsenate and arsenite.  Interestingly, 
when ptacChArsR was added to pTnArsRLacZ, a two-fold repression was observed, 
which once again was alleviated with the addition of arsenate and arsenite (Figure 3.6 C).  
This indicated that the transposon arsR gene product (ptacTnArsR) was unable to 
regulate the chromosomal arsenic-resistance operon, but the chromosomal arsR gene 
product (ptacChArsR) could regulate the chromosomal and transposon ars systems.  
However, the transposon arsR gene product was a much more effective repressor of the 
transposon ars system (four-fold repression) than the chromosomal arsR gene product 
(only two-fold repression).  This indicates that the transposon ArsR is better equipped to 
regulate the transposon ars system than the chromosomal ArsR.  It was noticeable that 
activity was higher when ptacTnArsR was added in trans to pChArsRLacZ (Figure 3.6 
A).  This higher activity however, was not affected by the addition of arsenate or arsenite, 
and is thus not relevant to this regulatory study.       
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Figure 3.6:  Expression of β-galactosidase of the following promoter constructs:  A: the 
chromosomal arsR (pChArsRLacZ), B: the chromosomal arsB (pChArsBLacZ) and C: 
the transposon arsR (pTnArsRLacZ) in the presence and absence of 25 μM arsenite and 
arsenate.  ptacGL (control), ptacChArsR (chromosomal arsR expressed from a tac 
promoter) and ptacTnArsR (transposon arsR expressed from a tac promoter) were added 
in trans.  All assays were carried out in triplicate and bars represent standard deviations of 
three experiments. 
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3.4. Discussion 
The chromosomal arsenic resistance operon of At. caldus contains the same ars genes as 
conventional chromosomal ars operons of e.g. E. coli and Staphylococcus, but it has an 
atypical arrangement with the arsC and arsR genes divergently transcribed to the arsB 
gene (Figure 2.2), although a similar arrangement was also found in At. ferrooxidans. In 
such a divergent arrangement, it is expected that the arsRC and arsB genes would be 
regulated separately. 
 
RT-PCR analysis carried out with RNA isolated from E. coli ACSH50Iq transformed 
with pTcC-#4 revealed that ORF1, arsC and arsR are transcribed as a single 
transcriptional unit and that arsB and ORF5 are transcribed as one transcriptional unit.  
ORF1 showed homology to a cadmium inducible protein (CadI) of Mycobacterium 
tuberculosis.  CadI proteins are often found between or adjacent to arsenic resistant 
genes, like in Mycobacterium bovis, Bacillus subtilis and Mycobacterium tuberculosis 
(Hotter et al., 2001).  It was therefore not surprising to find ORF1 transcribed with arsC 
and arsR.  Moore et al. (2005) found that cadmium was able to induce the ars operon of 
B. subtilis.  β-galactosidase analysis of ArsR-LacZ promoter fusions showed that 
cadmium was unable to induce the At. caldus chromosomal ars operon.  This indicated 
that the At. caldus chromosomal ArsR is unable to bind cadmium and dissociate from the 
promoter region of the DNA like the ArsR of B. subtilis does.  ORF5 did not show any 
identity to ars genes and therefore it was very surprising that it was transcribed with 
arsB, as it shows no connection to arsenic systems of other organisms.  We have also 
shown in chapter 2 that it was not needed for and did not enhance resistance to arsenate 
or arsenite.  However, these analysis were conducted in the heterologous host E. coli 
ACSH50Iq.  No conclusions could be deduced from RT-PCR analysis performed with 
RNA isolated from At. caldus #6, possibly due to the inability to isolate mRNA as a 
result of the slow growth rate of At. caldus.  Different results may be obtained when this 
experiment is repeated in At. caldus.  As can be seen in Figure 3.4 a and b, ethidium 
bromide-stained agarose gels of RT-PCR amplification products showed the same 
intensity of the PCR product with RNA isolated from E. coli ACSH50Iq in the absence of 
arsenic as with RNA isolated when arsenate or arsenite was present.  The RT-PCR 
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experiments however, were not quantitative and therefore do not give an indication of 
induction levels.  Quantitative RT-PCR experiments as well as mRNA transcriptional 
studies using Northern hybridization will have to be performed in order to determine to 
what extent arsenate and arsenite induces the At. caldus chromosomal ars operon.     
 
Using promoter fusions to a β-galactosidase reporter gene, we showed that 25 µM is the 
optimum concentration of arsenate and arsenite to use for induction of the At. caldus 
chromosomal ars operon.  Five µM arsenate/arsenite was unable to fully induce the ars 
operon and 100 µM had an inhibitory effect on cell growth.  Arsenate was more efficient 
in inducing the ars operon in low phosphate media than in LB media (Figure 3.2 b and c).  
This was expected, as it is well known that arsenate uptake is inhibited in the presence of 
phosphate.  In the LB medium phosphate would compete with the arsenate for uptake 
into the cell.  Less arsenate would thus be taken up when cells are grown in LB media 
and a true reflection of arsenic uptake and induction would not be given.   
β-galactosidase assays also showed that the At. caldus chromosomal ars operon was 
regulated by ArsR.  The ars operon of E. coli plasmid R773 has been shown to be 
induced by arsenite, but not arsenate (Wu and Rosen, 1993).  Arsenate is first reduced to 
arsenite by the ArsC reductase before induction takes place.  We showed that the At. 
caldus chromosomal ArsR was induced by arsenate and arsenite in the E. coli ars mutant 
ACSH50Iq which contained no ArsC.  This suggests that the At. caldus chromosomal 
ArsR can either bind arsenate and arsenite, or that another mechanism exists that can 
convert arsenate to arsenite, which then binds to the ArsR to induce the ars operon. 
Results from Chapter 2 also suggested the possibility that another mechanism may exists 
that can convert arsenate to arsenite.  Two other ArsR proteins that group with the At. 
caldus chromosomal ArsR, the At. caldus transposon ArsR (Tuffin et al., 2005) and the 
At. ferrooxidans ArsR (Butcher and Rawlings, 2002) have also been shown to be induced 
by arsenate and arsenite.  It may be that the metal-binding sites of these atypical ArsRs 
(which contains a conserved LVAYLTENCC domain) are able to bind arsenate and 
arsenite.  The At. caldus chromosomal ArsR was also able to cross-regulate the At. caldus 
transposon ars system, but the transposon system was unable to regulate the 
chromosomal ars system.  This suggested that, in spite of having amino acid sequence 
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identities of 45%, the chromosomal ArsR was able to bind to the DNA of the 
chromosomal and transposon ars systems, while the transposon ArsR was only able to 
bind to the DNA of the transposon system.  It has been shown that the ArsR of E. coli 
plasmid R773 was able to regulate the E. coli chromosomal ars system and that the 
chromosomal ArsR was able to regulate the ars system of plasmid R773 (Xu et al., 
1996).  It was thus not surprising to find that the At. caldus chromosomal ArsR was able 
to regulate the two different ars systems.  However, it was surprising to find that the 
transposon ArsR was unable to regulate the chromosomal ars operon.  Due to the fact 
that arsR sequences contain no obvious DNA binding motif (Wu and Rosen, 1991), it is 
difficult to speculate as to why the chromosomal ArsR can regulate the transposon ars 
system, but not visa versa. The chromosomal ArsR however, was not able to regulate the 
transposon ars system as well as the transposon ArsR, suggesting that the chromosomal 
ArsR is not optimally designed for the regulation of the transposon ars system. 
 
By binding to the promoter sequence, ArsR functions at a transcription level.  Regulatory 
studies were done by using lacZ fusions, which is both a transcriptional as well as a 
translational fusion.  It is possible that there may be another level of regulation at the 
translational level, which could be masking the full regulatory potential of ArsR.  This 
could be a reason why the fusion to arsR gave much lower activity than the fusion to 
arsB.  Another reason for the lower activity of the fusion to arsR may be that the RBS of 
the arsR is much weaker than the RBS of the arsB (Figure 3.1).  A third possible reason 
for the lower arsR expression may be that ArsR must always be made to a certain extent 
in order to repress the ars operon in the absence of arsenic.  Because arsR and arsC are 
transcribed as one transcriptional unit, ArsC will also be made when it is not required.  
This low level of expression will ensure that only small amounts of ArsR and ArsC will 
be made in the absence of arsenic.  To check for regulation on just a transcriptional level, 
Northern blots analysis will have to be performed.                 
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4.1. Introduction 
As a result of the acidophilic, chemoautolithotrophic mode of life and its inhibition by 
organic compounds, At. caldus occupies an environmental niche with relatively few other 
bacterial species.  In such an isolated niche, the amount of genetic transfer that would 
have taken place between At. caldus and other soil microorganisms, is uncertain.  It is 
more likely that exchange would have occurred between At. caldus and other acidophilic 
organisms living in the same environment.  However, the finding of a broad-host-range 
mobilizable plasmid (pTF-FC2) in At. ferrooxidans (which occupies the same ecological 
niche as At. caldus) may indicate that these microorganisms are not as genetically 
isolated as was initially thought (Rawlings et al., 1993).  Research into the molecular 
biology of these biomining bacteria is of great importance in order to optimize the 
biomining process.  This research however, is inhibited greatly by a lack of an easily 
usable genetic system.  
 
Currently two mechanisms exist to transfer genetic material into At. ferrooxidans.  The 
first mechanism, electroporation, was achieved by Kusano et al. (1992) using natural 
plasmids from At. ferrooxidans as the vector and the merA gene (mercury reductase) as a 
selectable marker.  Researchers were able to reisolate recombinant plasmids, and 
restriction enzyme cleavage patterns indicated that no plasmid rearrangements had 
occurred.  They also showed that an IncQ-type of plasmid replicon was able to reproduce 
in At. ferrooxidans.  However, this transformation procedure had several difficulties.  Of 
30 strains electroporated, only one gave transformants, and at a very low frequency.  
Selection for mercury resistance was also problematic because At. ferrooxidans cells took 
a long time to form colonies and mercury is naturally very volatile.  
 
The second mechanism of gene transfer into At. ferrooxidans concerns the use of 
conjugation, using a procedure described by Jin et al. (1992).  Matings were carried out 
using filters on plates containing an inorganic thiosulphate medium with 0.05% yeast 
extract added.  Using this method, IncP, IncQ and IncW plasmids could be conjugated 
into At. ferrooxidans recipients (Peng et al., 1994).  Conjugation frequency was improved 
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by optimizing donor to recipient ratios as well as pH and medium composition (Liu et al., 
1999).   
 
No gene transfer systems for At. caldus have been reported.  This limits research into the 
molecular biology of At. caldus considerably.  Although the external pH environments of 
At. caldus and E. coli are very different, the internal pH and cytoplasmic environment of 
the two bacteria are similar.  There is therefore a good probability that genes from other 
bacteria will function in At. caldus.  Based on evidence presented by de Groot et al. 
(2003) it is known that three At. caldus strains (#6, “f” and MNG) contain ars genes 
carried on a transposon as well as a chromosomal copy of ars genes.  Three At. caldus 
strains (BC13, KU and C-SH12) contain only a chromosomal set of ars genes.  It has 
been shown that the ars genes located on the transposon confer high levels of resistance 
to arsenate and arsenite (Tuffin et al., 2004).  It is known that, due to selective pressure, 
the biomining bacterial population became more resistant to high levels of arsenic 
(Rawlings and Woods, 1995).  It is possible that an increase in resistance of At. caldus 
was obtained by the acquisition of the transposon systems.  Based on the above, it was of 
interest to see if the acquisition of a transposon operon by the E. coli ars mutant 
ACSH50Iq containing only the chromosomal ars genes would increase arsenic resistance 
in E. coli. A gene transfer system for At. caldus will enable the introduction of the 
transposon ars operon to At. caldus strains harboring only the chromosomal ars genes.  
This will enable the effect the transposon ars system has on ars resistance to be 
determined and might shed light as to why certain strains of At. caldus acquired the 
transposon system.   
 
Here I report on the levels of arsenic resistance conferred to E. coli by the At. caldus 
chromosomal and transposon ars systems individually and in combination.  I also report 
on the introduction of the At. caldus #6 transposon ars system to a strain of At. caldus 
harboring only a chromosomal copy of ars genes by conjugation and on changes in levels 
of arsenite resistance after the acquisition of the transposon operon. 
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4.2. Methods 
 
4.2.1. Media, bacterial strains and plasmids 
Bacterial strains, plasmids and primers used in this study are shown in Table 4.1.  E. coli 
strains were grown in Luria-Bertani (LB) broth medium (Sambrook et al., 1989) with 
ampicillin (100 μg/ml) or kanamycin (50  μg/ml) added as required.  At. caldus strains 
were grown at 370C in three different types of media: (a) tetrathionate medium (3 mM), 
sterilized and adjusted to pH 2.5 (Rawlings et al., 1999b), (b) sodium thiosulfate medium, 
sterilized and adjusted to pH 4.6, or (c) elemental sulfur (S0) medium (Jin et al. 1992), 
sterilized and adjusted to pH 4.6.  For the sodium thiosulfate medium, the same basal 
salts and trace elements as the tetrathionate medium were used, but it contained 50 mM 
Na2S2O3 instead of 50 mM K2S4O6.  For the S0 medium, elemental sulfur was sterilized 
by adding 0.5 g S0 to 5 ml water and heated to 105oC for 1 h on two successive days.  
The sterilized sulfur was then added to the basal medium (0.5 g/l).  
 
Table 4.1.  Bacterial strains, plasmids and primers used in this study 
 
Strain, plasmid 
or primer 
Description Source or 
reference 
Strains   
At. caldus   
#6 Fairview mine, Barberton, S. Africa Rawlings 
et.al. (1999b) 
BC13 (ATCC 
51756) 
Birch coppice, Warwickshire, UK Hallberg & 
Lindström 
(1994) 
KU (DSM 
8584) 
Kingsbury coal spoil, UK Hallberg & 
Lindström 
(1994) 
C-SH12 (DSM 
9466) 
Continuous bioreaktor, Brisbane, Australia Goebel & 
Stackebrandt 
(1994) 
   
E. coli   
DH5α Ф80dlacZΔM15, endA1, recA1, gyrA96, thi-1, 
hsdR17 (rk-, mk+), relA1, supE44, deoR,Δ(lacZYA-
argF) U169  
Promega 
XL 1 Blue recA1, endA1, gyrA96, thi, hsdR17 (rk-, mk+), relA1, 
supE44, relA1, lac [F’ proAB+ lacIqZΔM15 
Stratagene 
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::Tn10(tetr)] 
ACSH50Iq rpsL, Δ(lac-pro), Δars::cam Butcher & 
Rawlings 
(2002) 
HB101 F-, Δ(mcrC-mrr), hsdS20, recA13, ara-14, proA2, 
lacY1 λ-, galK2, rpsL20(Smr), xyl-5, mtl-1, supE44 
Boyer and 
Roulland-
Dussoix 
(1969) 
CSH56 F-, ara, Δ(lac pro) supD, nalA, thi Cold Spring 
Harbor 
Laboratory, 
Cold Spring 
Harbor, N.Y. 
   
Plasmids   
pEcoR252 Apr, EcoRI inactivation cloning vector Zabeau & 
Stanley (1982) 
pBluescript SK Apr, LacZ’, ColE replicon, cloning vector Stratagene 
pGL10 Kmr, RK2/RP4 replicon, cloning vector A. Toukdarian 
pSa Kmr, Cmr, Spr, IncW replicon, mobilizing plasmid Tait et al. 
(1982) 
pTcC-PH29 Apr, A blunted 2.9kb PvuII-HindIII fragment from 
pTcC-#4 cloned into a blunted BglII site of  pEcoR252  
This study 
pEcoBlunt Apr, pEcoR252 blunted at the BglII site and relegated 
to inactivate the EcoRI endonuclease 
Tuffin et al. 
(2005) 
pTnArs1GL Kmr, The “transposon-like” arsenic operon isolated 
from At. caldus #6, truncated in the tnpA gene, in the 
cloning vector pGL10. 
Tuffin et al. 
(2005) 
pTn2 Asr Kmr, transposon transconjugant isolated from a 
mating experiment performed in E. coli 
Tuffin et al. 
(2005) 
   
Primers* Sequence (5’-3’)  
RNAarsAF AATACCGCGAACGCATCG  Tuffin et al. 
(2005) 
RNAarsAR AGAAGAGGCTGCTCAGC  Tuffin et al. 
(2005) 
fDD2 
(BamHI)(SalI) 
CCGGATCCGTCGACAGAGTTTGATCITGGCTCAG  Rawlings et 
al. (1995) 
rPP2 
(HindIII)(XbaI) 
CCAAGCTTCTAGACGGITACCTTGTTACGACTT Rawlings et 
al. (1995) 
  
*Restriction enzyme sites incorporated into primers are indicated in parenthesis and are 
shown in bold in the primer sequence 
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4.2.2. DNA isolation and manipulations 
Small-scale plasmid preparation, restriction endonuclease digestion, ligation, gel 
electrophoresis and Southern blot hybridization were performed using standard methods 
described previously (Sambrook et al., 1989).  Large-scale preparation of plasmid DNA 
was done with the Nucleobond AX100 (Macherey-Nagel) or by the alkaline lysis method 
followed by CsCl gradient centrifugation (Current protocols).  Labeling of probes, 
hybridization and detection was performed by using a dioxigenin-dUTP nonradioactive 
DNA labeling and detection kit (Roche).  Total DNA was extracted from various At. 
caldus strains as follows:  At. caldus cells were harvested by centrifugation, washed 3 
times in acidified water (pH 1.8) and resuspended in TE buffer (pH 7.6).  Cell lysis was 
done with 10% SDS in the presence of proteinase K (20 mg/ml) and lysozyme (2 mg/ml) 
at 370C for 1h and then at 500C for 1h.  7.5 M NH4Ac was added and to the cell lysates 
and it was left at room temperature for 45 min.  Precipitation of DNA was done with 
ethanol, washed twice in 70% ethanol and resuspended in TE buffer (pH 7.6).  
 
4.2.3. PCR 
The polymerase chain reaction was performed with primers described in Table 1, using 
50 ng of chromosomal DNA in a 50 μl volume containing 2 μM MgCl2, 0.25 μM of each 
primer, 200 μM each of dNTP’s and 1 u TaqI polymerase.  The reaction was carried out 
in a Biometra thermocycler with an initial denaturation temperature of 940C for 60 s, 
followed by 25 cycles of denaturation (30s at 940C), an annealing step of 30 s, and a 
variable elongation step at 720C.  Annealing temperatures and elongation times were 
altered as required.  
 
4.2.4. Arsenic resistance assays 
To determine the growth of At. caldus in the presence of arsenite, cells were cultured in 
tetrathionate  medium containing different concentrations of arsenite.  Actively growing 
cultures were diluted 100-fold into fresh media and incubated for 19 days, and the 
absorbance at OD600nm was determined every second day.  The growth of At. caldus in the 
presence of arsenate was not tested, as the phosphate concentration in the growth medium 
would contribute to arsenate resistance (Silver et al. 1981).  To test for arsenic resistance 
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in E. coli, constructs were transformed into competent E. coli ACSH50Iq cells.  Growth 
assays to determine the resistance to arsenate (AsV) were performed in low-phosphate 
medium (Oden et al., 1994) supplemented with 2 mM K2HPO4.  Overnight cultures were 
diluted 100-fold into fresh medium containing the appropriate antibiotics and 1.5 mM 
sodium arsenate.  The cultures were incubated at 370C and the absorbance at OD600 nm 
was determined every hour until stationary phase was reached.   
 
4.2.5. Mating assays 
Donor (E. coli HB101 with pSa or pTn2) and recipient (E. coli CSH56 and At. caldus 
BC13, KU and C-SH12) strains were cultured separately in sodium thiosulfate medium 
(pH 4.6) with appropriate antibiotic selection. For E. coli HB101 and CSH56 the medium 
contained 0.05% (m/v) yeast extract.  Cells were washed three times in 0.8% (w/v) NaCl 
solution and mixed in a donor/recipient ratio of 1:5.  The solid medium was prepared in 
two parts, A (double-strength basal salts at pH 4.8 [Rawlings et al., 1999b] and agar) and 
B (2% [w/v] sodium thiosulfate [Na2S2O3]) which were combined in equal volumes after 
autoclaving and cooling to 50oC.  The solid medium was supplemented with 0.05% (w/v) 
yeast extract when used as a mating medium for E. coli and At. caldus.  A 0.22 micron 
filter (Osmonics Inc. A02SP02500) was placed on the solid media and 200 μl of the 
donor/recipient mixture was spotted on the filter.  The plate containing the filter and 
mixture was incubated at 37 oC for 11 days.  The filter was washed in 5 ml of 0.8% NaCl 
solution, and vigorously shaken to dislodge mating cells.  Cells were pelleted by a 2-min 
spin in a mirocentrifuge and resuspended in 1 ml of  0.8% NaCl solution.  For the E. 
coli/E. coli matings the solution was plated onto Luria agar (LA) media that selected for 
the transconjugant cells, while the E. coli/At. caldus mating solutions were transferred to 
the sodium thiosulfate solid and liquid media without yeast extract, with selection for 
transconjugant cells.   
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4.3. Results 
 
4.3.1. Difference in effectiveness of the chromosomal and transposon arsenic 
operons 
To compare arsenic resistance of the transposon and chromosomal ars operons, assays 
were performed with E. coli ACSH50Iq (pTnArs1GL + pEcoBlunt) and E. coli 
ACSH50Iq (pTcC-PH29 + pGL10).  Resistance conferred by the individual operons was 
also compared to that conferred by the two operons when present on compatible co-
resident plasmids in E. coli ACSH50Iq (pTnArs1GL + pTcC-PH29).  Growth curves were 
performed in the presence of 1.5 mM arsenate and in the absence of arsenate.  The 
growth curves without arsenate served as a control to show that E. coli ACSH50Iq 
transformed with the different plasmids grew at the same rate.   Growth curves in the 
presence of arsenite was not tested as the presence of arsenate tested for the functionality 
of both ArsC (converting arsenate to arsenite) and ArsB (exporting the arsenite out of the 
cell).   
 
 
Figure 4.1:  Genetic map of the At. caldus #6 transposon copy of arsenic resistance genes 
and subclones used in this study.  The dotted line indicates a spontaneous arsDA deletion.  
IR, inverted repeats.  The * indicates a methylated restriction enzyme site.     
 
Results shown in Figure 4.2 indicate that in the absence of arsenate growth of all three 
strains was approximately the same irrespective of the plasmids that it contained or their 
selection.  The transposon copy of arsenic resistance genes conferred much more 
resistance to arsenate than the chromosomal copy.  The difference in resistance is not a 
true reflection however, due to the fact that pTnArs1GL was carried on the low-copy 
vector pGL10, while pTcC-PH29 (contains the chromosomal arsRBC5) was carried on 
the moderate-copy vector pEcoR252.  The difference would have been bigger if both ars 
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operons were on the same copy number vector.  When both operons were placed together 
in the E. coli ACSH50Iq ars mutant, no significant difference was seen between cells 
harboring both operons and cells harboring only the transposon operon (Figure 4.2). 
 
4.3.2. Addition of the transposon ars system to strains only carrying the 
chromosomal ars genes 
It has been shown that all six strains of At. caldus have a basic chromosomal arsenic 
resistance system, possibly an arsRBC system.  The three strains isolated in South Africa 
(#6, MNG and “f”) however, have acquired a transposon-located arsenic resistance 
mechanism, as all three isolates gave a positive hybridization signal using the transposon-
borne arsDA, isolated from At. caldus #6, as a probe.  The non-South African strains 
(KU, BC13 and C-SH12) did not give a signal when probed with arsDA (de Groot et al., 
2003; Tuffin et al., 2004).  It is also known that the transposon ars system confers higher 
resistance to arsenic than the chromosomal system.  It was of interest to see if we could 
transfer the transposon ars system to one of the At. caldus strains that only contains the 
chromosomal ars system, and to determine whether an increase in arsenic resistance 
would be acquired. 
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Figure 4.2:  Growth curves performed in the E. coli ars mutant ACSH50Iq in the 
presence and absence of 1.5 mM arsenate.  Each data point represents the results of two 
assays of two independent experiments.  Error bars indicate standard deviations.  Optical 
density (OD) readings were recorded at 600 nm. 
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E. coli HB101 containing either the broad host range conjugative plasmid pSa or pTn2 
(pSa into which TnAtcArs had been transposed, Tuffin et al., 2005) was mated with At. 
caldus strains BC13, KU and C-SH12 for 11 days.  At. caldus transconjugants were then 
selected in inorganic S2O3 media containing Km at pH 4.6.  All of the At. caldus strains 
were able to grow on 100 mg/ml kanamycin (which selects for pSa).  Difficulty was 
experienced in getting At. caldus to form well-isolated colonies on plates.  Therefore total 
DNA was extracted and a PCR experiment using the transposon arsA primers 
(RNAarsAF/RNAarsAR) was conducted (Table 4.1, Figure 4.3).  A 600 bp product was 
observed when using C-SH12-pTn2 total DNA as template, which corresponds to the size 
of the product the ArsA primer pair would form.  This indicated that the transposon copy 
of ars genes (pTn2) did transfer from HB101 to C-SH12.  No products were formed 
when using total DNA from BC13-pTn2 and KU-pTn2 as template.  It is possible that the 
Km resistance observed in At. caldus BC13-pTn2 and KU-pTn2 was due to the 
breakdown of Km in the media.   
 
 
Figure 4.3:  An ethidium bromide-stained agarose gel showing PCR amplification 
products when using an RNAarsAF/RNAarsAR primer combination.  A product was only 
obtained for C-SH12-Tn2 and the positive control pTn2.  
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To confirm that At. caldus was the organism that grew in the S2O3 media and that no 
contamination occurred, the chromosomal DNA that was extracted from At. caldus 
strains C-SH12, BC13 and KU grown in the presence of 100 mg/ml kanamycin was used 
and a 16S rDNA PCR was performed.  The PCR product was digested with BamHI and 
StuI (Figure 4.4).  The fragments obtained indicated that the 16S rDNA was that of At. 
caldus and not a possible contaminating organism, or the E. coli HB101 donor strain. 
 
 
Figure 4.4:  An ethidium bromide-stained agarose gel showing the 16S rDNA PCR 
amplification products when using chromosomal DNA isolated from At. caldus strains 
BC13, KU and C-SH12, digested with BamHI and StuI. 
 
A Southern blot experiment was carried out where chromosomal DNA from At. caldus C-
SH12 (pSa) and At. caldus C-SH12 (pTn2) transconjugants as well as pSa and pTn2 
plasmid DNA were digested with KspI and probed with pSa and the transposon-borne 
arsD.  When probing with arsD a signal was obtained only for lanes containing At. 
caldus C-SH12 (pTn2) and pTn2, indicating that the transposon copy did transfer and that 
it is not present in untransformed At. caldus C-SH12 and in At. caldus C-SH12 (pSa) 
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transconjugants (Figure 4.5 a).  When probed with total pSa (Figure 4.5 b), several 
fragments were obtained for At. caldus C-SH12 (pSa) and At. caldus C-SH12 (pTn2) 
transconjugants, as well as for pSa and pTn2 plasmid DNA, and as expected no signal for 
untransformed At. caldus C-SH12 DNA.  With At. caldus C-SH12 (pTn2) and pTn2 
DNA an additional 5 kb KspI signal was obtained that was not obtained with At. caldus 
C-SH12 (pSa) and pSa DNA.  This 5 kb signal represents a KspI fragment stretching 
from a KspI site in TnAtcArs to a KspI site in pSa, and therefore why it was not obtained 
in DNA extracts containing pSa only. 
 
 
Figure 4.5:   Southern blot experiment where At. caldus C-SH12 (pTn2) and At. caldus 
C-SH12 (pSa) transconjugants as well as untransformed At. caldus C-SH12 and pTn2 and 
pSa DNA were digested with KspI and probed with (A) the transposon arsD and (B) pSa.   
 
 
Next we tested whether At. caldus C-SH12 (pTn2) transconjugants would be more 
resistant to arsenic than At. caldus C-SH12 transformed with just pSa and also to show 
that the addition of pSa does not have an effect on arsenic resistance.  Growth curve 
experiments were done where At. caldus C-SH12 (pSa) and At. caldus C-SH12 (pTn2) 
transconjugants were grown in the presence of 0, 20, 30, 40 and 50 mM arsenite.  After 
eight days, At. caldus cells containing the transposon copy of arsenic resistance genes (C-
SH12-pTn2) were able to grow on 30 mM arsenite, while the At. caldus cells harboring 
only the chromosomal ars genes (C-SH12-pSa) showed weaker growth, even at 20 mM 
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arsenite.  After 13 days, At. caldus C-SH12 (pTn2) was able to grow on 50 mM arsenite, 
while At. caldus C-SH12 (pSa) was sensitive to 30 mM arsenite.  After 19 days C-SH12-
pSa was still sensitive to 30 mM arsenite (Figure 4.6).  These results indicate that the 
addition of the transposon ars operon of At. caldus strain #6 to At. caldus C-SH12 
increased the resistance to arsenite more than two-fold.         
 
 
Figure 4.6:  Arsenite growth curves performed with At. caldus C-SH12 (pTn2) and At. 
caldus C-SH12 (pSa) transconjugants in the presence of various concentrations of 
arsenite.  Cell densities were determined (OD 600nm) and a percentage resistance was 
calculated (growth in the absence of arsenite was equivalent to 100%) after 19 days.  
Each data point represents duplicate results of at least two experiments.  Error bars 
indicate standard deviations.  
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4.4. Discussion 
It is known that At. caldus #6 has an ars operon carried on a transposon (de Groot et al., 
2003; Figure 4.1) and in this study we identified the chromosomal ars operon of this 
organism.  Tuffin et al. (2004) showed that the ars genes on the transposon confer high 
levels of resistance to arsenate and arsenite.  Growth curve experiments conducted with 
the transposon and chromosomal copy of ars genes in E. coli ACSH50Iq revealed that the 
transposon system conferred higher levels of resistance to arsenate than the chromosomal 
system.  To determine arsenate resistance levels when both systems were in the same 
organism, growth curves were conducted where the chromosomal and transposon 
systems were placed together in trans in E. coli ACSH50Iq.  No significant difference was 
observed between cells harboring both systems and cells harboring only the transposon 
system, indicating that the two operons did not have a synergistic effect on arsenate 
resistance and that resistance levels were similar to those of the transposon.  However, 
this study was done in E. coli, and these results may not be a true reflection on the levels 
of resistance in At. caldus. 
 
It is well known that the bacterial biomining population evolved to become more resistant 
to high levels of arsenic over a short period of time (Rawlings and Woods, 1995).  In 
order to demonstrate that the acquisition of the transposon ars system resulted in the 
increase of arsenic resistance in At. caldus, a system had to be developed where the 
transposon copy of ars genes could be introduced into At. caldus strains only having the 
chromosomal ars operon (BC13, KU and C-SH12).  Using a conjugational system, the 
transposon ars system (carried on the conjugative pSa) was transferred from E. coli 
HB101 to At. caldus C-SH12.  Transformants were selected with kanamycin.  Southern 
bolt hybridization (Figure 4.5) and PCR analysis (Figure 4.3) confirmed the transfer of 
the transposon ars system from E. coli HB101 to At. caldus C-SH12.  The banding 
pattern of the Southern blot experiment also indicated that no plasmid rearrangements 
occurred during the conjugation process.  We were unable to transfer the transposon ars 
system to At. caldus BC13 and KU.  Although kanamycin resistance was also observed 
for At. caldus KU and BC13, it is most likely due to the breakdown of the kanamycin 
following extended aeration at low pH.  Studies conducted by Hallberg and Lindstrom 
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(1996) showed that antiserum generated against whole cells from At. caldus KU 
recognized whole cells of isolates BC13 and KU, but not C-SH12.  The authors propose 
that this lack of recognition by the antiserum is most likely due to the fact that the 
lipopolysaccharide (LPS) of isolate C-SH12 differs from the LPS of BC13 and KU.  This 
means that At. caldus C-SH12 can be considered to belong to a different serotype from 
that of BC13 and KU.  A difference in cell structure may thus be the reason why we were 
unable to transfer DNA to strain KU and BC13.  
 
Growth curve experiments with At. caldus C-SH12 (pSa) and At. caldus C-SH12 with the 
introduced transposon operon (pTn2) were conducted to determine if the acquisition of 
the transposon operon could have resulted in the increase in arsenic resistance of certain 
At. caldus strains.  Introduction of the transposon system to At. caldus C-SH12 resulted in 
an increase of arsenite resistance of more than two-fold.  In the presence of arsenite the 
growth rate of the culture of transconjugants was also much faster than C-SH12 cells with 
only the chromosomal ars system.  The increased levels of resistance and rate of growth 
had a dramatic effect on growth in the presence of arsenite (Figure 4.6).  Based on these 
results we speculate that At. caldus #6 became more resistant to arsenic most likely by the 
acquisition of the transposon ars system.  
 
The development of a conjugation system to transfer genes from E. coli to At. caldus C-
SH12 is a major breakthrough in the study of the molecular biology of At. caldus.  
Optimization of this system may be achieved by optimizing donor to recipient ratios, pH 
and medium composition.  Researchers in our laboratory are currently developing a 
mechanism to introduce gene knockouts in At. caldus.  This system, together with the 
conjugation system, will enable us to study the molecular biology of biomining bacteria 
in greater depth than is currently possible.  This could enable us to genetically engineer 
strains that could grow faster, at lower pH, at higher temperatures, at higher cell densities 
and with smaller quantities of added nutrients (Rawlings and Kusano, 1994) in order to 
achieve great economical savings in the biomining industry.    
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Chapter 5 
General Discussion 
 
Arsenic resistance (ars) systems had been identified in many different bacteria.  Two 
common forms of the ars operon have been identified.  The most common form consists 
of three genes (arsRBC) and is found on plasmids of S. xylosus (pSX267) and S. aureus 
(pI258).  The second form consists of five genes (arsRDABC) and was found on plasmids 
R773 and R46 of E. coli and more recently on transposons of At. caldus (AY821803), L. 
ferriphilum (DQ057986), A. faecalis (Ay297781) and M. flagellatus 
(NZ_AADX01000013) (Tuffin et al., 2006).  During the sequencing of the E. coli 
chromosome, the first chromosomally encoded arsenic resistance genes were identified 
(Diorio et al., 1995).  Since then, with more chromosomal sequencing projects underway, 
arsenic resistance genes have been identified on many more bacterial chromosomes, and 
generally take the form arsRBC. 
 
In a previous study two copies of transposon-linked ars operons had been identified in At. 
caldus strain #6 (Figure 2.1 a and b; Tuffin et al., 2004).  Using Southern blot analysis de 
Groot et al. (2003) identified a possible chromosomal ars operon in At. caldus strain #6 
that was different to the ars genes in the transposon.  The aim of this study was to isolate 
and sequence the third ars operon.  Once characterized, expression and regulatory studies 
were performed and possible interaction between the transposon-located and 
chromosomal ars operons was analyzed.   
 
Sequence analysis of the At. caldus #6 chromosomal ars operon revealed an arsCRB 
operon.  This ars operon however, differs from the conventional chromosomal arsRBC 
operons of E. coli and Staphylococcus spp. where the operon is transcribed as one 
transcriptional unit (Diorio et al., 1995).  The At. caldus chromosomal ars operon is bi-
directional, with the arsC gene located upstream of the arsB gene and the arsC and arsR 
genes divergently transcribed to arsB.  This divergent arrangement of the ars genes raised 
the possibility that transcription in the two directions might be regulated differently.   
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 In ars systems where an ArsA is absent (as in the At. caldus chromosomal ars operon), it 
is believed that the ArsB uses membrane potential rather that ATP hydrolysis as an 
energy source to export arsenite out of the cell.  However, with acidophilic 
microorganisms like At. caldus this is likely to be different, as they have a reversed 
membrane potential, with a positive rather than negative inside membrane potential 
(Martin, 1990).  Nevertheless, the At. caldus ars genes conferred enhanced resistance to 
arsenate and arsenite when cloned in E. coli.  The mechanism how arsenite is exported by 
ArsB in this acidophilic organism lacking an ArsA is still unknown.  
 
Alignment studies showed that the At. caldus chromosomal ArsC protein grouped with 
ArsC proteins of the Trx family (Figure 2.9).  This suggested that this ArsC would use 
thioredoxin rather than glutathione as a reducing power to convert arsenate to arsenite.  
When tested to see if thioredoxin aids the ArsC in converting arsenate to arsenite, it was 
surprising to find that the At. ferrooxidans thioredoxin gene (trxA) was unable to help 
ArsC convert arsenate to arsenite.  Based on the alignment studies and the high identity to 
the ArsC of At. ferrooxidans, it is likely that thioredoxin rather than glutathione is used 
by the At. caldus chromosomal ArsC as a reducing power.  A possible explanation is that 
the At. ferrooxidans trxA gene may not complement the At. caldus chromosomal ArsC to 
reduce arsenate to arsenite. 
 
Recently the crystal structures of ArsC proteins of the Trx and GSH/Grx clades have 
been determined and mechanisms of arsenate reduction predicted (Martin et al., 2001; 
Zegers et al., 2001).  Sequence analysis of the At. caldus chromosomal ArsC revealed 
that it contains, like other ArsC proteins of the Trx clade, four cysteine residues (Cys10, 
Cys15, Cys82 and Cys90) with spacing similar to those of other ArsC proteins of the Trx 
clade.  Based on the above mentioned evidence, we propose that the At. caldus 
chromosomal ArsC will function similar to the B. subtilis ArsC (Figure 1.7).  
 
RT-PCR analysis done in E. coli revealed that ORF1, arsC and arsR are transcribed as 
one transcriptional unit and that arsB and ORF5 are also transcribed as a single 
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transcriptional unit.  Reporter gene studies in the E. coli ars mutant ACSH50Iq indicated 
that the level of expression in the direction of arsB was about five-fold higher than in the 
direction of arsRC.  The arsB expression was also repressed to a greater extent by ArsR 
than arsRC expression.  A divergent chromosomal ars operon was also identified in At. 
ferrooxidans (Butcher et al., 2000).  The At. caldus chromosomal arsC, arsR and arsB 
genes exhibited 78%, 74% and 85% identity, respectively, to the At. ferrooxidans 
chromosomal ars genes.  This high similarity between the ars genes of the two organisms 
suggests that they may have a common ancestor.  Although the genome of At. 
ferrooxidans has been sequenced, the ars genes are the first from the chromosome of At. 
caldus to be reported.  It is therefore too early to know whether the relatedness between 
ars genes reflects a general relationship between At. ferrooxidans and At. caldus or 
whether it is a feature of ars genes. 
 
Sequence alignments of the At. caldus chromosomal ArsR with its closest matches from 
the NCBI database showed that none of these ArsR proteins contain the conserved metal 
binding motif (ELCVCDL) known to be involved in the binding of arsenite.  Arsenite 
binds to the cysteine residues in this domain, resulting in a conformational change to 
ArsR that causes the repressor to dissociate from the promoter, which then results in the 
expression of the ars genes (Shi et al., 1994).  The SmtB/ArsR family of transcriptional 
regulators have two metal binding sites, the α3N in the α3 helix and the α5C metal 
binding site in the α5 helix (Busenlehner et al., 2003).  It is known that the ELCVCDL 
motif is located in the α3 helix.  The At. caldus chromosomal ArsR and its closest 
matches however, contain a conserved LVAYLTENCC domain near the C-terminal end 
of the protein (Figure 2.10).  The two cysteine residues in this domain, together with 
another cysteine five to seven residues towards the C-terminal, may form the metal 
binding domain of these atypical ArsR proteins.  The fact that this possible metal binding 
domain is located in the α5 helix strengthens the possibility that this could be the At. 
caldus chromosomal ArsR’s metal binding domain, as Busenlehner et al. (2003) showed 
that this family of transcriptional regulators has metal binding domains in the α3 and/or 
α5 helices.   
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Despite the lack of the conventional ELCVCDL metal binding motif on the At. caldus 
chromosomal ArsR, translational fusions of the predicted promoter regions to a 
promoterless reporter gene (lacZ) showed that the expression from the arsB and arsR 
promoters were repressed in the presence of an intact arsR gene in trans.  This repression 
was relieved with the addition of arsenite and arsenate (Figure 3.2).  This indicated that 
the atypical ArsR does regulate expression from the arsB and arsR promoters.  No 
detectable difference in the ability of arsenate and arsenite to derepress the transcription 
of the ars genes was observed.  However, it was very interesting to find that ArsR was 
induced by arsenate, as most ArsR regulators respond to arsenite but not arsenate.  The 
ArsR protein of At. ferrooxidans (with which the At. caldus chromosomal ArsR has 74% 
identity) has also been shown to be induced by arsenate (Butcher et al., 2000).  The ArsR 
protein of At. caldus is only the third example (all from Acidithiobacillus) of an arsenic 
regulator that is derepressed by both forms of arsenic.  As no ArsC was present when 
ArsR was induced by arsenate and arsenite, it suggests that these atypical ArsR proteins 
can bind either arsenate or arsenite, or that a mechanism other that ArsC exists that can 
convert arsenate to arsenite prior to binding to the ArsR.  Metal binding sites for both 
arsenate and arsenite might be a common characteristic for this atypical ArsR family of 
transcriptional regulators. 
 
In future work it will be important to show that the ArsR binds to the predicted promoter 
regions.  Shi et al. (1994) showed, by using gel mobility shift assays, that the E. coli 
R773 ArsR was able to bind to the predicted promoter region.  Gel mobility shift assays 
can similarly be used to show that the At. caldus chromosomal ArsR binds to the 
promoter sequence in the absence of an inducer.  If the ArsR does not bind in the 
presence of arsenite and arsenate, it will confirm our results that arsenate and arsenite can 
act as inducers of the At. caldus chromosomal ArsR.  If mutations of Cys94, Cys95 and 
Cys101 by site-directed mutagenesis result in the loss of induction of ArsR by arsenate and 
arsenite, it will indicate if the predicted LVAYLTENCC domain is indeed the metal 
binding domain and that these three cysteines are involved in arsenic binding.  
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An investigation of how the chromosomal and transposon ars systems were likely to 
interact when both were present in the same bacterium was carried out, as TnAtcArs is 
also found in At. caldus #6.  Although the transposon and chromosomal ars operons are 
quite different and although the two ArsR proteins share only 45% sequence identity, 
promoter fusion studies in E. coli indicated that the At. caldus chromosomal ArsR was 
able to regulate the promoters (both directions) of its own operon as well as cross-
regulate the transposon ars promoter.  However, regulation of the transposon promoter by 
the chromosomal ArsR was not as effective as regulation by its own ArsR protein, 
indicating that the chromosomal ArsR is not optimally designed for the regulation of the 
transposon ars operon.  Growth curve experiments conducted with the transposon and 
chromosomal copies of ars genes revealed that the transposon system conferred much 
higher levels of arsenic resistance than the chromosomal system in a heterologous host 
(Figure 4.2).  The very much higher levels of gene expression from the transposon operon 
might be the reason for these higher levels of arsenic resistance conferred by the 
transposon operon in E. coli.   
 
However, these experiments were done in a heterologous host, E. coli, and may therefore 
not directly reflect what happens in At. caldus.  The fact that co-transcription of accessory 
genes (ORF1 and ORF5) was observed, but had no effect on arsenic resistance in E. coli 
is something of an anomaly.  It could be that these ORFs confer some property that was 
not examined or that co-transcription in E. coli was artefactual.  mRNA studies with 
RNA isolated from At. caldus would be able to confirm if the results obtained in the 
heterologous host, E. coli, were a true reflection of what happens in At. caldus.  If the 
accessory genes are co-transcribed with the ars genes in At. caldus, knockout mutants in 
At. caldus would then shed more light on the functions of these genes. 
 
It is known that three At. caldus strains (#6, “f” and MNG) that were previously exposed 
to arsenic contain two sets of arsenic resistance genes, a set on the chromosome as well 
as a set carried on a transposon, while strains BC13, KU and C-SH12 only contain a 
chromosomal copy of arsenic resistance genes (de Groot et al., 2003).  In this study it 
was shown that in E. coli, the transposon copy of ars genes confers much higher levels of 
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arsenic resistance than the chromosomal copy.  We wanted to check on a possible 
difference in levels of ars resistance if the transposon arsenic system was introduced to a 
strain of At. caldus only harboring the chromosomal ars genes.  A major problem was 
that no easy gene transfer system exists for these acidophilic organisms.  No success has 
been achieved by chemical transformation and Kusano et al. (1992) were able to 
transform DNA to At. ferrooxidans by electroporation to only one strain of 30 strains 
electroporated.  A more successful conjugational system was used by Jin et al. (1992) and 
was further improved by Liu et al. (1999).  No DNA transformation systems for At. 
caldus had been reported prior to this study.      
 
It is well known that the bacterial population used in the biomining process became 
highly resistant to arsenic over a period of three years (Rawlings and Woods, 1995).  In 
order to demonstrate that the acquisition of the transposon ars system resulted in an 
increase in arsenic resistance in At. caldus, a system had to be developed where the 
transposon copy of ars genes could be introduced to strains harboring only a 
chromosomal copy.  Using a conjugative system, the transposon ars system was 
introduced to At. caldus C-SH12.  This was the first reported study where DNA was 
successfully transferred to At. caldus.  As expected, the introduction of the transposon ars 
operon to At. caldus C-SH12 resulted in an dramatic increase of ars resistance (Figure 
4.6).  It was not possible to determine by how much arsenic resistance was increased, 
because growth of the transformed cultures occurred at concentrations above at which 
arsenite precipitated.  Based on these results we speculate that At. caldus #6 obtained 
higher levels of arsenic resistance most likely by the acquisition of the transposon ars 
system from the gene pool. 
 
The development of a genetic transfer system for At. caldus is of great importance in the 
future study of the molecular biology of this organism and possibly other acidophilic 
organisms.  Researchers in our laboratory are currently developing a system to introduce 
gene knockouts in At. caldus.  These two systems will enable us to study the molecular 
biology of these biomining bacteria in greater depth than is currently possible.  At. caldus 
C-SH12 formed indistinct colonies on solid medium, and it was therefore not possible to 
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calculate the conjugation frequency.  A means of obtaining more distinct At. caldus C-
SH12 colonies on solid media has recently been achieved by replacing agarose with 
phytogel as a gelling agent.  As we are now able to calculate the transformation 
frequency, experiments are currently in progress using this plasmid transfer system to 
optimize a conjugation system for At. caldus. 
 
As the dominant iron-oxidizing bacterium in arsenopyrite biooxidation tanks, it was 
believed that a strain of Leptospirillum ferriphilum (isolated from a commercial 
biooxidation tank treating a gold-bearing arsenopyrite concentrate at the Fairview mine in 
South Africa) would also possess an effective arsenic resistance mechanism.  This was 
the case, as Tuffin et al. (2006) showed that L. ferriphilum does, like At. caldus, carry a 
set of arsenic resistance genes on a transposon.  This was not surprising, as L. 
ferriphilum, like At. caldus, was isolated from a very arsenic rich environment.  The L. 
ferriphilum transposon ars operon had a very similar gene layout as the transposon ars 
operon of At. caldus, except for the absence of ORF7 and the arsDA duplication.  
Although these two ars operons originated from bacteria from the same environment, the 
amino acid sequence of their gene products were not necessarily the most closely related, 
with high sequence identity to genes on transposons from A. faecalis and M. flagellatus 
as well (Tuffin et al., 2006; Figure 5.1).  The differences in DNA sequence between the 
transposon ars genes of At. caldus and L. ferriphilum are far to substantial for the 
transposons to have passed from At caldus to L. ferriphilum or vice versa in the 
biooxidation environment.  This suggests that these two types of bacteria have acquired 
the ars transposons independently of each other.   
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TnLfArs
tnpR     arsR arsC  arsD            arsA             CBS       arsB                                        tnpA
TnAtcArs
A. faecalis
tnpR     arsR arsC arsD            arsA           arsD          arsA                    ORF7        CBS         arsB                                        tnpA
arsR arsC  arsD           arsA             CBS       arsB                                       tnpA
M. flagellatus
tnpA                        tnpR       arsRC arsD           arsA           CBS        arsB
 
Figure 5.1:  Diagrammatic representation of transposon located ars operons isolated 
from Leptospirillum ferriphilum Fairview (TnLfArs), Acidithiobacillus caldus #6 
(TnAtcArs), Methylobacillus flagellatus and Alcaligenes faecalis.  Inverted repeats are 
shown as vertical bars.  The white box downstream of M. flagellatus arsB represents a 39 
aa TnpA remnant.  Taken from Tuffin et al. (2006). 
 
Like in At. caldus, the L. ferriphilum transposon located ars genes conferred higher levels 
of arsenic resistance than the chromosomal ars genes in E. coli.  The chromosomal ars 
genes were also very poorly expressed.  Because the overexpression of arsB is lethal to 
cells, organisms do not necessarily want high expression levels of ars genes.  If they live 
in an environment with low levels of arsenic, the low levels of expression from the 
chromosomal ars operons will probably be sufficient to confer arsenic resistance.  Only 
when they are placed under selective pressure would they acquire an additional system 
that would confer higher levels of arsenic resistance.  Tuffin et al. (2006) also showed 
that the L. ferriphilum strain containing the transposon ars operon was more resistant to 
arsenic than L. ferriphilum strains harboring only a chromosomal copy of ars genes.  It 
thus seems that the quickest or easiest way for these bacteria to have survived these 
arsenic rich environments, was by the acquisition of another arsenic operon, as the time 
to mutate an existing operon (like the chromosomal ars operon) may take thousands of 
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years.  The fact that these biooxidation environments are not sterile opens many options 
as to where these arsenic transposons originated from.  The findings in this study are 
consistent with the prediction, reported by Woese (2004), that “cosmopolitan genes”, of 
which arsenic resistance genes are a typical example, are more likely to be a 
characteristic of a certain environment than of particular lineages.  If these “cosmopolitan 
genes” are not restricted to certain lineages, they will most likely pass between different 
types of bacteria within an environment that selects for them.   Kondratyeva et al. (1995) 
suggested that both arsenic and zinc resistant strains of At. ferrooxidans have increased 
copy numbers of chromosomal genes encoding resistance.  In this study we answered the 
question of how these biomining organisms became more resistant to arsenic in a relative 
short period of time.  This increase in resistance was acquired probably not by an increase 
in copy number of arsenic resistance genes, but by the acquisition of a highly resistant 
arsenic operon carried on a transposon.           
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Appendix One: Annotated sequence obtained from pTcC-#4 
 
Shown below is the double stranded sequence of the At. caldus chromosomal fragment 
obtained in pTcC-#4 during the course of this study.  Protein translations of the ten open 
reading frames encoded on this fragment have been shown below the DNA sequence.  
Restriction endonuclease sites are labeled above the DNA sequence.  The sequence to 
which primers were designed is underlined and labeled in white boxes.  The start codons 
of open reading frames are labeled in grey boxes and the putative ribosome binding sites 
of arsR and arsB are shown in bold.  Arrows indicate the direction of transcription. 
 
 
 
 
1      GATCCCGACACCACCGAGATAAGCCCTCACTGCCTACGGCTCGCCGTCCGCAAACCGTTA 
       CTAGGGCTGTGGTGGCTCTATTCGGGAGTGACGGATGCCGAGCGGCAGGCGTTTGGCAAT 
 
61     GGCGCGACACGCTTCCAGGGTGGCTGTGCCTGGTGCTGGGCGAGCGCTTATCCCGAGAAA 
       CCGCGCTGTGCGAAGGTCCCACCGACACGGACCACGACCCGCTCGCGAATAGGGCTCTTT 
 
121    GTCGCACGGTTTACCTCGACTCCGTACCGGGCACCAGAAATACCGGCTCTTGGTCGGCGG 
       CAGCGTGCCAAATGGAGCTGAGGCATGGCCCGTGGTCTTTATGGCCGAGAACCAGCCGCC 
                  *  R  S  E  T  G  P  V  L  F  V  P  E  Q  D  A  P   
 
181    GCATGGTGGCGAGCTCTTCTTCCGTCATCCGAGCGTAAATTTCGAGGAGATAACCCGTGG 
       CGTACCACCGCTCGAGAAGAAGGCAGTAGGCTCGCATTTAAAGCTCCTCTATTGGGCACC 
         M  T  A  L  E  E  E  T  M  R  A  Y  I  E  L  L  Y  G  T  P 
  
          ORF1-RT_Rev 
241    GATCGCGCAGCCAGAGTTCGTGCAGAGGTGTGCCGCGCCAGGTGCTGCGCGGCGGCTTGA 
       CTAGCGCGTCGGTCTCAAGCACGTCTCCACACGGCGCGGTCCACGACGCGCCGCCGAACT 
         D  R  L  W  L  E  H  L  P  T  G  R  W  T  S  R  P  P  K  V 
        
301    CCACCTCGGCACCGGCGGCCACGGCGCGATGGTAGGCGGCGATCACCGCTTCCTTGCTCC 
       GGTGGAGCCGTGGCCGCCGGTGCCGCGCTACCATCCGCCGCTAGTGGCGAAGGAACGAGG 
         V  E  A  G  A  A  V  A  R  H  Y  A  A  I  V  A  E  K  S  R 
 
361    GCACTCCCAGGCCCACGTGGTAGAGGCTGTAGGTGTCGAGGGGCTCGTCCCGGTCGTTGA 
       CGTGAGGGTCCGGGTGCACCATCTCCGACATCCACAGCTCCCCGAGCAGGGCCAGCAACT 
         V  G  L  G  V  H  Y  L  S  Y  T  D  L  P  E  D  R  D  N  V 
 
421    CGAGAATCACCAGATTCAGGCAGAGATCGGGGACGATGAAGGTGCTGAAGCGCGCCGTCT 
       GCTCTTAGTGGTCTAAGTCCGTCTCTAGCCCCTGCTACTTCCACGACTTCGCGCGGCAGA 
         L  I  V  L  N  L  C  L  D  P  V  I  F  T  S  F  R  A  T  Q 
 
                                                                 BstEII 
481    GTTGTCTGGGCTCAACCCCGAAAAAGTCCCGATAGAAGGCCGTGCTGCGGGCAAGATCGG 
       CAACAGACCCGAGTTGGGGCTTTTTCAGGGCTATCTTCCGGCACGACGCCCGTTCTAGCC 
         Q  R  P  E  V  G  F  F  D  R  Y  F  A  T  S  R  A  L  D  T  
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  HindIII 
541    TTACCCGGAAGCTTAGATGAAATTCCTGGCGAGCGGGCACCAGGGGAGACAACTCGGTGG 
       AATGGGCCTTCGAATCTACTTTAAGGACCGCTCGCCCGTGGTCCCCTCTGTTGAGCCACC 
         V  R  F  S  L  H  F  E  Q  R  A  P  V  L  P  S  L  E  T  S 
 
       Start ORF1 
601    ACATGCAGTAATCCTCAGGGTTCACTGTGACCAATGCGTTCCAGTTCCGTGCGCAGGCGA 
       TGTACGTCATTAGGAGTCCCAAGTGACACTGGTTACGCAAGGTCAAGGCACGCGTCCGCT 
         M            *  P  E  S  H  G  I  R  E  L  E  T  R  L  R   
 
661    CTGGGATCTTCGGCTAGCCATTCGGCGACGGGCAGTTGCAAAAGCGCCTCGATGCGATGG 
       GACCCTAGAAGCCGATCGGTAAGCCGCTGCCCGTCAACGTTTTCGCGGAGCTACGCTACC 
       S  P  D  E  A  L  W  E  A  V  P  L  Q  L  L  A  E  I  R  H   
 
                                   ArsC-RT_Fw 
721    CGCAGGATTCGATAGGCTTTCTCGAAAGCGGCCTCGATTTCCGCCTCGCTGCCGGTCGCC 
       GCGTCCTAAGCTATCCGAAAGAGCTTTCGCCGGAGCTAAAGGCGGAGCGACGGCCAGCGG 
       R  L  I  R  Y  A  K  E  F  A  A  E  I  E  A  E  S  G  T  A   
 
781    TTGGCGGGATCGTCTACCCCCCAATGGGCGCGCAGGGCAGGGCCGAGATAGGCCGGGCAG 
       AACCGCCCTAGCAGATGGGGGGTTACCCGCGCGTCCCGTCCCGGCTCTATCCGGCCCGTC 
  K  A  P  D  D  V  G  W  H  A  R  L  A  P  G  L  Y  A  P  C  
 
                                            EcoRV 
841    GTCTCGCCAGCGGCACTGGCGCAGACGGTGATGACGATATCCGGGGTAGTGGGCAGATCG 
       CAGAGCGGTCGCCGTGACCGCGTCTGCCACTACTGCTATAGGCCCCATCACCCGTCTAGC 
       T  E  G  A  A  S  A  C  V  T  I  V  I  D  P  T  T  P  L  D   
 
901    TCCCAGGACTTGCTGGCGAGACCTTCGGTAGAGAAGCCTTCCCGCTGCAGGAGGGCAACA 
       AGGGTCCTGAACGACCGCTCTGGAAGCCATCTCTTCGGAAGGGCGACGTCCTCCCGTTGT 
       D  W  S  K  S  A  L  G  E  T  S  F  G  E  R  Q  L  L  A  V   
 
961    CTGCGCGGATGCACATAACCTGCCGGATGGCTGCCGGCGCTGCTGGCGTGGAGCCTGCCC 
       GACGCGCCTACGTGTATTGGACGGCCTACCGACGGCCGCGACGACCGCACCTCGGACGGG 
       S  R  P  H  V  Y  G  A  P  H  S  G  A  S  S  A  H  L  R  G   
 
                                ArsC-RT_Rev and ChArsRR 
1021   TGGGCAAGGCCGTTGAGGGTGGCTTCGGCCAGGATGGAACGACAGGAGTTGCCGGTGCAC 
       ACCCGTTCCGGCAACTCCCACCGAAGCCGGTCCTACCTTGCTGTCCTCAACGGCCACGTG 
       Q  A  L  G  N  L  T  A  E  A  L  I  S  R  C  S  N  G  T  C   
 
                                  Start arsC 
1081   AGAAAGAGGATCTCGGGGGTTTTCATCGGTGTCACCTCGGTGGGGCGGCGGAAGCGGTGG 
       TCTTTCTCCTAGAGCCCCCAAAAGTAGCCACAGTGGAGCCACCCCGCCGCCTTCGCCACC 
       L  F  L  I  E  P  T  K  M       *  R  P  P  A  A  S  A  T  A 
 
1141   CTGCTGCGCTGGATTCGGACTCGTCGGGGATAGTGCAGGATTGGGTGCCGCGACAGCAGT 
       GACGACGCGACCTAAGCCTGAGCAGCCCCTATCACGTCCTAACCCACGGCGCTGTCGTCA 
         A  A  S  S  E  S  E  D  P  I  T  C  S  Q  T  G  R  C  C  N 
 
1201   TTTCGGTAAGGTAGGCGACCAGGGAGCGCACCACGGGCATCTGCGCCCGGTAGCGCTGGA 
       AAAGCCATTCCATCCGCTGGTCCCTCGCGTGGTGCCCGTAGACGCGGGCCATCGCGACCT 
         E  T  L  Y  A  V  L  S  R  V  V  P  M  Q  A  R  Y  R  Q  F  
 
1261   AACGTCCCTCGCGGTGGACGATGACGAGATCGGCGTGCTGCAGAACCTTGAGGTGAAAGG 
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       TTGCAGGGAGCGCCACCTGCTACTGCTCTAGCCGCACGACGTCTTGGAACTCCACTTTCC 
         R  G  E  R  H  V  I  V  L  D  A  H  Q  L  V  K  L  H  F  S   
 
                                                           StuI 
1321   ATACGCCGTTGTGCAGTTGCCCGATCCGTTCGGCAATCTGGCCGGAGAAAAGGCCTTCCG 
       TATGCGGCAACACGTCAACGGGCTAGGCAAGCCGTTAGACCGGCCTCTTTTCCGGAAGGC 
         V  G  N  H  L  Q  G  I  R  E  A  I  Q  G  S  F  L  G  E  P 
 
            ChArsBLacZF 
1381   GCTCGTGCTCCACCAGTAGGCGAAAAATGGCGAGCCGCACCGGCGAGGCCAGGGCCTCGA 
       CGAGCACGAGGTGGTCATCCGCTTTTTACCGCTCGGCGTGGCCGCTCCGGTCCCGGAGCT 
         E  H  E  V  L  L  R  F  I  A  L  R  V  P  S  A  L  A  E  L 
 
                        PvuI ChArsRLacZR    Start arsR 
1441   GGCGGGCGACAATGCGATCGCTGTGCTCTTCGGTCATGGGATTCCAATGGTTCAAGTTAG 
       CCGCCCGCTGTTACGCTAGCGACACGAGAAGCCAGTACCCTAAGGTTACCAAGTTCAATC 
         R  A  V  I  R  D  S  H  E  E  T  M 
                         ArsR-RT Fw 
 
                                       ChArsRF 
1501   ATTGAATTATTGACAAATGTTTTTGGCTCGTCAAGACTACCGGCAATTTCACCCAAGGAG 
       TAACTTAATAACTGTTTACAAAAACCGAGCAGTTCTGATGGCCGTTAAAGTGGGTTCCTC 
 
  Start arsB      ChArsBLacZR 
1561   TACAGGATGCTTGCCCTGGCCATCTTCGTTGTGACCCTGATCCTCGTCATCTGGCAGCCC 
       ATGTCCTACGAACGGGACCGGTAGAAGCAACACTGGGACTAGGAGCAGTAGACCGTCGGG 
              M  L  A  L  A  I  F  V  V  T  L  I  L  V  I  W  Q  P   
 
1621   AAGGGACTCCAGATCGGTTGGAGTGCCATGGGCGGTGCGGTCGTCGCCCTGGCCACCGGG 
       TTCCCTGAGGTCTAGCCAACCTCACGGTACCCGCCACGCCAGCAGCGGGACCGGTGGCCC 
        K  G  L  Q  I  G  W  S  A  M  G  G  A  V  V  A  L  A  T  G   
 
1681   GTCATCACCTGGAGCGATATTCCTGTGGTCTGGCATATCGTCTGGGATGCTACCTTTACC 
       CAGTAGTGGACCTCGCTATAAGGACACCAGACCGTATAGCAGACCCTACGATGGAAATGG 
   V  I  T  W  S  D  I  P  V  V  W  H  I  V  W  D  A  T  F  T   
 
1741   TTCGTCGCCCTCATCATCATCTCCCTGATTCTGGACGAAGCCGGTTTCTTCCATTGGGCG 
       AAGCAGCGGGAGTAGTAGTAGAGGGACTAAGACCTGCTTCGGCCAAAGAAGGTAACCCGC 
        F  V  A  L  I  I  I  S  L  I  L  D  E  A  G  F  F  H  W  A   
 
1801   GCTCTGCACGTGGCGCGCTGGGGCGGTGGGCGTGGGCGTCGGCTCTTCCCCCTCATCGTC 
       CGAGACGTGCACCGCGCGACCCCGCCACCCGCACCCGCAGCCGAGAAGGGGGAGTAGCAG 
        A  L  H  V  A  R  W  G  G  G  R  G  R  R  L  F  P  L  I  V   
 
1861   CTGCTGGGGGCGATGATTTCTGCCGTATTCGCCAACGACGGGGCGGCGCTGCTGCTCACC 
       GACGACCCCCGCTACTAAAGACGGCATAAGCGGTTGCTGCCCCGCCGCGACGACGAGTGG 
        L  L  G  A  M  I  S  A  V  F  A  N  D  G  A  A  L  L  L  T   
 
                           ChArsRLacZF 
1921   CCCATCGTCATGGCCATCCTGTTGCGGCTCGACTTCTCACCCAAGGCCACCTTCGCCTTT 
       GGGTAGCAGTACCGGTAGGACAACGCCGAGCTGAAGAGTGGGTTCCGGTGGAAGCGGAAA 
        P  I  V  M  A  I  L  L  R  L  D  F  S  P  K  A  T  F  A  F   
 
1981   GTCATCGCCACCGGTTTTGTGGCCGATACCACCAGTCTGCCGCTGATGATCTCTAACCTC 
       CAGTAGCGGTGGCCAAAACACCGGCTATGGTGGTCAGACGGCGACTACTAGAGATTGGAG 
        V  I  A  T  G  F  V  A  D  T  T  S  L  P  L  M  I  S  N  L   
 
 116
 
 
2041   GTCAACATCGTCAGCGCCAATTATTTCAATATCACGTTTGATCGCTATGCCCTGGTGATG 
       CAGTTGTAGCAGTCGCGGTTAATAAAGTTATAGTGCAAACTAGCGATACGGGACCACTAC 
        V  N  I  V  S  A  N  Y  F  N  I  T  F  D  R  Y  A  L  V  M   
 
2101   GTACCGGTGGATCTGGTGGCACTGGCGGCCACCCTGGGGGTGCTCTGGCTTTACTTTCGT 
       CATGGCCACCTAGACCACCGTGACCGCCGGTGGGACCCCCACGAGACCGAAATGAAAGCA 
        V  P  V  D  L  V  A  L  A  A  T  L  G  V  L  W  L  Y  F  R   
 
                                                                  BamHI 
2161   CGCTCCGTGCCCGCGTCCTATCCTACCGCCCACCTCGACGCTCCGCGCACGGCCATCCAG 
       GCGAGGCACGGGCGCAGGATAGGATGGCGGGTGGAGCTGCGAGGCGCGTGCCGGTAGGTC 
        R  S  V  P  A  S  Y  P  T  A  H  L  D  A  P  R  T  A  I  Q   
 
2221   GATCCTGTGGTCTTCCGTGCCGCCTTTCCGGTGCTGGTTTTGCTACTAATCGCCTACTTC 
       CTAGGACACCAGAAGGCACGGCGGAAAGGCCACGACCAAAACGATGATTAGCGGATGAAG 
        D  P  V  V  F  R  A  A  F  P  V  L  V  L  L  L  I  A  Y  F   
 
2281   GTTACCGCGCAGTGGCAGGTACCGGTATCGGTGGTGACGGGGGCTGGGGCGCTGATCCTC 
       CAATGGCGCGTCACCGTCCATGGCCATAGCCACCACTGCCCCCGACCCCGCGACTAGGAG 
        V  T  A  Q  W  Q  V  P  V  S  V  V  T  G  A  G  A  L  I  L   
 
2341   CTCGCTTTGGCCGGACGTTGGTTGCAGGGCGGGCGCGGCGCCCGCATTCCCGTACGCAAG 
       GAGCGAAACCGGCCTGCAACCAACGTCCCGCCCGCGCCGCGGGCGTAAGGGCATGCGTTC 
        L  A  L  A  G  R  W  L  Q  G  G  R  G  A  R  I  P  V  R  K   
 
2401   GTCTTGCACGAGGCCCCCTGGCAGATCGTGATTTTCAGCCTCGGGATGTATCTGGTGGTC 
       CAGAACGTGCTCCGGGGGACCGTCTAGCACTAAAAGTCGGAGCCCTACATAGACCACCAG 
        V  L  H  E  A  P  W  Q  I  V  I  F  S  L  G  M  Y  L  V  V   
 
2461   TATGGGCTGCGCAATGCCGGTTTGACCAACTATGTGGCCATGGCCCTGGCGTATCTGGCG 
       ATACCCGACGCGTTACGGCCAAACTGGTTGATACACCGGTACCGGGACCGCATAGACCGC 
        Y  G  L  R  N  A  G  L  T  N  Y  V  A  M  A  L  A  Y  L  A   
 
                     ArsB-RT Fw 
2521   GCACAAGGTACCGTTCTGGCGGCGATTGGGTCAGGCTTCCTGGCCGCGGCGCTGTCCTCG 
       CGTGTTCCATGGCAAGACCGCCGCTAACCCAGTCCGAAGGACCGGCGCCGCGACAGGAGC 
        A  Q  G  T  V  L  A  A  I  G  S  G  F  L  A  A  A  L  S  S   
 
2581   GTGATGAACAACATGCCGGCGGTTTTGGTGGGCGCCTTGGCCATCCACCAACTGCCGGTG 
       CACTACTTGTTGTACGGCCGCCAAAACCACCCGCGGAACCGGTAGGTGGTTGACGGCCAC 
        V  M  N  N  M  P  A  V  L  V  G  A  L  A  I  H  Q  L  P  V   
 
            BamHI 
2641   GCCACGGATCCGTTGATACGGGAAATCTTCGTCTACGCCAACATCATCGGTTGCGATCTT 
       CGGTGCCTAGGCAACTATGCCCTTTAGAAGCAGATGCGGTTGTAGTAGCCAACGCTAGAA 
        A  T  D  P  L  I  R  E  I  F  V  Y  A  N  I  I  G  C  D  L   
 
2701   GGCCCCAAGTTCACGCCCATCGGCAGTCTGGCCACCCTGCTCTGGCTGCATGTGCTGGGC 
       CCGGGGTTCAAGTGCGGGTAGCCGTCAGACCGGTGGGACGAGACCGACGTACACGACCCG 
        G  P  K  F  T  P  I  G  S  L  A  T  L  L  W  L  H  V  L  G   
 
2761   CGCAAAGGCATGACCGTGACCTGGGGCCAATACATGCGCACCGGACTCCTCATCACCCCG 
       GCGTTTCCGTACTGGCACTGGACCCCGGTTATGTACGCGTGGCCTGAGGAGTAGTGGGGC 
        R  K  G  M  T  V  T  W  G  Q  Y  M  R  T  G  L  L  I  T  P   
 
 117
 
 
2821   CCGGTACTGTTCCTGACGCTGCTGGCCTTGGCGGCTTGGTTGCCACTACTCTGAAAAAGG 
       GGCCATGACAAGGACTGCGACGACCGGAACCGCCGAACCAACGGTGATGAGACTTTTTCC 
        P  V  L  F  L  T  L  L  A  L  A  A  W  L  P  L  L  * 
 
                          Start ORF5 
2881   CGTTTGAGAAATTTTGTCTTCCCTCGGGTCATGCGCGAACGGTTCGGCCATGGCCGGATG 
       GCAAACTCTTTAAAACAGAAGGGAGCCCAGTACGCGCTTGCCAAGCCGGTACCGGCCTAC 
                                      M  R  E  R  F  G  H  G  R  M   
 
                                 ORF5-RT Rev 
2941   TTGCGACCCGGTGAGGTCCGCCACCGCAATCCCTGCCAAACGCGGCACACCTGCGCTTCC 
       AACGCTGGGCCACTCCAGGCGGTGGCGTTAGGGACGGTTTGCGCCGTGTGGACGCGAAGG 
        L  R  P  G  E  V  R  H  R  N  P  C  Q  T  R  H  T  C  A  S   
 
                         ORF5-RT Fw 
3001   ATGTTGCGGACTGCCGGGGAAGATCCTAGGTGGATTGCCGGCCAGATGGGGTATGAAGAC 
       TACAACGCCTGACGGCCCCTTCTAGGATCCACCTAACGGCCGGTCTACCCCATACTTCTG 
        M  L  R  T  A  G  E  D  P  R  W  I  A  G  Q  M  G  Y  E  D   
 
3061   GGGGTACGACTCGACTGGGGTAGGCTCATCAGGTGCCCCATGTCAACCCATCTGCCTAGA 
       CCCCATGCTGAGCTGACCCCATCCGAGTAGTCCACGGGGTACAGTTGGGTAGACGGATCT 
        G  V  R  L  D  W  G  R  L  I  R  C  P  M  S  T  H  L  P  R   
 
                         BstEII 
3121   GCAGGACTCTCGCCCTTTGGTCACCATTGGATCAAAAGAACGGGGCGGCGAAGCATAGGG 
       CGTCCTGAGAGCGGGAAACCAGTGGTAACCTAGTTTTCTTGCCCCGCCGCTTCGTATCCC 
        A  G  L  S  P  F  G  H  H  W  I  K  R  T  G  R  R  S  I  G   
 
3181   CTGGAAATGGCAATCTCATGGATGGTGCGAAAGGGGAGACTCGAACTCCCACGCCTTGCG 
       GACCTTTACCGTTAGAGTACCTACCACGCTTTCCCCTCTGAGCTTGAGGGTGCGGAACGC 
        L  E  M  A  I  S  W  M  V  R  K  G  R  L  E  L  P  R  L  A   
 
 
3241   GCGCTGGAACCTAAATCCAGTGCGTCTACCAATTCCGCCACTCTCGCCTTTACGCTATCT 
       CGCGACCTTGGATTTAGGTCACGCAGATGGTTAAGGCGGTGAGAGCGGAAATGCGATAGA 
        A  L  E  P  K  S  S  A  S  T  N  S  A  T  L  A  F  T  L  S   
 
                                      BamHI       Start ORF6 
3301   TAAGCACTAACCGCTCTTTTCACAACGACGAGGATCCCATGGCCAAGTCATCATCCCAAC 
       ATTCGTGATTGGCGAGAAAAGTGTTGCTGCTCCTAGGGTACCGGTTCAGTAGTAGGGTTG 
        *                                     M  A  K  S  S  S  Q    
 
3361   CCTCTCGGTTGCGTCGCCTTCTGGCTGTCGAGTCGGCGCGGATCATGGCGGAGGAGGGCA 
       GGAGAGCCAACGCAGCGGAAGACCGACAGCTCAGCCGCGCCTAGTACCGCCTCCTCCCGT 
       P  S  R  L  R  R  L  L  A  V  E  S  A  R  I  M  A  E  E  G    
 
                                                         ORF6-RT Rev 
3421   TTGCGGACTACCGCTTTGCCAAGGAGAAGGCGGCCCGCCGCCTGGGTAGCGGCAGCACCC 
       AACGCCTGATGGCGAAACGGTTCCTCTTCCGCCGGGCGGCGGACCCATCGCCGTCGTGGG 
       I  A  D  Y  R  F  A  K  E  K  A  A  R  R  L  G  S  G  S  T    
 
                                                              PvuII 
3481   AGCAAGATTGGCCCAGCAACTCGGAGATCCAGGCCGAACTCAAGGCGCGGTTGCAGCTGT 
       TCGTTCTAACCGGGTCGTTGAGCCTCTAGGTCCGGCTTGAGTTCCGCGCCAACGTCGACA 
       Q  Q  D  W  P  S  N  S  E  I  Q  A  E  L  K  A  R  L  Q  L    
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3541   TTCACGGCGAATCCCAACCCCTCGAACTGCGCCGCCTTCGGGAGGTTGCGCTGGAGGCCA 
       AAGTGCCGCTTAGGGTTGGGGAGCTTGACGCGGCGGAAGCCCTCCAACGCGACCTCCGGT 
       F  H  G  E  S  Q  P  L  E  L  R  R  L  R  E  V  A  L  E  A    
 
3601   TGGGCTGGCTCAAGGATTTTCGTCCCTTGCTCGCAGGTGCGGTACTCAACGGCACGGCCA 
       ACCCGACCGAGTTCCTAAAAGCAGGGAACGAGCGTCCACGCCATGAGTTGCCGTGCCGGT 
       M  G  W  L  K  D  F  R  P  L  L  A  G  A  V  L  N  G  T  A    
 
3661   CGCGCCATAGCGCCATCGTTCTGCATCTCTTTGCCGATACCCCGGAGAGCGTCATCTTTT 
       GCGCGGTATCGCGGTAGCAAGACGTAGAGAAACGGCTATGGGGCCTCTCGCAGTAGAAAA 
       T  R  H  S  A  I  V  L  H  L  F  A  D  T  P  E  S  V  I  F    
 
3721   TTCTCATGGATCAGCAGGTGGCCTATGAAGAGGGCTGGCAGCGGCTGCATTTCGGCGACG 
       AAGAGTACCTAGTCGTCCACCGGATACTTCTCCCGACCGTCGCCGACGTAAAGCCGCTGC 
       F  L  M  D  Q  Q  V  A  Y  E  E  G  W  Q  R  L  H  F  G  D    
 
3781   AAGCGCCCCAGGAGTATCCCCAGATCCGCATGACCCGTGGGGGGGCAGAATTGCGTCTGG 
       TTCGCGGGGTCCTCATAGGGGTCTAGGCGTACTGGGCACCCCCCCGTCTTAACGCAGACC 
       E  A  P  Q  E  Y  P  Q  I  R  M  T  R  G  G  A  E  L  R  L    
 
3841   TCATCTTTGCTCCCGACGAGGATCGGCGCCGTCCGGCATCGGCGGTGGACGGTAAGCCTC 
       AGTAGAAACGAGGGCTGCTCCTAGCCGCGGCAGGCCGTAGCCGCCACCTGCCATTCGGAG  
       V  I  F  A  P  D  E  D  R  R  R  P  A  S  A  V  D  G  K  P    
 
3901   TACAGCGGGTCAACGCCCAGCAGTTGCAACGTTTGCTGGATTCCGAGGCATCACTGCCCG 
       ATGTCGCCCAGTTGCGGGTCGTCAACGTTGCAAACGACCTAAGGCTCCGTAGTGACGGGC 
       L  Q  R  V  N  A  Q  Q  L  Q  R  L  L  D  S  E  A  S  L  P    
 
3961   CTTATTCCTGAGGTGTCGGTAAAACCTCTGGACTGGGCGTTGGACGAAGGTGCTGCCAAC 
       GAATAAGGACTCCACAGCCATTTTGGAGACCTGACCCGCAACCTGCTTCCACGACGGTTG 
       A  Y  S  * 
         *  E  Q  P  T  P  L  V  E  P  S  P  T  P  R  L  H  Q  W  S    
 
4021   TTACCAGACTGAGGGCGATGAAGATGGCGATCATGCCCAGGCTTTCCCAGCCGCCCGGTA 
       AATGGTCTGACTCCCGCTACTTCTACCGCTAGTACGGGTCCGAAAGGGTCGGCGGGCCAT 
         V  L  S  L  A  I  F  I  A  I  M  G  L  S  E  W  G  G  P  V 
 
                PvuII 
4081   CCTCGTCCAGCTGCCACCAGGCCGCGAGGACGCCGATGAGCGGCGCCAGCAGCATGGCCA 
       GGAGCAGGTCGACGGTGGTCCGGCGCTCCTGCGGCTACTCGCCGCGGTCGTCGTACCGGT 
         E  D  L  Q  W  W  A  A  L  V  G  I  L  P  A  L  L  M  A  M 
 
4141   TGCCGGCTACCCCCGACGGTAGATGCTTGAGGGCATAGGCCCAAAGCAGGTAGGCAATGG 
       ACGGCCGATGGGGGCTGCCATCTACGAACTCCCGTATCCGGGTTTCGTCCATCCGTTACC 
         G  A  V  G  S  P  L  H  K  L  A  Y  A  W  L  L  Y  A  I  A 
 
4201   CCGTACCCGGTATGACATTGTAGACTAGGGCGGCGGTGAAGAGCGGGCTCCACTGGATAC 
       GGCATGGGCCATACTGTAACATCTGATCCCGCCGCCACTTCTCGCCCGAGGTGACCTATG 
         T  G  P  I  V  N  Y  V  L  A  A  T  F  L  P  S  W  Q  I  R 
 
4261   GCAGGGGGTCTATCCAAAGGCTTACGACAATGAGACCGACGGCGCCCAAGGCCGTCTGCC 
       CGTCCCCCAGATAGGTTTCCGAATGCTGTTACTCTGGCTGCCGCGGGTTCCGGCAGACGG 
         L  P  D  I  W  L  S  V  V  I  L  G  V  A  G  L  A  T  Q  W   
 
4321   AGAAAGTCGCGTTGAGGAGATCCTGGCCCGGTGGCATGTGGCGTTTTTGCCAGATGGCGG 
 119
       TCTTTCAGCGCAACTCCTCTAGGACCGGGCCACCGTACACCGCAAAAACGGTCTACCGCC 
         F  T  A  N  L  L  D  Q  G  P  P  M  H  R  K  Q  W  I  A  A   
 
4381   CCCCCGCCCACAGTAGGCCCGATAACAGCGCAAAGGCCGGTCCTTGCCAGGCGCCATGAA 
       GGGGGCGGGTGTCATCCGGGCTATTGTCGCGTTTCCGGCCAGGAACGGTCCGCGGTACTT 
         G  A  W  L  L  G  S  L  L  A  F  A  P  G  Q  W  A  G  H  F  
 
4441   AATCCCACGGGCTCAATATGCACAAGAGCCCCAGTAGCGCCAGAAGGAGCGCTGGCCAAT 
       TTAGGGTGCCCGAGTTATACGTGTTCTCGGGGTCATCGCGGTCTTCCTCGCGACCGGTTA 
         D  W  P  S  L  I  C  L  L  G  L  L  A  L  L  L  A  P  W  H   
 
4501   GCAGTCCGTGCAGACGCTCCCCCAAAAGTGGCCAAGCCAGCAGCATGAGCCAGATGGGCA 
       CGTCAGGCACGTCTGCGAGGGGGTTTTCACCGGTTCGGTCGTCGTACTCGGTCTACCCGT 
         L  G  H  L  R  E  G  L  L  P  W  A  L  L  M  L  W  I  P  M 
 
4561   TCATGTACACGAGGATGGCCGTCTTTCCCGCGCCGCCATATTCCAGGGCCCAGAGGGTGA 
       AGTACATGTGCTCCTACCGGCAGAAAGGGCGCGGCGGTATAAGGTCCCGGGTCTCCCACT 
         M  Y  V  L  I  A  T  K  G  A  G  G  Y  E  L  A  W  L  T  F   
 
4621   AACCCACAAAGCCGGTGCTCTGCAGCAGGCCAAAGGGCAGGACGTAGCGTAGGGGAGGTC 
       TTGGGTGTTTCGGCCACGAGACGTCGTCCGGTTTCCCGTCCTGCATCGCATCCCCTCCAG 
         G  V  F  G  T  S  Q  L  L  G  F  P  L  V  Y  R  L  P  P  R 
 
4681   GCCGCAGGGGACGTTTCAGGAGCAGTAGCAAGGGGAGGAGCACGACCGCCCCCAGGGCCA 
       CGGCGTCCCCTGCAAAGTCCTCGTCATCGTTCCCCTCCTCGTGCTGGCGGGGGTCCCGGT 
         R  L  P  R  K  L  L  L  L  L  P  L  L  V  V  A  G  L  A  V   
 
4741   CGCGTAGTGCCGCAAAGATCAGGGGTGGGCAGTCCTCTATGGCTACCTTCATGACCACCC 
       GCGCATCACGGCGTTTCTAGTCCCCACCCGTCAGGAGATACCGATGGAAGTACTGGTGGG 
         R  L  A  A  F  I  L  P  P  C  D  E  I  A  V  K  M  V  V  W 
 
4801   AGTTGTAGCCCCAGATCAGGGCAATGGTGACGATGGCGGCAAGGGGAAGCCAGGGAGCAG 
       TCAACATCGGGGTCTAGTCCCGTTACCACTGCTACCGCCGTTCCCCTTCGGTCCCTCGTC 
         N  Y  G  W  I  L  A  I  T  V  I  A  A  L  P  L  W  P  A  P 
 
                              Start ORF7 
4861   GGGTCGGGGAGTGAGTGCGCATGAAAGTCCGCGGGCGGCCAAAAAAGATCGGGAAAGACC 
       CCCAGCCCCTCACTCACGCGTACTTTCAGGCGCCCGCCGGTTTTTTCTAGCCCTTTCTGG 
         T  P  S  H  T  R  M 
 
4921   ACCGCGCCGCTACGGTGGCCTCTCCCGTATCTTAGAATAGCCTAATGATGCACTTTGGCG 
       TGGCGCGGCGATGCCACCGGAGAGGGCATAGAATCTTATCGGATTACTACGTGAAACCGC 
                                                 *  H  H  V  K  A   
 
          PvuI                   SalI 
4981   CGATCGTAGGCAGCCGGCCACGGCCAGTCGACGCCCAACCGTGCGGCCGCCTGCAAGGGC 
       GCTAGCATCCGTCGGCCGGTGCCGGTCAGCTGCGGGTTGGCACGCCGGCGGACGTTCCCG 
       R  D  Y  A  A  P  W  P  W  D  V  G  L  R  A  A  A  Q  L  P   
 
5041   CAGTATGGATTACGCAGCAGTTCCCGCGCCAGAGCCACGGCGTCCGCCTGTTCCGTGACG 
       GTCATACCTAATGCGTCGTCAAGGGCGCGGTCTCGGTGCCGCAGGCGGACAAGGCACTGC 
       W  Y  P  N  R  L  L  E  R  A  L  A  V  A  D  A  Q  E  T  V   
 
5101   AGAATGTGCTCTGCCTGCATGGCCTCAGTGATGAGGCCGACGGCGACGGTAGGAATGCCG 
       TCTTACACGAGACGGACGTACCGGAGTCACTACTCCGGCTGCCGCTGCCATCCTTACGGC 
       L  I  H  E  A  Q  M  A  E  T  I  L  G  V  A  V  T  P  I  G   
 
 120
 
 
5161   ACGGCCCGACGGATGGCTGCGGCGAAGGGCGTCTGGAAGCCGGGGCCAGCGGGGATTTTC 
       TGCCGGGCTGCCTACCGACGCCGCTTCCCGCAGACCTTCGGCCCCGGTCGCCCCTAAAAG 
       V  A  R  R  I  A  A  A  F  P  T  Q  F  G  P  G  A  P  I  K   
 
                                                          StuI 
5221   GCGTCTGGAGTCAGGCCGCCGCTACTGCAGTGTACGACATCCACGCCGCAGGCCTGGAGT 
       CGCAGACCTCAGTCCGGCGGCGATGACGTCACATGCTGTAGGTGCGGCGTCCGGACCTCA 
       A  D  P  T  L  G  G  S  S  C  H  V  V  D  V  G  C  A  Q  L   
 
5281   TCCCGACTGAAGGCGATGGACTGCTCCAGATCCCAGCCTCCCTCCACCCAATCCGTGGCC 
       AGGGCTGACTTCCGCTACCTGACGAGGTCTAGGGTCGGAGGGAGGTGGGTTAGGCACCGG 
       E  R  S  F  A  I  S  Q  E  L  D  W  D  D  E  V  W  D  T  A   
 
5341   GATATGCGCACCCAGAGGGGGAGCTCCTCGGGCCAGACGGCGCGTACCGCGGTCGCCACC 
       CTATACGCGTGGGTCTCCCCCTCGAGGAGCCCGGTCTGCCGCGCATGGCGCCAGCGGTGG 
       S  I  R  V  W  L  P  L  E  E  P  W  V  A  R  V  A  T  A  V     
 
5401   TCCAGCGGAAAGCGCACACGTCCGGAAAAATCGCCGCCGTAAGCGTCGTCCCGTCGGTTG 
       AGGTCGCCTTTCGCGTGTGCAGGCCTTTTTAGCGGCGGCATTCGCAGCAGGGCAGCCAAC 
       E  L  P  F  R  V  R  G  S  F  D  G  G  Y  A  D  D  R  R  N   
 
5461   CTGATGGGGGAGAGGAAACTGTGCAGGAGATAGCCATGGGCCATGTGCAGTTCCAGCACC 
       GACTACCCCCTCTCCTTTGACACGTCCTCTATCGGTACCCGGTACACGTCAAGGTCGTGG 
       S  I  P  S  L  F  S  H  L  L  Y  G  H  A  M  H  L  E  L  V   
 
5521   TGAAAGCCGGCCCGGTGCGCACGCCGGGCGGCCGCCACGAAGTCCGCCTTCACCCGCTCC 
       ACTTTCGGCCGGGCCACGCGTGCGGCCCGCCGGCGGTGCTTCAGGCGGAAGTGGGCGAGG 
       Q  F  G  A  R  H  A  R  R  A  A  A  V  F  D  A  K  V  R  E 
 
5581   ATATCCTCTGTGCTGAGGGGACGGGGGATGGTGTGGGAAGGGCTGAAGGCCAATGCACTG 
       TATAGGAGACACGACTCCCCTGCCCCCTACCACACCCTTCCCGACTTCCGGTTACGTGAC 
       M  D  E  T  S  L  P  R  P  I  T  H  S  P  S  F  A  L  A  S   
 
5641   GGGGCTACCGGCTGCCAGCCCAGTTCCGCCTCGGGTGGGATGGGTTGACCTCCATGGAAG 
       CCCCGATGGCCGACGGTCGGGTCAAGGCGGAGCCCACCCTACCCAACTGGAGGTACCTTC 
       P  A  V  P  Q  W  G  L  E  A  E  P  P  I  P  Q  G  G  H  F   
 
                      StuI 
5701   GGGGCTGCCGTCGAGGCCTTGCGGCCCGCATGGGCGATCTGTATGCCGGCAACGGCACCT 
       CCCCGACGGCAGCTCCGGAACGCCGGGCGTACCCGCTAGACATACGGCCGTTGCCGTGGA 
       P  A  A  T  S  A  K  R  G  A  H  A  I  Q  I  G  A  V  A  G   
 
5761   TGCTCCTGCAAAAAGCGAACGATGGGCGCCAGGGCGTCGGCCTGGACATCGTTCCAGATG 
       ACGAGGACGTTTTTCGCTTGCTACCCGCGGTCCCGCAGCCGGACCTGTAGCAAGGTCTAC 
       Q  E  Q  L  F  R  V  I  P  A  L  A  D  A  Q  V  D  N  W  I   
 
5821   CCCAGATCTTGTGGCGATATGCGACCTTCCGGACTTACCGCCGATGCCTCCACCAAAATG 
       GGGTCTAGAACACCGCTATACGCTGGAAGGCCTGAATGGCGGCTACGGAGGTGGTTTTAC 
       G  L  D  Q  P  S  I  R  G  E  P  S  V  A  S  A  E  V  L  I   
 
         StuI 
5881   AGGCCTGCTCCGCCCACGGCACGACTGCCCAGGTGCACCCGGTGCCAGTCTCCGGCGACG 
       TCCGGACGAGGCGGGTGCCGTGCTGACGGGTCCACGTGGGCCACGGTCAGAGGCCGCTGC 
       L  G  A  G  G  V  A  R  S  G  L  H  V  R  H  W  D  G  A  V   
 
 121
 
 
                                           Start ORF8 
5941   CCATCGGGAGTCGAATACTGGCACATGGGGGCCATTACGATCCGGTTGCGTAAGGTGACG 
       GGTAGCCCTCAGCTTATGACCGTGTACCCCCGGTAATGCTAGGCCAACGCATTCCACTGC 
       G  D  P  T  S  Y  Q  C  M  P  A  M 
 
6001   GAACGCAGTGTCCAGGGGGTGAACAGACGCTGGGTCACGCCTGCACTCCCAAGCCGCGCC 
       CTTGCGTCACAGGTCCCCCACTTGTCTGCGACCCAGTGCGGACGTGAGGGTTCGGCGCGG 
                                          *  A  Q  V  G  L  G  R  G 
 
6061   CGAGATGCGCCAGGGTCATTTCCCAGCCCTCCTGCGCCGGTCCGGCGCGGTAGCTGTCGC 
       GCTCTACGCGGTCCCAGTAAAGGGTCGGGAGGACGCGGCCAGGCCGCGCCATCGACAGCG 
         L  H  A  L  T  M  E  W  G  E  Q  A  P  G  A  R  Y  S  D  R   
 
6121   GGCGGTCACTGAAGAAGCCGTGCGGGGCCTCCGGAAAGACCGTGAGCGTATAACGCTTCT 
       CCGCCAGTGACTTCTTCGGCACGCCCCGGAGGCCTTTCTGGCACTCGCATATTGCGAAGA 
         R  D  S  F  F  G  H  P  A  E  P  F  V  T  L  T  Y  R  K  K   
 
6181   TGGCGGTGCTCAGGGCCGCAGCGATGCGGCCATGCTCTTCCGGGGTAATGGAGCTGTCCT 
       ACCGCCACGAGTCCCGGCGTCGCTACGCCGGTACGAGAAGGCCCCATTACCTCGACAGGA 
         A  T  S  L  A  A  A  I  R  G  H  E  E  P  T  I  S  S  D  E 
 
6241   CGGCGCCGTAGAGCAGGAGCAGGGGAGCCTGCATCTGGTTCACGTGACCCAGGAGCGGCG 
       GCCGCGGCATCTCGTCCTCGTCCCCTCGGACGTAGACCAAGTGCACTGGGTCCTCGCCGC 
         A  G  Y  L  L  L  L  P  A  Q  M  Q  N  V  H  G  L  L  P  P 
 
6301   GACGTCCGGCAGGGTCTTTATCCGGGGCGATACCGCCGCCGTAAAAAGCTACGGTCGCCG 
       CTGCAGGCCGTCCCAGAAATAGGCCCCGCTATGGCGGCGGCATTTTTCGATGCCAGCGGC 
         R  G  A  P  D  K  D  P  A  I  G  G  G  Y  F  A  V  T  A  A   
 
6361   CCACGCGCTCAGCGAGCTGGGCATTGGCGAGGAAGGCATAGCGCCCACCCATACAAAAGC 
       GGTGCGCGAGTCGCTCGACCCGTAACCGCTCCTTCCGTATCGCGGGTGGGTATGTTTTCG 
         V  R  E  A  L  Q  A  N  A  L  F  A  Y  R  G  G  M  C  F  G 
    
6421   CCAGCACACCGACCTTTGGACCACGTACCTCAGGACGCTGGAGTACACTCGCCACGGTGG 
       GGTCGTGTGGCTGGAAACCTGGTGCATGGAGTCCTGCGACCTCATGTGAGCGGTGCCACC 
         L  V  G  V  K  P  G  R  V  E  P  R  Q  L  V  S  A  V  T  T  
 
6481   TTTGGGCTTCCGCCATGACCTGGTCGTCCTTGAGCGTGCGCAGGTGCCCGATGGCGCCGT 
       AAACCCGAAGGCGGTACTGGACCAGCAGGAACTCGCACGCGTCCACGGGCTACCGCGGCA 
         Q  A  E  A  M  V  Q  D  D  K  L  T  R  L  H  G  I  A  G  D 
  
6541   CGAAGTCCGTGTATTCATAGACCTTGCCGTGATAGATGTCGGGCACGATGGCGCAGTAAC 
       GCTTCAGGCACATAAGTATCTGGAACGGCACTATCTACAGCCCGTGCTACCGCGTCATTG 
         F  D  T  Y  E  Y  V  K  G  H  Y  I  D  P  V  I  A  C  Y  G 
 
                                                            StuI 
6601   CGGCCTTGGCGAGGCGCTCTGCCAGCTCTCGAAAATGCTCGTTCACGCCAAAGGCCTCGA 
       GCCGGAACCGCTCCGCGAGACGGTCGAGAGCTTTTACGAGCAAGTGCGGTTTCCGGAGCT 
         A  K  A  L  R  E  A  L  E  R  F  H  E  N  V  G  F  A  E  I 
 
6661   TGAATACGAGTACCGCGGGGTGCGGTCCAGGATTCGTGGGGCGCGCGTACCAGGCGCGAA 
       ACTTATGCTCATGGCGCCCCACGCCAGGTCCTAAGCACCCCGCGCGCATGGTCCGCGCTT 
         F  V  L  V  A  P  H  P  G  P  N  T  P  R  A  Y  W  A  R  L   
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                                                   Start ORF9 
6721   GCGAAGGGTTCAGTTCCAGCCACTCGGATTGTATTGCAGACATGGAATCTCCTGTTGCTA 
       CGCTTCCCAAGTCAAGGTCGGTGAGCCTAACATAACGTCTGTACCTTAGAGGACAACGAT 
         S  P  N  L  E  L  W  E  S  Q  I  A  S  M 
                                            PvuI 
6781   TTCACGGGGTGGGCGACACCATTATCCTACCGACCGATCGGTACTTTCGTAAAGTCTCTG 
       AAGTGCCCCACCCGCTGTGGTAATAGGATGGCTGGCTAGCCATGAAAGCATTTCAGAGAC 
 
6841   GAGAGGGCTCGAATCCAGGACTCAGGGACGCAAGGAGCCCAGGTACAGGCGGAGCTGCCC 
       CTCTCCCGAGCTTAGGTCCTGAGTCCCTGCGTTCCTCGGGTCCATGTCCGCCTCGACGGG 
                             *  P  R  L  S  G  L  Y  L  R  L  Q  G       
 
6901   AAGGCAGCGCCGGTACGCATCCACCGACTGGGCATTTTTGCCAAGACCGACGCAACCCTC 
       TTCCGTCGCGGCCATGCGTAGGTGGCTGACCCGTAAAAACGGTTCTGGCTGCGTTGGGAG 
        L  C  R  R  Y  A  D  V  S  Q  A  N  K  G  L  G  V  C  G  E 
 
6961   GACTCCGGCAACGATGAACAGGGCCGCCTCAGCGGCGACGACATCGCCACGCACGTGACC 
       CTGAGGCCGTTGCTACTTGTCCCGGCGGAGTCGCCGCTGCTGTAGCGGTGCGTGCACTGG 
        V  G  A  V  I  F  L  A  A  E  A  A  V  V  D  G  R  V  H  G 
 
7021   CGCCTCCTGACCGCGTGCCAGGGCTTGGGCAAGCACCTCCGTCCAGCGCTCGAGGATCAC 
       GCGGAGGACTGGCGCACGGTCCCGAACCCGTTCGTGGAGGCAGGTCGCGAGCTCCTAGTG 
        A  E  Q  G  R  A  L  A  Q  A  L  V  E  T  W  R  E  L  I  V 
 
7081   CTGCAGGGCTTGGCGAAATTGCTCGTCCAGCGGGCTCATTTCTTGAATCAGGTTGTTGAG 
       GACGTCCCGAACCGCTTTAACGAGCAGGTCGCCCGAGTAAAGAACTTAGTCCAACAACTC 
        Q  L  A  Q  R  F  Q  E  D  L  P  S  M  E  Q  I  L  N  N  L   
 
7141   GGGGCAGCCGTAGCGCAAAACCCGTTCGTCCGCGCTGGCGATCTTGTCGCAGAGGATTTT 
       CCCCGTCGGCATCGCGTTTTGGGCAAGCAGGCGCGACCGCTAGAACAGCGTCTCCTAAAA 
        P  C  G  Y  R  L  V  R  E  D  A  S  A  I  K  D  C  L  I  K 
 
7201   GTCCAGTTGCTCCAGAGGGTCATCGCCCTCGCTGAGGGGCGCAAACCAGCGTCTTGCCAG 
       CAGGTCAACGAGGTCTCCCAGTAGCGGGAGCGACTCCCCGCGTTTGGTCGCAGAACGGTC 
        D  L  Q  E  L  P  D  D  G  E  S  L  P  A  F  W  R  R  A  L 
 
7261   ATCGGGAGCGATTACGTCGTGCACCACCGCAAGGCCAAGTTCCTGCTTGGTGCCGAAGTG 
       TAGCCCTCGCTAATGCAGCACGTGGTGGCGTTCCGGTTCAAGGACGAACCACGGCTTCAC 
        D  P  A  I  V  D  H  V  V  A  L  G  L  E  Q  K  T  G  F  H 
 
7321   GTGGTACAGCGCGCCCTTGCTCACAGAGGTCTTGGCCAGGATGCGCTCCAGACTTGCCGC   
       CACCATGTCGCGCGGGAACGAGTGTCTCCAGAACCGGTCCTACGCGAGGTCTGAACGGCG 
        H  Y  L  A  G  K  S  V  S  T  K  A  L  I  R  E  L  S  A  A 
 
7381   CTGAAAGCCGCATTCCAGTATCTCAGCGTAGGCTGCTGCGAGCAGGTCGTTGCGCGTCTG 
       GACTTTCGGCGTAAGGTCATAGAGTCGCATCCGACGACGCTCGTCCAGCAACGCGCAGAC 
        Q  F  G  C  E  L  I  E  A  Y  A  A  A  L  L  D  N  R  T  Q 
 
7441   CTCCGGATTACGAGATTTTCTCAGTGTGTCCACCATGGTCTGATCAAAATACCGACCAAT 
       GAGGCCTAATGCTCTAAAAGAGTCACACAGGTGGTACCAGACTAGTTTTATGGCTGGTTA 
        E  P  N  R  S  K  R  L  T  D  V  M  T  Q  D  F  Y  R  G  I  
 
7501   CGGTATTTCGTCAAGACCTTGTATGCGTCCACCACCTTTGGCACTGGGGCTGATGTTGCA 
       GCCATAAAGCAGTTCTGGAACATACGCAGGTGGTGGAAACCGTGACCCCGACTACAACGT 
        P  I  E  D  L  G  Q  I  R  G  G  G  K  A  S  P  S  I  N  C 
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7561   GGAGGAAGGATAGCGGTGGTTGTTGGCCGAGTCGATGGTGTGGTCGTTCGGCGTTGTAGA 
       CCTCCTTCCTATCGCCACCAACAACCGGCTCAGCTACCACACCAGCAAGCCGCAACATCT 
        S  S  P  Y  R  H  N  N  A  S  D  I  T  H  D  N  P  T  T  S 
 
7621   AGACGAGCCACTCGGCGAGTTTTTGGTTGAAGCGGGCGAGGTCGGTGAAGAGCAGGTCTT 
       TCTGCTCGGTGAGCCGCTCAAAAACCAACTTCGCCCGCTCCAGCCACTTCTCGTCCAGAA 
        S  S  G  S  P  S  N  K  T  S  A  P  S  T  P  S  S  C  T  K   
 
              SalI                               Start ORF10 
7681   CGTGGTAGTCGACGAAGGATTCCTGGATGGTGCGATTGAAGCGTTCGGCATGGGCATTCA 
       GCACCATCAGCTGCTTCCTAAGGACCTACCACGCTAACTTCGCAAGCCGTACCCGTAAGT 
        T  T  T  S  S  P  N  R  S  P  A  I  S  A  N  P  M  P  M 
 
7741   TTTTTGGGGTCTTGGGGTAGGTATACCAACGGGCGATCTGCTGTTCCGTGAGGGTTTGGG 
       AAAAACCCCAGAACCCCATCCATATGGTTGCCCGCTAGACGACAAGGCACTCCCAAACCC 
 
7801   ACGGCGGCGAGGGCCGCCTGGGTGTGGCGTGTGGCTTTGCTGGGTAAAGCGACGGCCAAG 
       TGCCGCCGCTCCCGGCGGACCCACACCGCACACCGAAACGACCCATTTCGCTGCCGGTTC 
 
7861   GCAAAGGCGCTGGCTGGATCGATGAAGGTGACGAGGTAGCGTTTCAGCCCGTCGCGAACC 
       CGTTTCCGCGACCGACCTAGCTACTTCCACTGCTCCATCGCAAAGTCGGGCAGCGCTTGG 
 
7921   TGCTCGATAGTGTCCACCGCCAGGCACTGCAAGGCAGTGGTGGCCACCCCCTTGGGCTTG 
       ACGAGCTATCACAGGTGGCGGTCCGTGACGTTCCGTCACCACCGGTGGGGGAACCCGAAC 
 
7981   CGCGGCTTGCGAGAACGCCGCACAGGCTTGGCGCGACCACGGGCATCGAGGCGCGCGGGG 
       GCGCCGAACGCTCTTGCGGCGTGTCCGAACCGCGCTGGTGCCCGTAGCTCCGCGCGCCCC 
 
8041   CTGTGGCGCATTTTATCCGGTGCACGGGCGATGATTCTGCCGAGGGTGGACACCGATGGC 
       GACACCGCGTAAAATAGGCCACGTGCCCGCTACTAAGACGGCTCCCACCTGTGGCTACCG 
 
8101   AGCGCGATACCCTTCTCCGCACACCAGGGGCGCAGCAGGACGTGCAGCTTGTCCTTGCCG 
       TCGCGCTATGGGAAGAGGCGTGTGGTCCCCGCGTCGTCCTGCACGTCGAACAGGAACGGC 
 
8161   AGATTGGGGTGAAGGGTACGTAGCCGCCGAATTTCCGCTACCAGCCTGGGGTCGGTCTTG 
       TCTAACCCCACTTCCCATGCATCGGCGGCTTAAAGGCGATGGTCGGACCCCAGCCAGAAC 
 
8221   GGGCTGCGTCGGCGTTTGGGCGCGCTGGACTGGCTGGCCAGGGCGGCGGGATTGCCGCCT 
       CCCGACGCAGCCGCAAACCCGCGCGACCTGACCGACCGGTCCCGCCGCCCTAACGGCGGA 
 
8281   TCGGCCTTCAAGGCCGCTCGCCACCGATAGAGCGTCCTTCGGGACACCCCAAAGGCATCG 
       AGCCGGAAGTTCCGGCGAGCGGTGGCTATCTCGCAGGAAGCCCTGTGGGGTTTCCGTAGC 
 
8341   CAGGCGGCCACCAAACCGTGTTTGTCCCAGAACTGTACAATTCTGAGTCGCTCTTGCGCA 
       GTCCGCCGGTGGTTTGGCACAAACAGGGTCTTGACATGTTAAGACTCAGCGAGAACGCGT 
 
                                                              BamHI 
8401   TCTTTCGGAGTCATCTCCCAACGATGCCCCAAGCCCGCTACCCGGTAAAACCCTCGGATC 
       AGAAAGCCTCAGTAGAGGGTTGCTACGGGGTTCGGGCGATGGGCCATTTTGGGAGCCTAG 
 
8461   CAGTTCTTAATAAGAGGTCATTGTTAATACGCAAAAAACGGGGGTTGGGATGCGTTGAAT 
       GTCAAGAATTATTCTCCAGTAACAATTATGCGTTTTTTGCCCCCAACCCTACGCAACTTA 
 
8521   AGGGTAGCCTTGGCGACGATCAGCGCAGCCACCACAGCAATAACAGCAATAGCGCGCTGC 
       TCCCATCGGAACCGCTGCTAGTCGCGTCGGTGGTGTCGTTATTGTCGTTATCGCGCGACG 
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                                           EcoRI 
8581   CGATGGTGACGGCACCGCTGATCAGGGCGACGCCGAGAATTCTGCGTGCCTGCACGTACT 
       GCTACCACTGCCGTGGCGACTAGTCCCGCTGCGGCTCTTAAGACGCACGGACGTGCATGA 
 
8641   CGCTCTGGGGTGATTGCTCTTTATCGCTCACGGTGTCGGCTCCCGCGCCTCTTCAAAGGC 
       GCGAGACCCCACTAACGAGAAATAGCGAGTGCCACAGCCGAGGGCGCGGAGAAGTTTCCG 
 
                                                  EcoRV 
8701   ACAGACCCAAATGTCACGCCCGAGTTCCCGCGTCGGTAGCCGATATCCCTCCTCCCGGTC 
       TGTCTGGGTTTACAGTGCGGGCTCAAGGGCGCAGCCATCGGCTATAGGGAGGAGGGCCAG 
 
8761   CAGACTGTTGGGAGAACGAAGGCTCAGGGCGTAAGCACCACTCCGACGGAAATCGTCCAC 
       GTCTGACAACCCTCTTGCTTCCGAGTCCCGCATTCGTGGTGAGGCTGCCTTTAGCAGGTG 
 
8821   GTATCCGGATGCTCGCCTCTGCGAACAGCGGAGCGGTAGGAACAGATCTCCGCGCAGGCG 
       CATAGGCCTACGAGCGGAGACGCTTGTCGCCTCGCCATCCTTGTCTAGAGGCGCGTCCGC 
 
8881   TGCATAAGTTCACAAACCTTTGGCACTTCTTTGGCGAGGGAGGAGTGCCATGCAGGTTCA 
       ACGTATTCAAGTGTTTGGAAACCGTGAAGAAACCGCTCCCTCCTCACGGTACGTCCAAGT 
 
                     BamHI 
8941   ACATGTCGGGTACCGGATCCAGGCGTCTTCCAACGCTTGCAAAAAATGCGTGTGGCCACC 
       TGTACAGCCCATGGCCTAGGTCCGCAGAAGGTTGCGAACGTTTTTTACGCACACCGGTGG 
 
9001   GTCCATAGTCGCTGGAGTGTGTTCAGGAGGTGAGCTGTGGCTGCGGAACGCGGTGGCGGT 
       CAGGTATCAGCGACCTCACACAAGTCCTCCACTCGACACCGACGCCTTGCGCCACCGCCA 
 
9061   GTGCGTTTGCTGCGATACAGGGCTAGCGTGTTGTGGTTGGCGCTGCTCTTGTTGGCCTTT 
       CACGCAAACGACGCTATGTCCCGATCGCACAACACCAACCGCGACGAGAACAACCGGAAA 
 
9121   TCGGCGCAGGCTCTGGGGGTAGACGAGGGGAATCTGCAGGTTGAGGTACAGCGGGTTGCC 
       AGCCGCGTCCGAGACCCCCATCTGCTCCCCTTAGACGTCCAACTCCATGTCGCCCAACGG 
 
9181   GATGGCTTCGCGGTATATGCGGTATTCCCGGTAGCGGTGACGCCAGCTCGAGCCTTTGCG 
       CTACCGAAGCGCCATATACGCCATAAGGGCCATCGCCACTGCGGTCGAGCTCGGAAACGC 
 
9241   GTGATGACGGATTACGGGCATATGGCGCAGTTCATCCCGCAGATGCACAAAAGCCAGGTG 
       CACTACTGCCTAATGCCCGTATACCGCGTCAAGTAGGGCGTCTACGTGTTTTCGGTCCAC 
 
9301   CTGTGGCGTGACGGAGCGCACGAGTCGGTACTCCAGGAAGGGTCCATCAAACTCCTGTGG 
       GACACCGCACTGCCTCGCGTGCTCAGCCATGAGGTCCTTCCCAGGTAGTTTGAGGACACC 
 
9361   TTACGTATCCCCACCTTTGTGGTGATGTCCGTGCATCGGCTGTCGGATCGAGCGGTGCGC 
       AATGCATAGGGGTGGAAACACCACTACAGGCACGTAGCCGACAGCCTAGCTCGCCACGCG 
 
9421   TTTCACAGTACCGGAGGGAGCATGGCGATCCGCGGGCAGGCCGAGGTCCGCGCGTCGGCC 
       AAAGTGTCATGGCCTCCCTCGTACCGCTAGGCGCCCGTCCGGCTCCAGGCGCGCAGCCGG 
 
9481   GACGGCAGCGTGGTGGAGTATCGCGCCACACTGGAACCCCAGACCCTGGTGCCCATGGGT 
       CTGCCGTCGCACCACCTCATAGCGCGGTGTGACCTTGGGGTCTGGGACCACGGGTACCCA 
 
                                                    StuI 
9541   CTTGCCCAGAATCTCGTGGCTCGCTACATCCGCGGGCAGATGGAGGCCTTACGCGCGGAA 
       GAACGGGTCTTAGAGCACCGAGCGATGTAGGCGCCCGTCTACCTCCGGAATGCGCGCCTT 
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9601   ATGCTGCGGTTTGGGTGACGGGCGCCTACATCCAAAAGTCTGCCGCTGTCGTAGTGTGGG 
       TACGACGCCAAACCCACTGCCCGCGGATGTAGGTTTTCAGACGGCGACAGCATCACACCC 
 
9661   TGGGCAGCATGCGATTGCCCACGTTTCCTTCCTTCCTGATC 
       ACCCGTCGTACGCTAACGGGTGCAAAGGAAGGAAGGACTAG 
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